Documente Academic
Documente Profesional
Documente Cultură
292
M E M O M E D 2 0 14
2 0 14
C 04
VASODILATATOARE PERIFERICE
293
ilfcmorator de fnrmacologic
C 04 A VASODILATATOARE PERIFERICE
Compr. film. elib. prel. 400 mg. Ct. x 20; 60;1000. Pa 6,13;
18,40;-.
C 04 AD DERIVATI PURINICI
C 04 AE
*
* *
C 04 AD
!SB! //Jo.
><
DERIVAJI PURINICI
PENTOXIFYLLINUM
C 04 AE
DIHIDROERGOTOXI NA (CODERGOCRINUM)
.//Jo. P-6L
MEMOMED
294
2 0 14
MEMOMED
4
201
295
lllc111orator de f an11ncologlc
P-6L
NICERGOLINUM
Fein. Absorb\i a orala rapida. Efect de prim pasaj hepatic
C 04 AX
VINCAMINUM
f&.
ortoslalica.
30;1500. Pa 6,76;-;
P-6L
10. Pa 9,26
NAFTIDROFLURYLUM
f&.
P-6L
M EMOMED
296
/of cmorator
M E M OM E D
2 0 14
2 0 14
C 05
C 05 A ANTIHEMOROIDALE TOPICE
GINKGO BILOBA
A se vedea N 06 DX
297
ti farmaco/ogfc
P-6L
VASOPROTECTOARE
C 05 B MEDICAJIA ANTIVARICOASA
C 05 C MEDICAJIA CAPILARELOR
*
* *
C 05 A ANTIHEMOROIDALE TOPICE
C 05 AA
* *
C 05 AA
P-RF
298
MEMOMED
M E M O M E D 2 0 14
299
2 0 14
Mcmomtor de fnrmacotngfc
fumozitor
Hldrocortizon acetat 8,9 g
Tetraciclina 0,02 g
Benzocaina 8,3 mg
Procaina HCI 5 mg
Supozit. Ct. x 6;12. Pa 6,55;-.
.lJ.nrul.fill1
Hidrocortizon 0,448 g %
Tetraclclina 1 g %
Lidocaina 0,1g %
Unguent. Tub 18 g.Pa 11,56
P-RF
C 05 AD
P-RF
Unguent
4%
Calciu dobesilat
2%
Lidocaina HCI
Polietilenglicol
Tub 30 g unguent plus canula aplicatoare. Pa 22,31
Crema
50 mg/g
20 mg/g
Crema. Tub 30 g.
Crema
58 mg/g
5 mgfg
Tub 20 g.
Ind. Hemoroizi.
Admin. lni\al un supozi.tor sau o aplica\ie de crema diminea\a r;;i
seara, ultenor un supoz1tor sau o aplica\ie de crema pe zi.
Supozi!or
120 mg
10 mg
Ct. x 10.
OTC
fumozitor
400 mg
40 mg
Ct. x 10.
M E MOMED
300
M E M O M E D 2 0 14
2 014
301
ltle111amtor de fnr111acalogfl!
VIATROMB FORTE
forschungs, Austria)
C 05 B
MEDICAJIA ANTIVARICOASA
(Cyathus
Ex quirere Pharma-
COMBINATll
OTC
* *
OTC
OTC
A se vedea B 01 AB
LIOTON GEL (A.Menarini, Italia)
Heparina sodica 100.000 u.i./100 g. Gel Tub 20 g; 50 g; 30 g
100 g.
MEMOMED
302
2 0 14
M E M O M E D 2 0 14
303
C 05 C
MEDICAJIA CAPILARELOR
C 05 CA BIOFLAVONOIDE
05
ex
tratamentul ulcerului varicos, tratamentul leziunilor posttraumatice ale articula\iilor i \esuturilor moi: luxa\ii, entorse,
contuzii, Tntinderi musculare, afec\iuni ale meniscului,
tenosinovite, contracturi , hematoame.
C 05 CA BIOFLAVONOIDE
RUTOSIDUM
ALTE PREPARATE
CALCll DOBESILAS
C 05 BX
* *
> OTC
4@
> P-6L
> OTC
Retinopatie diabetica.
MEM OMED
304
ME MOM E D
14
2 0 14
Memomtor de farmacologie
20
305
Memomtor de farmacologle
DIOSMINUM, COMBINATll
P-6L
/S"c>. @
c 05 ex
P-6L
ANTOCIANOZIDE
OTC
M E M O M E D 2 0 14
306
M E M OM ED 20
14
ftfemomtor de farmacologie
307
Memomtor de farmacolo g le
OTC
Scaderea permeabilita\ii
capilarelor.
capilare,
cre9terea
rezisten\ei
Admin. Local, de 2-3 oripe zi,in strat sub\ire, cu masaj u9or (nu
in trombonebite).
REPARIL (Madaus, Germania)
Draj.gastrorez. 20 mg. Ct
OTC
Fein. Absorb\ie digestiva cu pie. seric la 2 ore. Ciclu enterohepatic. Eliminare prin urina ??i fecale. Ac\iune venoasa maxima la
2 ore, durata 6 ore.
308
MEMOM ED
2 0 14
MEMOM ED
c 07 BETABLOCANTE
Fdin. Efecte inhibitoare asupra celor cinci proprieta\i fiziologice
fundamentale ale miocardului,cu scaderea forJei de contrac\ie, a
frecven\ei ;;i excitabilita\ii. Unele substan\e au ;;i ac\iune
simpatomimetica intrinseca (pafiial agonista) ;;i de tip chinidinic.
Ac\iune antiaritmica, antianginoasa, antihipertensiva. Scaderea
tensiunii intraoculare. Clasificare:
A.in func\ie de afinitatea pentru receptorii adrenergici.
a) Neselective :oxprenolol. pindolol, bopindolol,propranolol,
tertatolol, timolol, sotalol.
b) Selective (beta-1): metoprolol , atenolol, acebutolol.
betaxolol, nebivolol, bisoprolol,celiprolol, talinolol.
c) Belablocante cu ac\iune alfa-blocanta: carvedilol,
labetolol.
B. in func\ie de ac\Junea simpatomimetica intrinseca ;;i cea
de tip chinidinic.
a) Cu ambele ac\iuni: oxprenolol.
b) Cu ac\iune simpatomimetica intrinseca: pindolol,
celiprolol, bopindolol.
c) Cu ac\iune de tip chinidinic: metoprolol,propranolol.
d) Fara cele doua ac\iuni: atenolol, bisoprolol, timolol,
tertatolol, sotalol.
Betablocantele cardioselective, la doze mai mici decal cele
uzuale, produc mai rar bronhospasm. La doze mai mari
selectivitatea dispare. Substan\ele cu ac\iune simpatomimetica
intrinseca produc mai rar bradicardie, cre;;terea trigliceridelor ;;i
scaderea HDL colesterolului.
Ind. Hipertensiune arteriala, angina pectorala, aritmii cardiace .
Administrate precoce,in infarct miocardic, reduc dimensiunile ;;i
dezvoltarea; post inrarct,atenolol ;;i metoprolol scad mortalitatea
timpurie, propranolol ;;i timolol scad rnortalitatea tardiva.
Reducerea mortalita\ii postinfarct este diminuata de betablocante
cu ac\iune simpatornirnetica intrinseca.in insuficien\a cardiaca
bisoprolol, carvedilol sau rnetoprolol, asociate cu tratarnent
standard {diuretic, digitalic, inhibitor ACE) scad riscul de
spitalizare ;;i dirninua rnortalitatea la bolnavi cu insuficien\a slaba,
rnoderata sau severa. Hipertiroidisrn, cardiorniopatia hipertrofica,
glaucom (uz local). Anxietate {oxprenolol, propranolol, atenolol).
Sindrom de abstinen\a la alcoolici (atenolol, propranolol). Tremor
esen\ial (atenQIOI, propranolol). Migrena (propranolol. timolol,
metoprolol,nadolol,atenolol). Varice esofagiene (atenolol).
R.a. Astenie, hipotensiune, bradicardie, hipoglicemie, accelerarea tranzitului digestiv, dislipidemie, bronhospasrn, agravarea
Insur. cardiace, depresi e, irnpoten\a, sindrorn Raynaud,
insomnie, delir.
309
2 0 14
/lfl!morator de farmacufrigic
*
* *
C 07 A
C 07 B
BETABLOCANTE
BETABLOCANTE
C 07 F
BETABLOCANTEiN COMBINAJIE
CU ALTE ANTIHIPERTENSIVE
ITIAZIDE
* *
C 07 A
BETABLOCANTE
C 07 AA
BETABLOCANTE NESELECTIVE
C 07 AB
BETABLOCANTE SELECTIVE
C 07 AG
*
* *
C 07 AA
BETABLOCANTE NESELECTIVE
PROPRANOLOLUM
h>, @
P-6L
Fein. Absorb\i e digestiva rapida ;;i completa. Pie seric la 1-2 ore.
T 1/2 3 ore. Metabolitul principal, 4-hidroxipropranolol activ
farmacodi namic. Excre\ia renala (3-4% neschimbat, 15-20%
glicuronoconjugat), completa in 48 ore. Epurarea este mull
incetinita la hepatici ;;iin insuficien\a cardiaca. Cone.in lapte
MEMOMED
310
2 014
M E M O M E D 2 0 14
Jlfemomtor defnrmncologle
311
Jlfemomtor de fnrmncologfe
4@
SOTALOLUM
P-6L
---"<---:.
(i'c:,"j_l\ : j
.Ji.,:.'.f'i<i'. (1-F
:
C 07 AB BETABLOCANTE SELECTIVE
METOPROLOLUM
&@
z1
. ,.,/
4
1
-IT 1
l' ). D !)
312
M E M O M E D 2 0 14
M E M O M E D 2 0 14
z!.
313
5. Pa 22,16
Compr. 25 mg; 50 mg; 10D mg. Ct. x 2D; 30,200D; x 20; 3D;
100D x 20; 30; 1000. Pa 1,90;-;-; Pa 4,75. Pa -;7,12;-.
3,51; 6,56
20; 3D.
compr. elib. prel. (EP) 25 mg; 50 mg; 100 mg; 20D mg.
Ct. x 10; 14; 28; 30; 50; 56; 6D; 98;100. Pa
20. Pa 3,51;8,09.
MEMOMED
314
20
MEMOMED
14
2 0 14
31S
10; 20;
BETAXOLOLUM
P-6L
ATENOLOLUM
P-6L
Compr. film. 20 mg. Ct. x 14; 20; 28; 30. Pa 7,41; 10,6;
14,84; 15,89.
20. Pa
BISOPROLOLUM
P-6L
Fein. Absorb\ie orala peste 90%. T 112 10-12 ore. Exc re\ie
renala, 50% ca atare, 50% ca metaboli\i inactivi.
Compr. film 5 mg; 10 mg. Ct. x 30; 50; 1.QQ. Pa 8,55; 25,01.
Pa 18,12; 49.43
M E M OME D
316
2 014
MEMOM ED
14
20
317
lllcmorator de farmaco/oglc
Compr. 5 mg. Ct. x 7; 10; 14; 20; 2.!!: 30; 56; 60. Pa 22,93.
NEBILET (Berlin Chemie AG Menarini Group, Germania)
Compr. 5 mg. Ct. x 7; 14; 2.6_ . Pa 34,55.
Compr. film 5 mg;10 mg.Ct. >< 10; 14; 20;28; 30; 50; 56; 60:
100. Pa 8,55; 18,12.
Compr. 2,5 mg; 5 mg. Ct x 14; 28; ;N; 50; 100. Pa -; 24,87.
NEBIVOLOL ACTAVIS (Actavis, Romania)
BISOTENS 5 - 10 (Antibiotice,Romania)
Compr. 5 mg. Ct. x 7;10; 14; 20; 28; ;N; 50; 56; 90; 100;
500. Pa 23,20.
Compr. film. 2,5 mg; 5 mg; 10 mg. Ct. x 20; 30; 50; 100. Pa
14,76; 22,31; 32,72.
NEBIVOLOLUM
P-6US
Compr.5 mg.Ct. x 7; 10; 14; 20; 28; 30: 50; 56; 100. Pa
Compr.5 mg. Ct. x 7;10; 14; 20; 28; 30; 50;56; 60;90; 100;
120.Pa
Compr.5 mg. Ct. x 7, 10, 14, 20, 28, 30, 50, 56,60, 90, 100,
120 Pa 27,07.
MEM OM ED
318
Mcmorator
C 07 AB
M EM OMED
2 0 14
1/cfnrmacologlc
ACETYLSALICYLICUM+BI SOPROLOLUM
2 0 14
319
Memorntor de farmncolo g lc
P6L
Cornpr. film. 3,12 mg; 6,25 mg; 12,5 mg;25 mg.Ct. x 30; 50;
100. Pa -.
CARVEDILOL ALVOGEN 6,25 - 12,5 - 25 (Alvogen,
Luxemburg)
Compr. film. 6,25 mg; 12,5 mg; 25 mg. Ct. >< 30. Pa -
C 07 AG
CARVEDILOLUM
P6L
Compr. film. 3,12 mg; 6,25 mg; 12,5 mg; 25 mg. Ct. >< 5; 7;
10; 14; 15; 20;28;30; 40;50;56 ;60;90;98; 100; 120; 150;
200; 250; 300; 400; 500; 1000. Pa 7,32; 14,81;21,99
320
M E M O M E D 2 014
MEMOMED
/lfc11mmtor de fnr111ncologlc
NEBIVOLOL
2 0 14
321
P-6L
Compr. 6,25; 12,5 mg; 25 m,g.Cl. >< 30. Pa 6,70; 13,10; 23.
23,62
91 ALTE ANTIHIPERTENSIVE
P-6L
9,06.
C 07 B
BETABLOCANTE I TIAZIDE
P-6L
C 07 FD
BISOPROLOL
91 ALTE ANTIHIPERTENSIVE
Britanie)
P-6L
MEMOMED
M E M O M E D 2 0 14
322
C 07 N
c 08
2 0 14
323
P6L
*
I
I
\
* *
M EM O M E D
14
M E M O M E D 2 0 14
324
M cmorntor de farmacologle
20
325
C 08 CA
DIHIDROPIRIDINE
AMLODI PINUM
Compr. 5 mg; 10 mg. Ct. x 14; 20; 30; 50; 100. PaP-6L
Compr. 5 mg, 10 mg. Ct. " 14; 20; 28; 30; 50; 100. Pa
9,00; 10,96.
AMLOD IPINA CIPLA (Cipla UK Limited, Marea Britanie )
Compr. 5 mg, 10 mg. Ct. x 30. Pa -
Compr. 5 mg; 10 mg. Ct. x 28; 30; 56; 60; 84; 90; 98; 100.
Pa -
Compr. 5 mg, 10 mg. Ct. x 10; 14; 28; 30; 50; 56; 60; 100;
180; 500. Pa -
MEMOMED
326
M E M OM E D
14
2 0 14
20
327
Compr. 5 mg; 10 mg. Ct. x 10; 14; 20; 28;30; 50; 98; 100;
200;300; 500. Pa 7,63; 14,05.
; 90.
Pa 11,40; 19,26.
FELODIPINUM
P-6L
11,53
14,05
Compr. 5 mg; 10 mg. Ct. x 4; 10; 14; 20; 28; ; 50; 60; 98;
100; 300; 500. Pa 19,94; 29,68.
caps. 5 mg; 10 mg. Ct. x 14; 28; 30; 56; 90; 98; 100.
Pa -
30 Pa 15,69;
M EM O M E D
328
----
2 0 14
MEMOMED
14
Mcmom/01 defnrmacologlc
20
329
NIMODIPINUM
P-6L
28. Pa 21,59
MEMOMED
330
2 0 14
P-6L
LACIDIPINUM
Fdin.Ac\iuni asemanatoa re nifedipinei.
><
M& I&
LERCANIDIPINUM
331
Compr. film. 10 mg; 20 mg. Ct >< 14; 15; 28; M!; 50; 56; 60;
90; 98; 100. Pa 21.09; 26,92. Pa 32.91;43,54
M E M O M E D 2 0 14
Fein. Absorbti e completa din tubul digestiv. Pie seric la 1,5-3 ore.
Biotransformare intensa la primul pasaj hepatic. T1/2 8-10 ore.
Fdin. Blocheaza selectiv canalele de calciu voltaj-dependente de
tip 1. Scade tensiunea arteriala prin relaxarea muchilor netezi
vasculari. Nu are efect inotrop negativ.
C 08 D
C OB DA DERIVAJI DE FENILALCHILAMINA
C 08 DB DERIVAJI DE BENZOTIAZEPINA
* *
C OB DA DERIVAJI DE FENILALCHILAMINA
VERAPAMILUM
ISBI I&
P-6L
332
M E M OM E D
2 0 14
M EM O MED
2 014
333
lllemom/01de fnrmflcologic
/llc111omtor de fnn11ncolugic
!(iOC
C 08 DB
; 100. Pa 22,60
DERIVAJIDE BENZOTIAZEPINE
OILTIAZEMUM
P-6L
Caps. elib. prel. 200 mg; 300 mg. Ct. " 7; 28. Pa -
334
M E M O M E D 2 0 14
Mcmorator th!fnn11ncologie
M E M O M E D 2 0 14
ilfemomtor de fn rmncologlc
335
C 09
C 09 A
C 09 B
C 09 C ANTAGON l TI Al ANGIOTENSINEI II
C 09 D
C 09
*
* *
C 09 A
336
MEMOMED
2 0 14
M E M O M E D 2 0 14
337
CAPTOPRILUM
Fein. Absorb\ie orala buna, pie plasmatic dupa o ora. Eliminare
urinara 95%
in 24 ore.
Fdin. Laten\a 60-90 minute.
30. Pa 4,64
M EM O M ED
338
2 014
M E M O M E D 2 0 14
339
ilfcmorntor de fnn11acologfc
@@
P-6L
Compr. 2,5 mg; 5 mg; 10 mg; 20 mg. Ct. >< 20. Pa -; 3,67;
4,39; 7,94;
Sol.injJperf. 1,25mg/ml. Fiole 1ml. Ct. >< 5. Pa 15,45
Compr. 5 mg; 10 mg; 20 mg. Ct. >< 20; 30; 1000. Pa 3,64;
4 ,39; 8,75
@@
P-6L
340
M E M O M E D 2 0 14
M E M O M E D 2 0 14
/llcmomtor de fnrmnco/ogle
Admln. Oral. HTA. lni\ial 2,5 mg/zl.intre\iere 0-40 mg/ziintrpriza. lnsuf. cardiaca. lni\ial 2,5 mg/zi. lntre\rnere 5-20 mg/zr
intr-o priza. Dupa infarct miocardic, cnd presi ea slst._ este
120 mmHg. lni\ial 5 mg/zi, 2 zile, aper 10 !119/Z mtr-o rr:a. La
pres. sis!. 100-120 mrnHg, ini\ial 2,5 mg. lntre\rnere, pana la 5
mg/zi, ntr-o priza.. Nefropatie diabetica. lni\ial 2,5 mg/zi.
intre\inere 10-20 mg/ziintr-o priza.
341
Compr.2,5 mg, 5 mg,10 mg,20 mg.Ct. x 14; 20; 30; 50; 56;
98; 100. Pa 7,37; 12,87; 23,37
><
compr.2 mg, 4 mg, 8 mg. Cl. x 30; 60; 90; Ct. x 30; 60;
90; Ct. x 7; 14; 28; 30; 50; 60; 90; 100. Pa 134426 87
49,45
. ' '
PRESTARIUM (Servier,Fran\a)
compr.4 mg; 8 mg.Ct. x 30; 500; 1000; x 30. Pa Compr.film. .5 mg; 5 mg;10 mg. Ct. x 30 Pa -;41,11; 63,61
Compr. orod1spersabile 2,5 mg;5 mg; 10 mg. Ct. x 5; 10; 14;
20; 30; 50; 60; 90; 100; 120; 500. Pa -
P-6L
-----
M E M O M E D 2 0 14
342
M E M O ME D 2014
343
Memom/ol' de fnl'mncologie
Compr. 2 mg; 4 mg; 8 mg. Ct. x 10: 30; 60; 90. Pa -; 23,14;
Compr. 2,5 mg; 5 mg; 10 mg. Ct. x 28. Pa 4,62; 6,69; 9,21
44,36
PIRAMIL (Sandoz, Romania)
PRINDEX (Glenmark Pharmaceutical s S.R.O, Cehia)
Compr. 4 mg; 8 mg. Ct. x 14: 20; 28; 30; 56: 60 Pa 26,9;
Compr. 2,5 mg; 5 mg; 10 mg. Ct. x 10; 20; Zft; 30; 100. Pa
54,01
RAMIGAMMA 5 mg - 10 mg (Worwag Pharma. Germania)
PERINEVA (KRKA Polska SP. Z.0.0. - Polonia)
Compr. 2 mg: 4 mg; 8 mg. Ct x 10; 14;28; 30; 50; 56; 60; 90;
100. Pa STOPPRESS (Pharmaceutical Works Polpharma SA,
Polonia)
Caps. 1,25 mg; 2,5 mg; 5 mg; 10 mg. Ct. >< 7; 14; 21 ; 28; 30;
50; 90; 100. Pa -
Compr. 5 mg; 10 mg. Ct. x 7; 10; 14; 20; 28; 30; 42; 50; 56;
60; 98; 100; 500; 1000; x 20; 28; 30; 50; 56; 60; 98; 100;
500; 1000. Pa 7,10; 9,49.
@ /lip,
P-6L
Compr. 2,5 mg; 5 mg; 10 mg. Ct. x 30. Pa RAMIPRIL LPH (Labormed Pharma S.A. - Romania)
Caps. 2,5 mg; 5 mg; 10 mg. Ct. x 10; 14; 20 ; 28; 30; 56; 60;
100. Pa @RAMIPRIL (Teva, Romania)
Compr. 5 mg; 10 mg. Ct x 50
10,75; 24,04.
. Pa 9,92:
MEMOMED
344
M E M O M E D 2 0 14
20 14
345
Mcmomtor de fan11acologlc
@@
BENAZEPRILUM
P-6L
Compr. 2,5 mg: 5 mg; 10 mg. Ct. x 7; 10; 14; 15; 18; 20; 28;
30; 45; 50; 6 90; 9 99; 10 300; 500; x 10; 14; 15; 18;
20; 21; 28; 30; 45; 50; 56; 90; 98; 99; 100; 300; 500; x 7; 10;
14; 15; 18;20;28;30;45;50;56; 90;98; 99; 100;300;500.
@@
QUINAPRILUM
P-6L
><
@@
FOSINOPRILUM
P-6L
ZI.
16,75
Compr. 5mg; 10 mg;20 mg. Ct. x 10; 14; 20: 28; 30; 42; 50;
98; 100; 250; 500. Pa -
30. Pa -
@@
P-6L
Compr. 10 mg; 20 mg. Ct. x 10; 14; 20; 21; 28; 30; 42; 50;
56; 60; 98; 100; 400; 500. Pa 13,54; 18,58.
Admin.
M E M O M E D 2 0 14
346
M E M O M E D 2 0 14
* *
347
@ (j;J
P-6L
ENALAPRIL
IDIURETICE
P-6L
><
30.
P-6L
M E M OMED
348
M E M O M E D 2 0 14
2 0 14
349
Mc111omtor de fnr111nco/ogic
PERINDOPRIL IDIURETICE
P-6L
P
6L
30. Pa -
350
M EMOM ED
MEMOMED
4
2 0 14
Mcmorator de fannacologie
201
351
/lfcmorator de fnn11acologi e
FOSINORPIL $1 DIURETICE
MONOTENS HGT (Pharmaswiss, Rep. Ceha)
Fosinopril 20 mg. Hidrocloroliazida 12,5 mg. Compr. Ct. "
10, 20, 28, 30, 50, 98, 100. Pa 20,52
P-6L
Ct x 7, 14, 28, 30, 35, 42, 50, 56, 90, 98, 100. Pa -; 65,25
LERCARIL (Recordati, lrlanda)
P-6L
ZOFENOPRI L $1 DIURETICE
P-6L
P-6L
M EMOM E D
352
2 0 14
.- P-6L
M EM OMED
2 014
353
Admln. 1 compr/zi.
aldosteronism primar.
.. P-6L
.. P-6L
EGIRAMLON {Egis,Ungaria)
Ramipril 2,5/5/5/10/10 mg;Amlodipin 2,5/5/10/5/10 mg.
Caps. Ct. x 28, . 56, 60, 90. Pa -; 28,66; 31,77; 40,99;
47,42
C 09 C
ANTAGONl TI Al ANGIOTENSINEI II
Fdin. Sartani. Antagoni ti specifici ai receptorilor AT1 ai angiotensinei II. Efecte hemodinamice asemanatoare cu inhibitorii
LOSARTANUM
..
P-
6L
Fein. Absorb\ie orala buna, neinnuen\ata de prezen\a alimentelor, biodisponibilitate sistemica 33% datorita biotransformarii la
primul pasaj hepatic (cit. P450), 14%intr-un metabolit mai activ.
Peak plasmatic la 1 ora i respectiv la 3 ore pentru metabolitul
activ, ale carui nivele plasmatice sunt superioare celor ale
drogului parental. Eliminare renala i biliara, ambii compu!ii
nedializabili.
Fdin. Metabolitul activ long-lasting cu o afinitate de 10 ori mai
mare decal drogul parental. Daza de 50 mg Losartan este
echiactivain 24 de ore cu cea de 20 mg Enalapril, 50-100 mg zi
Losartan au aceea i ef icacitate ca i 50-100 mg Ateno lol.
Favorizeaza eliminarea acidului uric; asocierea cu Hidroclorotiazida bine tolerata.
Ind. Reducerea riscului morbidila\ii cardiovasculare la pacien\ii
hipertensivi cu hipertrofie ventriculara stanga.
354
M EMOMED
2 0 14
Mcmomtor de fnrmncologie
M E M O M E D 2 0 14
355
VALSARTANUM
P-6L
Fein. Absorb\i e orala rapida, biodisponibilitate absoluta 23%,
legare plasmatica 97%. Eliminare digestiva 70% i renala 30%,
predominantin forma nemodificata.
Compr. film. 80 mg, 160 mg. Ct. x 2., 30, 84, 90. Pa 14,95;
22,79
Compr. film.40 mg; 80 mg; 160 mg. Ct. x 7, 14, 2., 30, 56,
90, 98; 280 Pa 71,91; 91,88; 116,60
Sol. orala 3 mg/ml. Flacon 160 ml. Ct. x 1.Pa 41,42.
Compr. film. 40 mg; 80 mg; 160 mg. Ct. x 7, 10, 14, 28, 30,
50, 56, 60, 84, 90, 98, 120, 180. Pa -;28,84;32,85
compr. film. 320 mg. Ct. x 7, 10, 14, 20, 28, 30, 56, 60,
84, 90, 98. Pa -
r
356
M EMOM ED
M E MOME D
4
20
14
201
357
Memomto1 de farmacolog fe
Caps. 80 mg; 160 mg. Ct. x 1, 14, 15, 28, 30, 56, 84, 90,98,
100; 2BO Pa 20,26, 32,59.
Compr. film 40 mg; 80 mg; 160 mg. Ct. x 14, 28, 56, 98, 280.
Pa-
.2.ft,
Compr. film 40 mg; 80 mg;160 mg. Ct >< 7, 10, 14, 20, 28, 30,
50, 56, 60,90, 98, 100. Pa WENZELL (Romastru, Romania)
56, 98. Pa
Compr. film 40 mg; 80 mg;160 mg. Ct >< 14, 28, 30, 56, 90.
Pa -;-; Pa 47,37; 50,79; Pa 66 ,00; 70,74
EPROSARTAN
Caps. 40 mg; BO mg; 160 mg.Ct. x 7, 10, 14, 28, 30, 56, 60,
84, 90, 98, 100. Pa -
Caps. 40 mg; Ct. x 1, 7, 14, 15, 28, 30, 56, 84, 90, 98, 100,
280. Pa -
Admin. 600 mg/zi, n doua prize, diminea\a !?i seara, n timpul sau
M EMOM E D
358
M E M O M E D 2 0 14
2 0 14
359
Afcmorator de fan11aco/ogi e
Memorator de farmacologie
Compr. film. 300'rng; 400 mg; 600 mg. Ct x 14, 28, 30, 56,
98, 100, 168, 500. Pa -
Compr. film. 75 mg; 150 mg; Ct. x 10, 14, 28, 30, 50, 56, 60,
90, 98, 100; x 10, 14, 28, 30,50, 56, 60, 90, 98, 100, 126,
154. Pa
P6L
Fein. Biodisponibilitate orala 60-80%, neinfluen\ata de prezen\a
Compr. film 75 mg; 150 mg; 300 mg. Ct. x 28,30, 50, 56, 60,
98, 100. Pa -
Compr. film 75 mg; 150 mg; 300 mg. Ct. x 14; 2; 30; 56; 84;
90; 98. Pa -; 33.14; 43,20.
Compr. 75mg; 150 mg; 300 mg. Ct. x 14; 28; 56; 98.
Pa
ATOKKEN {Romastru,Romania)
Compr. film 75 mg; 150 mg; 300 mg. Ct. x 14, 28, 30, 56, 84,
90, 98. Pa -18, 10; 29,43.
Compr. film 75 mg; 150 mg; 300 mg. Ct. x 28. Pa 40,39;
44,88; 60,29
Compr. 75 mg; 150 mg; 300 mg. Ct. x 10, 14, 28, 30, 56, 57,
58, 60, 84, 90, 98, 100, 500, 1000. Pa -.
MEM OME D
360
20
M EM O M E D 20 14
14
361
@@
TELMISARTANUM
Compr. 75 mg; 150 mg; 300 mg. Ct. " 14, 2B, 56, 9B.
Pa -.
@JRBESARTA N,MJKLICH (Miklich, Spania)
Compr. film 75 mg; 150 mg; 300 mg. Ct. x 14, 28, 30, 56, 84,
90, 9B. Pa -.
IRBESARTAN TERAPIA (Terapia, Romania)
Compr. film.75 mg; 150 mg; 300 mg.Ct. x 1,14 , 2,!!, 30, 56,
60, B4, 90, 9B. Pa -; 29,B2; 3B,B7.
P-6L
Compr.40 mg; 80 mg. Ct. x 14, 2,!!; 30;56; 90; 98; 360. Pa -.
IRBESARTAN TEVA (Teva, Olanda)
Compr.film .75 mg; 150 mg; 300 mg.Ct.
Compr. film. 20 mg; 40 mg; 80 mg. Ct x 14, 15, 28, 30, 56,
60, 90, 98. Pa -; 42,27;56,7B.
Compr. film. 75 mg; 150 mg; 300 mg. Ct x 14; 28; 30; 56; 84;
Compr. 20 mg; 40 mg; BO mg. Ct x 14, 15, 2.. 30, 56, 60, 90,
98. Pa -; 39,46; 52,99.
90;98. Pa-.
M E M O M E D 2 0 14
Mcmorator de farma cologie
M E M O M E D 2 0 14
Memomtor de Jarma cologle
362
363
Compr. film. 40 mg; 80 mg. Ct " 28, 30, 56, 60, 84, 90; 98.
Pa 42 ,27; 56,77.
(Dr .
Reddy 's
@@
> P-6L
Romania)
Fein. Dupa administrare orala este transformatin produs activ candesartan . Biodisponibllitate 40%. Pie plasmatic la 3-4 ore.
Eliminat neschlmbat prin urina i bila. T1/2 9 ore.
TELMISARTAN
LABORMED
(Labormed
Pharma,
Pa -; 39,46; 52,99.
TELMISARTAN RENANTOS (Renantos, Germania)
Compr.20 mg.Ct " 14, 28, 30, 56, 60,84, 90, 98, 100. Pa -.
CANDEGAMMA
Germania)
Compr.2 mg; 4 mg;8 mg; 16 mg; 32 mg. Ct. x 7, 10, 14, 2J:!,
30, 56, 98, 100, 300. Pa -;-; 33,77; 39,63; 72,06.
Romania)
Compr.4mg; 8 mg; 16 mg. Ct. x 7, 10, 14,15, 28, 30, 50, 56,
60, 84, 90, 98, 100. Pa - .
MEMOMED
364
2 0 14
M E M O M E D 2 0 14
365
OLMESARTANUM MEDOXOMILUM
Compr.8 mg; 16 mg. Ct. x 7, 14, 20, 2., 30, 50, 56, 60, 84,
90, 91, 98, 100, 250, 300, 500. Pa 33,45; 39,65.
Compr. 2 mg;4 mg; 8 mg; 16 mg; 32 mg. Ct. x 10, 14, 28,
30, 50, 56, 60, 98, 100. Pa -;-; 39,07; 48,03; 81,75.
CANDESARTAN LABORMED
Romania)
(Labormed Pharma,
CANDESARTAN CILEXETIL
Pharmaceuti cals S.R.L.. Romania)
TEVA
(Teva
Compr. 8 mg; 16 mg; 32 mg. Ct. x 7, 14, 15, 20, 28, 30, 50,
56, 60, 84, 90, 98, 100, 250, 300. Pa 23,07; 29,85; 36,65.
P-6L
41,42; 56,66.
@ (ilj
Compr. 10 mg; 20 mg;40 mg. Ct. x 14; jill; 56; 98. Pa 64,49;
83,74; 89,37.
AZILSARTANUM
P-6L
Compr. 8 mg; 16 mg. Ct. x 7, 14, 15, 20, 28, 30, 50, 56, 90,
98, 100. Pa 36,46; 44,87.
Compr.20 mg; 40 mg;80 mg. Ct x 14, 2., 30, 56, 90, 98. Pa
366
C 09 0
M E M O M E D 2 0 14
M E M O M E D 2 0 14
ANTAGO Nl TI Al ANGIOTENSINEI II ,
COMBINAJll
P-6L
367
IDIURETICE
P-6L
TECNIMEDE
368
M E M O M E D 2 0 14
M E M O M E D 2 0 14
Mc111omto1 de farmacologic
Mcmomlor de fannacologic
369
VANATEX
Polonia)
IRBESARTAN
> P-6L
IDIURETICE
14;
IRBESARTAN HIDROCLOROTIAZI DA
(Ranbaxy, Marea Britanie)
RANBAXY
za.
!iii DIURETICE
> P-6L
370
MEMOMED
20
M E M O M E D 2 0 14
14
371
Compr. Ct.
73,02.
CANDESARTAN
33,54; 32,72.
HIPOSTYN 8 mg/ 12,5 mg - 16 mg/ 12,5 mg (Teva,
Romania)
Cadesartan 8/16 mg. Hidrocloroliozida 12,5 mg
Compr.Ct. x 7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 84, 90, 98,
100. Pa -.
KARBICOMBI (Krka, Slovenia)
IDIURETICE
P-6L
48,92.
OLMESARTAN
I DIURETICE
P-6L
M E MOME D
372
M E M O M E D 2 0 14
2 0 14
C 09 DB
373
/lfemomtor de fan11aco/ogie
Memomtor de /armacologle
P-6L
P-6L
C 09 DX
P-6L
P-6L
M E M O M E D 2 0 14
ilfcmomtor de farmacologlc
M E M O M E D 2 0 14
Mcmomtor de Jarmacologlc
374
c 09 x
C 09 XA INHIBITORI Al RENINEI
C 10
HIPOLIPEMIANTE
P
6L
ALISKIRENUM
C 10 A
C 10 B
peptidic
*
* *
C 10 AB
FIBRAJI
Aliskiren 150 mg; 300 mg. Compr. film. Ct. x 7; 14; 28; 30;
50; 56; 84; 90; 98. Pa COMBINAJll
C 10 A
375
P-6L
C 10 AX ALTE HIPOCOLESTEROLEMIANTE
HIPOTRIGLICERIDEMIANTE
*
* *
C 10 AA INHIBITDRI Al HMG CoA REOUCTAZEI
Fdin. Statine. lnhibitori ai 3-hidroxi-3-meti l-glutaril coenzima A
reductaza (HMG-CoA-reductaza), enzima care intervine in
376
M E MOMED
M E M O M E D 2 014
2 014
377
Jlle111omtor tiejnrmnco/ogle
sinteza colesteroluluiin ficat. Scad LDL-colesterolul (cu 2560%), marind numarul receptorilor hepatici la LDL. lnfluen\eaza
mai pu\in HDL-colesteroloul i,;i trigliceridele. Stabilizeaza placile
de ateroscleroza sau exercita un efect direct asupra peretelui
vascular.
@@
P-6L
378
M E MOME D
2 014
ME MOMED
2 014
379
Mcmorntor defnrmncofogle
Compr. film. 10 mg; 20 mg; 40 mg. Ct. x 10; 14; 20; 28; 30;
50; 56; 60; 84; 90; 98; 100. Pa 9,21; 17,46; 31,51.
Compr. film. 10 mg; 20 mg; 40 mg. Ct. >< 30.Pa 9,35; 17,69;
31,99.
Compr. film. 10 mg; 20 mg;40 mg. Ct. x 10; 11.; 20; 28; 30;
50; 56; 84; 98; 100. Pa -; 3,16; 5,56. Pa -;13,61; 14,58. Pa
15,01; 30,03; 18,54.
LOVASTATlNUM
Compr. film. 10 mg; 20 mg; 40 mg. Ct. " 14; 28. Pa 8,72;
16,55;29,88.
P-6L
Compr.20 mg. Ct. x 10; 20; 28; 30; 50; 60;84;98; 100;112.
Pa 25,87.
Compr.film. 10 mg; 20 mg; 40 mg. Ct. " 10; 14; 20; 28; 30;
50; 56; 60;98; 100. Pa -.
380
M E M O M E D 2 0 14
M EM OM ED
Mcmomtor
Mcmora/ 01 de fa rmacologic
tit!
Jarmacologic
PRAVASTATINUM
@@
P-6L
2 0 14
381
Compr. film 10 mg; 20 mg; 40 mg;80 mg. Ct. x 7;10; 14; 15;
28; 30;50; 56; 60; 84;90; 98; 100; 200. Pa -;-;-;-;19,83;-;-;-;
-;-;-;-;-;-. Pa -;-;-;-;31,37;-;-;-;-;-;-;-;-;-. Pa -;-;-;-;58,84;-;-;-;-;
-;-;-;-;-. Pa -;-;-;-;94,46;-;-;...;-;-;...;-;-;-.
@@
FLUVASTATINUM
P-6L
Compr. film. 10 mg; 20 mg; 40 mg; 80 mg. Ct. x 10; 14; 20;
28; 30; 50; 56; 60; 84; 90; 98; 100. Pa 10,57; 15,82; 32,10;
50,04.
Compr. film. 10 mg; 20 mg; 40 mg. Ct. x 4; 7; 10; 14; 20; 28;
30; 50; 56; 60; 84;9; 98; 100. Pa
ATORVASTATI NUM
@
P-6L
382
M E M O M E D 2 0 14
M E M O M E D 2 0 14
Memorator de fnrmacologie
383
Compr. film. 10 mg; 20 mg; 40 mg. Ct. x 10; 14; 28; 30; 50;
56; 84;90; 98; 100; 112. Pa
Compr. film 10 mg. 20 mg; 40 mg. Ct. x 4; 7; 10; 14; 20; 28;
30; 50;56; 84; 98; 100; 200; 500 Pa 21,14; 31,51;63,06.
Compr. film 10 mg;20 mg; 40 mg. Ct. x 4; 7; 10; 14; 20; 28;
30; 50; 56; 84; 98; 100; 200; 500. Pa 19,43; 29,45; 53,61.
XAMARA (Dr. Raddy's, Romania)
@@
P-6L
MEM OM ED
364
M E M O M E D 2 0 14
2 0 14
385
Mcmomtor de fnrmncologl c
M cmomtor de fn,-mncologlc
7; 10; 26;
;m. Pa
75,14.
@ ROSUVASTATI NA TEVA (Teva Pharmaceutic als,
Romania)
Compr. film . 5 mg; 10 mg; 20 mg; 40 mg. Ct. x 14; 15; 20;
28; ;m; 56; 60; 90; 98; 100. Pa 50,53; 53,55; 92,42; 109,71.
C 10 AB
FIBRAJI
M E M O M E D 2 0 14
Mcmomtor de fnrma cologlc
M E M O M E D 2 014
M cmomtor de fn rmncologlc
386
ISBJ $
387
P-
6L
Fdin. Scade trigliceridele (31%), cre$1e HDL (9%), nu influen\eaza LDL colesterol. Reduce progresia aterosclerozei coronare
!?i a manifestarilor clinice.
Compr.film 160 mg. Ct. x 1; 10; 14; 15; 28;30; 50; 56; 60;
84;90; 100. Pa 26,89.
FENOFIBRATUM
P-6L
P-6L
Admin. Oral, ini\ial 100 mg de 3 orifzi, la mese. Daca colesterolemia este peste 4 g/I. ini\ial 400 mg/zi. Se men\ine aces!
dozaj pana la normalizarea colesterolemiei, apoi se scade la
200 mg/ziintr-o priza. Copii cu varsta peste 10 ani $i greutatea
peste 20 kg
Fein. Absorb\i e digestiva, pie plasmatic la 2 ore, legare in propof'\ii mari de proteinele plasmatice. Semivia\a plasmatica 17 ore.
Adm in. Oral 100 mg/zi,intr-o singura priza. Se va asocia cu
modificarea regimuiui alimentar.
LIPANOR (Sanofi-Avenlis, Fran\a) APP intrerupt
Capsule 100 mg. Ct. x 30.
MEMOMED
388
MEMOMED
2 0 14
2 014
389
Jlfe111orotor de farmacologie
P6L
P-RF
familiala.
C10 AX
C 10 AD
ACIDUM NICOTINICUM
ALTE HIPOCOLESTEROLEMIANTE I
HIPOTRIGLICERIDEMIANTE
P6L
M E M O M E D 2 0 14
390
M E MOM E D
201
391
Memomtor de farmaco/oglc
4
Memomtor de farmacolog/c
P s a 1c1une,
C!nd. As? erea cu slatine la bolnavi cu insuf
. H1persens1b1htate. Sarcina. alaptare. Hepatita evoluliaepat1ca .
A
fadamaIn
l' . 10t mgo.fzi,inlr-o pr.izain
orice moment aI z11e1., cu sau r
imen e. oza nu se a1usteaza la varstnlci - f h
uoara (scor Child-Pugh 5-6), insuf. renala. ,m msu . epat1ca
EZETROL (Merck Sharp & Dohme, Romania)
Compr. 10 mg. Ct.
C 10 B
C 10 BA
P-RF
Caps. moi 1000 mg. Ct. x 20; 24; 28; 30; 50; 56; 90; 100.
Pa-.
OMLIPEX (Sandoz, Romania)
Caps. moi 1000 mg. Ct. x 20; 24; 28; 30; 50; 56; 90; 100.
Pa -.
!SBJ /iSo
C 10 BX
ATORVASTATI N + AMLODIPI NA
g. ompr.f1lm.
Ct " 10' 14' 20' 28 30 SO 56 60, 9O; 100. Pa 55,75
392
MEMOMED
2 0 14
ilfe111orator de far111acofogit!
PREPARATE DERMATOLOGIC E
D 01
ANTIFUNGICE DE UZ
DERMATOLOGIC
D 03
PREPARATE PENTRU
TRATAMENTUL RANILOR'
ULCERELOR
D 04
D 05
ANTIPSORIAZICE
D 06
ANTIBIOTICE,. CHIMIOTERAPICE
DE UZ DERMATOLOGIC
D 07
CORTICOSTEROIZI , PREPARATE
DERMATOLOGICE
D 08
D 10
PREPARATE ANTIACNEICE
D 11
ALTE PREPARATE
DE UZ DERMATOLOGIC
ISLANDA)
Amlodipina 5 mg/10 mg; Atorvastatin 10 mg. Compr.film .
Ct >< 7;10; 14; 20;28; 30;50; 56; 60; 90; 98; 100.Pa 48,46;
55,17.
'
CADUET (Pfizer Europe, Marea Britanie)
Amlodipina 5 mg/10 mg; Atorvastatin 10 mg. Compr.film.
Ct >< 30. Pa 71,34;81,46.
Ind. Con\ine amlodipina 5 mg ;;i atorvastatina 10 mg fiind indicat
pentru prevenirea evenimentelor cardiovasculare la pacien\ii
hipertensivi, care prezinta 3 factori de rise cardiovascular
asocia(i.
Admin. lni(ierea tratamentului cu un comprimat filmat (5 mg/
10 mg), o data pe zi. Se poate cre;;te la un cornprirnat de 10 mg/
10 mg, o data pe zi.
DUPLECOR (Gedeon Richter Romania,Romania)
Atorvastatin 1O mg/20mg; Amlodipina 5 mg/10 mg.
Compr.film. Ct >< 30. Pa 48,82; 55,75; 64,10; 71,26.
Ind. Hipertensiune arteriale (asociata sau nu cu boala
coronariana cronica stabila), la pacienji adul(i care sufera ;;i de
una dintre urmatoarele afec11uni: hipercolesterolernie primara
(inclusiv hipercolesterolemie familiala (varianta heterozigota) sau
hiperlipidemie combinata (mixta) (corespunzand tipulul Ila !?i lib
din clasificarea Frederickson) ; hipercolesterolemie familiala
homozigota.
Admin . lni(ierea tratamentului cu un comprimat filmat (10 mg/5
mg),o data pe zi. Se poate cre;;te la un treptat dozele astfel 10
mg/1O mg; 20 mg/5 mg;20 mg/10 mg.
* *
ALEGEREA PREPARATELOR DERMATOLOGICE
Solu( ernulsii, suspensii se aplica pe piele (inclusiv pe scalp) si
ungh11. Cremee sut emulsii de uleiin apa, bine absorbile i
p1ele Se _aphca pe.pelea uea. Gelurile conjin baze hidrofile i
mu!t apa. Se aphca pe_fa!a ' scalp. Lo(iunile ;;i spray-urile se
aphca pe suprafe(e man ;;1 pe pielea cu par. Unguentele sunt
preparate grase, mai ocluzive decal cremele, se aplica pe pielea
M EM OMED
394
MEMOMED
2 0 14
'
* *
D 01 ANTIFUNGICE DE UZ DERMATOLOGIC
D 01 A
D 01 B
395
01
AC
CLOTRIMAZOLUM
OTC
Fdin. Spectrul de ac!iune cuprinde Epidermophyton , Microsporurn, Tricophyton, Coccidioides imitis, Histoplasma capsulatum, Aspergi llus , Candida. Mai pu\in sensibili sunt
Cryptococcus, Malassezia furfur, Sporotrix.
Ind.Afec\iuni cutanate i vaginale cu agen!ii men\iona\i laFdin.
Admin. Solu!ia 1% i crema 1% se aplica pe zonele afectate, de
2-3 ori pe zi, eel pu\in 2 saptamani dupa vindecarea clinica.
Comprimatele vaginale se administreaza de 1-2 ori pe zi,limp de
6-12 zile. Vindeca rea se ob\ ine in derma tornicoze: 3-4
saptamani, infec\ii cu eritrasma: 2-4 saptamani . pitiriazis
versicolor: 1-3 saptamani ,in vulvita i balanita candidozica: 1-2
saptamani.
*
* *
D 01 A
2 0 14
Ilfemomt or tiefan11acologi e
/lfcmorator de fnrmacologic
D 01 AA ANTIBIOTICE
D 01 AE
* *
D 01 AA ANTIBIOTICE
NATAMYCINUM
monas vaginalis.
MEMOMED
396
2 0 14
MEM OMED
397
014
Memomtmde fnrmncoi ogic
&IAJ
KETOCONAZOLUM
MICONAZOLUM
> P-RF
> P-RF
ISOCONAZOLUM
> P-RF
Fd/n. Fungicid pentru Tricophyton, Epidermophyton, Microsporum, Candida, Pityrosporum, Aspergillus, Nocardia ;;i bactericid pentru streptococ ;;i stafilococ .
Ind. lnfec\ii fungice superficiale ale pielii, la maini._ sa\ii
lnterdigitale, regiunea inghinala ;;i genitala. Eritrasma. P1t1naz1s
versicolor.
Admln. Aplicare orala, diminea\a ;;i seara, dupa bai ;;i spalare.
Durala medie a tratamentului este de 2-4 sapt. Pentru evitarea
recidivelor tratamentul se continua eel pu\in 2 saptamani dupa
vindecarea clinica.
> OTC
398
M E M OM E D
2 0 14
MEMOM E D
2 0 14
CICLOPIROXUM
FENTICONAZOLUM
399
Fdin. A.cliv mai ale fat de Candida, Epidermophyton ,Microspo'!1 ncophyton I rata de Malassezia furfur , germeni grampozi111 !?I gramnegallvr de suprainfec\ie, micoplasme chlamidii
tncomon as.
'
> P-RF
> OTC
MEM O M ED
400
MEM OMED
2 0 14
401
2 0 14
D 01 B
D 01 BA
/&.
TERBINAFINUM
P-RF
Romani
a)
OTC
28. Pa 18,21.
402
M EMOM ED
M EM OM ED
2 0 14
2 0 14
403
Jllemorator de fnn11acologlc
Jllcmorator de fan11acologie
D 03
PREPARATE PENTRU
TRATAMENTUL RANILOR $1
ULCERELOR
* *
D 03 A
CICATRIZANTE
D 03 AX ALTE CICATRIZANTE
DEXPANTHENOLUM
/&,. .. OTC
>- P-RF
404
M E M O M E D 2 0 14
/Item orator de fan11acolog le
M E M O M E D 2 0 14
405
ilfemomtor de fan11acologl11
COMBINATll PLANTE
P-6L
OTC
OTC
406
M E M OM E D
2 0 14
M emorntor de fnrmacologie
ANTIPRURIGINOASE, INCL.
ANTIHISTAMINICE,
ANESTEZICE DE UZ LOCAL
0 04
D 04 AA
M E M O M E D 2 0 14
Memomtor dv fan11nc ologie
D 05
ANTIPSORIAZICE
D 05 A
ANTIPSORIAZICE DE UZ LOCAL
D 05 B
ANTIPSORIAZICE DE UZ SISTEMIC
D 04 AA
* *
* *
0 05 A
DIMETINDENUM
407
OTC
D 05 AX AL E ANTIPSORIAZICE DE UZ LOCAL
COMBINAJll
P-RF
DIFENHIDRAMINUM
OTC
XAMIOL 50 (Leo Pharmaceutical, Danemarca)
0 05 B
ANTIPSORIAZICE DE UZ SISTEMIC
408
409
M E M O M E D 2 0 14
M EM O MED
/lfcmorntor de farmacolog fc
* *
D 05 BA PSORALENI DE UZ SISTEMIC
METHOXALENUM '
P-6L
2 0 14
D 05 BB
ACITRETINUM
P-RF
Fdin. Analog aromatic de sinteza al acidului retinoic. Normalizeaza procesele de proliferare celulara, de diferen\iere !?i
cheratinizare a epidermului.
Ind. Forme severe de psoriazis, (pustules, palmo-plantar),
ichtioze grave, keratodermii palmo-planlare, boala Darier, rebele
la tratamente clasice.
R.a. Cheilita descuamativa uscata, ragade ale comisurilor labiale,
uscaciunea !?i inflama\ia rnucoaselor !;ii epiteliilor de tranzi\ie cu
epistaxis, conjunctivita, intoleran\a la lentilele de contact,caderea
parului, paronichie, fragilitatea unghiilor, descuamarea palmelor
i plantelor , cefalee, scaderea vederii crepusculare, dureri
musculare i osleoarticulare, folosensibilizare, tulb. hepatice,
hipertrigliceridemie.
Sarcinii, aliiptare. Efecte teratogene :?i ernbriotoxice. Contraindica\ie rnajora pe durata tratamentului !?i doi ani dupii
intreruperea lui.
Conducere auto, lucrul la maini. Posibile tulburaride vedere,
scaderea vederii crepusculare.
Cind. Insur. renala sau hepatica, hiperlipidemie, asociere cu
tetracictine.
Pree. Control regulal(teste hepatice, lipide serice). Cei trata\i nu
pot dona sange limp de 2 ani de laincelarea tratamen ului.
410
M E M O M E D 2 0 14
M E M O M E D 2 0 14
411
D 06
ANTIBIOTICE I CHIMIOTERAPICE
DE UZ DERMATOLOGIC
0 06 A
0 06 B
CHIMIOTERAPICE
PENTRU APLICA Jll LOCALE
* *
0 06 A
0 06 AA
0 06 AX
D 06 AA
TETRACYCLINUM
P-RF
412
M E MOM E D
2 014
M E M O M E D 2 0 14
PRF
4 13
OTC
D 06 B
CHIMIOTERAPICE
PENTRU APLICAJll LOCALE
D 06 BA SULFAMIOE
D 06 BB ANTIVIRALE
Admin . Local
D 06 BX
ALTE CHIMIOTERAPICE
Gel 1 mg/g.Tub 5 g; 25 g. Pa
RETAPAMULINUM
PRF
D 06 BA SULFAMIDE
* *
SULFADIAZINUM
Fdin. Chimioterapic activ fa\a de colibacil, Pseudomonas, stafilo
coc, Proteus, l<lebsiella, Candida.
Ind. Arsuri infectate, rani suprainfectate, escare.
OTC
Crema 1%.Tub 50 g.
P-RF
M EM OMED
414
2 0 14
M E M O M E D 2 0 14
Memomtor de f armncologle
415
'
PODOPHYLLOTOXINUM
@@
P-RF
Ind. Condiloame acuminate externe cu suprafa\a sub 4 cmp,
altemand cu alte terapeuticl {crioterapie, chlrurgie).
D 06 BB ANTIVIRALE
ACICLOVIRUM
> P-RF
Fdin. Activ fa\a de virusul herpetic tip I ;>i II ;;i herpes zoster.
Ind. lnfec\ii cutanate cu virus herpes simplex, incluzand herpesul
genital i labial, ini\ial ;;i recurent. Keratita herpetica.
Admin. Unguentul 3%, aplica\ii locale de 5 ori pe zi, la 4 ore, eel
pu\in 3 zile dupa vindecare.
Cind. Copii.
Pree. Se evita pe pi lea normala ;;i pe rani. h tant pt. ochi. Daca
sunt mai multe cond1loane se trateaza simultan cateva.
IMIQUIMODUM
!AJ
SIP-RF
MEMOMED
416
2 0 14
M E M O M E D 2 0 14
/llc111ort11or de fnrmncologfe
417
/lfemomtor defannacologfc
><
0 07
CORTICOSTEROIZI
DE UZ DERMATOLOGIC
0 07 A
CORTICOSTEROIZI SIMPLI
O 07 C
CORTICOSTEROIZI
IN COMBINAJIE CU ANTIBIOTI CE
0 07 X
12. Pa
262,43
SINECATECHINE
PRF
;f;
D 06 BX ALTE CHIMIOTERAPICE
INGENOLI MEBUTAS
* *
0 07 A
CORTICOSTEROIZI SIMPLI
D 07 AA
D 07 AB
0 07 AC
0 07 AD
PRF
* *
0 07 AA
HYDROCORTISONUM
P-RF
418
M E M O M E D 2 0 14
Mcmomto,. de fnrmacolog fc
-----
M EM OMED
2 0 14
419
Mcmomtor de fa rmnco/oglc
/&.
ALCLOMET AZONUM
'
P-RF
HYDROCORTISONUM BUTYRATUM
BETAMETHASONUM
/&.
P-RF
/&.
P-RF
420
MEM OMED
MEMOMED 20
14
2 0 14
421
METHYLPREDNISOLONUM ACEPONAT
&&_
P-
&&
P-RF
Fdin. Antiinflamator.
Ind. Psoriazis, lupus eritematos discoid cronic, eczema I
dermalite eczematiforme , prurit intens localizat.
Admln. Aplica\ii locale de 2 ori pe zi.
CUTIVATE (Glaxo Wellcome Ltd,Marea Britanie)
Crema. Ung. 0,005%. Tub 15 g. Pa 10,31; 10,31
COMBINATll
P-RF
&&
P-RF
P-RF
MOMETASONUM
&
&&
P-RF
M E M O M E D 2 0 14
M E M O M E D 2 014
422
423
Mcmomt or de farmacologlc
20 g. Pa -
CORTICOSTEROIZI iN COMBINAJIE
CU ANTIBIOTICE
D 07 CB
cc
P-RF
* *
HIDROCORTIZON IANTIBIOTICE
D 07 CB
*
0 07 CA
P-RF
0 07 CA
0 07
* *
c
mg;
*
0 07
0 ,255
P-RF
424
ME MOME D
M E M O M E D 2 0 14
2 014
> PRF
IANTIBIOTICE
(Merck
Sharp
&
Dahme
D 07 X
D 07 XA
Ltd,
425
Afemorator defarmncologlc
S.R.L.,
D 07 XA
* *
> P-RF
Crema.Tub 25 g.Pa -
D 07 XB
FLUOCINOLON
IANTIBIOTICE
> P-RF
426
MEMOM ED
M E M OM E D
4
20 14
427
201
D 08 ANTISEPTICE I DEZINFECTANTE
D 08 AC BIGUANIDE I AMIDINE
D 08 AH DERIVATI DE CHINOLONE
P-
D 08 AG DERIVATI DE IOD
D 08 AJ
salicilic
. ..
:J:
* *
D 08 AC
BIGUANIDE IAMIDINE
CLORHEX IDlNUM
OTC
P-RF
OTC
0 08 AG DERIVATI DE IOD
POVIDONUM IODINATUM
OTC
P-RF
Ind. A. Chirurgie: rani, arsuri, ulcere de staza, pregatire preoperatorie, tratament postoperator, cateterlzare. Dermatologie:
MEMOM E D
428
2 0 14
M E M O M E D 2 0 14
Mcmomtor ticfarmncologlc
429
utilizeaza o singura data in decursul a 24 de ore ipentru maxim 35 zile. Nu trebuie utilizat n mod continuu.
Cind. Afec\iuni tiroidiene. dermatita herpetiforma Duhring, nounascu\i ?i sugari cu greutatea sub 1500 g.
COMBlNATll
0 08 AH DERIVAJIDE CHINOLONE
CHLORQUINALDOLUM
OTC
0 08 AJ
D 08 AX
COMPUIQUATERNARI OE AMONIU
BENZALKONll CHLORIDUM
DETTOLMED (Reckitt Benckiser (UK) Limited, Marea
Britanie)
OTC
Spray cut., sol 0,2%. Fl. 100 ml.
Ind. Pentru cura\area antiseptica a plagilor superficiale.
Admin. o singura data o doza completa (1-2 pulverizari) pe
suprafa\a fiecarei plagi ?i lasa\i sa ac\ioneze cinci minute. Se
M E M O M E D 2 0 14
430
M E M O M E D 2 014
431
0 10 PREPARATE ANTIACNEICE
COMBINATll
@@
P-RF
D 10 A
D 10 B
PREPARATE ANTIACNEICE
DE UtSISTEMIC
*
* *
D 10 A
D 1O AX
D 10 AE PEROXIZI
BENZOYLIS PEROXIDUM
* *
@@
f&
OTC
P-RF
Fdln. Cheratolitic, oxidant, antibacterian fa\a de Propionibacterium acnes. Neutralizeaza hipercheratinizarea i hipersecre\ia
seboreica eliminata de acnee.
0 10 AF ANTllNFECJIOASE
PENTRU TRATAMENTUL ACNEEI
ERYTHROMYCINUM
P-6L
ME MO ME D 2 0 14
Mcmorntor 1/c fnrmncologic
432
ME MO ME D 2 0 14
Mcmomtor de fnn11ncologlc
433
ERtTROMICINA, COMBINATll
D 10 BA
CLINDAMICINA, COMBINATll
ZANEA
(Meda
D 10 B
Pharma,
Germania)
P-
PREPARATE ANTIACNEICE
DE UZ SISTEMIC
RETINOIZI PENTRU TRATAMENTUL ACNEEI
ISOTRETINOINUM
Lili @ @
P-RF
Fein. Absorb\ ie variabila din tubul digestiv. Pie seric la 2-4 ore.
RF
P-RF
Gel. Clindamicina 10 mg/g;Peroxid de benzoil30 mg/g.Tub
30g.Pa 81
'
434
M E M O M E D 2 0 14
M E M O M E D 2 0 14
M cmorato,. de far11uzcologic
Jllcmorator de farmacologi c
435
D 11
ALTE PREPARATE
DE UZ DERMATOLOGIC
D 11 AF
D 11 AH
D 11 AX
I BATATURI
*
* *
D 11 AF
ACIDUM SALICYLICUM
OTC
436
M E M O M E D 2 0 14
M E M O M E D 20 14
!tfcmomtur de fnrmncolog fe
D 11 AH
PlMECROLIMUS
437
P-RF
P-6L
MINOXIDILUM
M E M OM E D
438
20
M E M O M E D 2 0 14
14
439
Memomtor tiefnrmncologie
Memomtor de fnrmncologie
TACROLIMUS
P-RF
PROTOPIC (Astellas Pharma Europe B.V.,Olanda)
P-RF
infec\iilor virale
EFLORNITHINUM
@@
P-RF
OTC
G
G 01
G 02
G 03
HORMONI SEXUALI $1
MODULATORll SISTEMULUI GENITAL
6 04
M E M O M E D 2 0 14
441
Mcmomtor de farmacologie
G 01 A
ANTllNFECJIOA SE I ANTISEPTICE
(EXCL.COMB .CU CORTICOSTEROIZI)
ANTIBIOTICE
*
ANTllNFECJ IOASE $1 ANTISEPTICE
GINECOLOGICE
*
G 01
G 01 A
*
A NTIBIOTICE
G 01 AC
DERIVATI DE CHINOLINA
G 01 AF
DERIVATI DE IMIDAZOL
G 01 AN
COMBINATll
Fdin. Antibacteri an, antitrichomonas ;;i anlicandida (prin nifuratel), la care se adauga ac\iunea anticandida a nistatinei.
33,74.
* *
A NTIBIOTICE
NATAMYCINUM
RF
Fdin. Antifungic cu ac\iune locala.
P-RF
*
G 01 AA
* *
G 01 AA
ISBI
P-
M E M O M E D 2 0 14
M E M O M E D 20 14
Memomtor de fnl'l11ncologle
442
G 01 AC
DERIVAJI DE CHINOLINA
DEQUALINIUM
Fdin. Campus cuaternar de amoniu cu un spectru largimpotriva
bacteriilor gram pozitive, l?i gram negative, fungi, Trichomonas
vaginalis.
Ind. lnfec\ii vagina le bacteriene, micotice sau protozoarice
(tricomoniaza). Asepsie preopera tor ie in interven\iile
ginecologice iobstetricale.
3.
G 01 AF DERIVAJI DE IMIDAZOL
MICONAZOLUM
METRONIDAZOLUM
443
1) /ft,
P-RF
P-RF
Fdln., R.a. Cind. Vezi clotrimazol.
Caps. moi vag. 200 mg; 400 mg. Ct. x 6: x 3. Pa: 5,96; 5,72
CLOTRIMAZOLUM
Fdin. Anlimicotic cu ac\iune locala !?i spectrul larg (Candida,
Tricophyton, Epidermophyton s.a.). Antibacteri an (stafilococ
auriu, streptococ piogen).
444
M E M O M E D 2 0 14
M E M O M E D 20 14
Me111omto1 de ftll'lnncologil!
P-RF
ECONAZOLUM
15 zile
consecutive.
un ovul seara
profund intravaginal, limp de 15 zile consecutive.
la
culcare,
4 /&
BUTOCONAZOLUM
IAJ
ISOCONAZOLUM
445
P-
P-RF
RF
4 /it
P-RF
><
P-RF
10 zile.
l<EFUNGIN (Antibiotice, Romania)
MECLON (Alfa Wasserman, Italia)
/S
P-RF
crema uz topic
Ovule
1 g%
5 g%
Tub 30 g. Pa: 9,63
100 mg
500 mg
Ct. x 10. Pa: 11,17
P-
RF
Fdin. Spectrul de activit ate cuprinde
iungi (Trichophyton ,
Microspor um, Epidermophyton), levuri (Candida, Cryptococcus.
Pityrosporum), mucegaiuri (Aspergillus, Sporotricum), bacterii
Grampozit ive (Streptococcus , Staphylococcus, Bacillus sublilis).
Clotrimazol
Metronidazol
M E M O M E D 2 0 14
446
ME MOM ED
2 014
447
Mcmorator de farmncologi c
P-RF
'
Clotrimazol (fiola)
Metronidazol (Oacon)
Crema
vaginala
4 g%
20 g%
Tub 30 g
Pa: 12,87
G 01 AX
NIFURATELUM
/&.
CICLOPIROXUM
P-6L
f&
POVIDONUM-IODINATUM
OTC
A se vedea D 08 AG
BETADINE OVULE (Egis Pharmaceuticals Ltd, Ungaria)
Polividon iodine 0,200 g
Ovule.Ct. x 14.
P-RF
448
M E M O M E D 2 0 14
M E M O M E D 2 0 14
449
Memomtor de fl1r111aco/ogfe
G 01 BA
ANTllNFECJIOASE/ANTISEPTICE - COMBINATll CU
CORTICOSTEROIZI ANTIBIOTICE I
CORTICOSTEROIZI
COMBINATll
CERVUGID (lrcon,Romania)
P-RF
OTC
MEMOMED
450
2 014
M E M O M E D 2 0 14
Memomtor de fnrmacologie
G 02
G 02 AD PROSTAGLANDINE
G 02 A
OCITOCICE
DINOPROSTONUM
G 02 B
CONTRACEPTIVE LOCALE
G 02 C
G 02 A
_&
SIP-RF
*
*
451
OCITOCICE
'
G 02 AD PROSTAGLANDINE
MISOPROSTOLUM
ERGOMETRINUM
@ &_
PR
P-RF
R.a. Rar gre\uri, vome. La doze mari !?i mai ales i.v. posibile
cre!?teri tensionale, ischemie periferica.
Cind. Sarcina,in cursul travaliului, hipertensiune arteriala, toxemie gravidica, asociere cu vasoconstrictoare, hipersensibilizare.
Admin. l.m. 1-2 fiole o data. l.v.foarte lent 1/2-1 fiola o data. Se
poate repeta la 2-4 ore, pana la 5 doze. Oral 1-4 fiole de 3 ori/zi.
452
M E M O M E D 2 0 14
M EM OM E D
453
G 02 B CONTRACEPTIVE LOCALE
G 02 BA CONTRACEPTIVE LOCALE
PRF
LEVONORGESTRELUM
2 0 14
10.
menstruate.
Cind. Sarcina, boala infiamatorie pelvina,cervicita,endometrita ,
neoplasm, hemoragii vaginale anormale, infec\ii vaginale.
Admin. Se introduce in cavitatea uterina
in ;;apte zile de la
debutul menstrua\iei de catre medici/cadre medicate cu
experien\ain introducerea SIU
*
*
G 02 BB CONTRACEPTIVE INTRAVAGINALE
BENZALCONll CHLORIDUM
OTC
M EMOMED
454
MEMOMED
2 0 14
455
2 014
G 02 CA SIMPATOMIMETICE TOCOLITICE
G 02 CB INHIBITORI DE PROLACTINA
ex
ALTE GINECOLOGICE
* *
G 02 CA SIMPATOMIMETICE TOCOLITICE
SIP-RF
HEXOPRENALINUM
hipotensiune ortostatica, pot dispare spontan. Confuzie, halucina\ii,excita\ie psihomotorie, delir, mai ales la doze mari i la cei
cu antecedente psihotice (necesita reducerea dozelor, eventual
oprirea tratamentului) . Uscarea mucoasei bucale, constipa\ie,
ederne ale membrelor inferioare, accentuarea ischemiei
periferice la bolnavi cu antecedente, reducerea aten\iei.
5. Pa: 18,06
G 02 CB INHIBITORI DE PROLACTINA
BROMOCRJPTI NUM
P-RF
ME M O ME D 2 0 14
Memorntnr de fnrmacologie
456
f.9MBINATll
457
M
EMO M
D 2 014
M cmomtor
deE
fnrmncologic
[SB]
OTC
G 02
ex
ALTE GINECOLOGICE
ATOSI BANUM
Fein. Cone. plasmatica de echilibruin era urmatoareinceperii
P-RF
OTC
x
30, 60,
Admin. 1 caps./zi.
P-RF
><
458
MEM OM E D
2 0 14
Mcmomtmde fnr11/f/cologic
G 03 X HORMONI SEXUALI I
MODULATORll SISTEMULUI GENITAL
G 03 A
G 03 B
ANDROGENI
G 03 C
ESTROGENI
G 03 D
PROGESTOGENI
G 03 F
COMBINATll DE PROGESTOGENI
I ESTROGENI
G 03 G
G 03 H
ANTIANDROGENI
G 03
*
G 03 A
G 03 AA
* *
CONTRACEPTIVE HORMONALE SISTEMICE
PROGESTOGENI IESTROGEN! COMBINATll FIXE
459
M E M O M E D 2 014
Mc111omtnr de ft ,,.mncologlc
P-6L
G 03 AB PROGESTOGEN I IESTROGEN!,
PREPARATE SECVENTIALE
G 03 AC PROGESTOGEN I
LEVONORGESTREL $1 ESTROGEN
P-6L
*
* *
G 03 AA PROGESTOGEN I IESTROGEN!,COMBINATll FIXE
Ind. Contraceptive orale.
R.a. Urticarie, eritem, prurit, cloasma, acnee; crampe musculare
la membrele inferioare, ame\eli, cefalee migrenoasa, crize
epileptice (la cele cu antecedente), stari depresive, tulburari
senzoriale; gre\uri, vome, tumori hepatice (rar), icier colestatic,
460
MEMOM ED
14
MEM O M E D 2014
Mcmomtor de ft1r111n cnlogic
Maron
Levonorgestrel
Etinilestradiol
Fumarat feros
76,05 mg
Draj. Ct. " (21+7); 3x(21+7). Pa: 7,89
DESOGESTREL !?I ESTROGEN
461
Alb
0,15 mg
0,03 mg
20
GESTODEN
IESTROGEN
P-6L
P-6L
Admin .21 zile, din prima zi a ciclului, cale un compr. 7 zile pauza.
MERCILON (NV Organon,Olanda)
Etinilestradiol 0,02 mg; Desogestrel 0,15 mg. Compr. cu
calendar 1 x 21; 3 x 21; 6 x 21. Pa: 17,55; 59,93;-.
Admin. Un compr./zi limp de 21 de zileincepand cu prima zi a
ciclului; pauza 7 zile. in primele 14 zile de administrare sunt
necesare masuri contraceptive complementare.
NOVYNETTE (Gedeon Richter, Ungaria)
Etinilestradiol 0,02 mg; Desogestrel 0,15 mg. Compr. film.
Ct. 1x 21; 3 x 21. Pa: 18,95; -.
Admin. 1 compr./zi limp de 21 zile, 7 zile pauza.
MEMOMED
462
2 0 14
M E M O M E D 2 0 14
11Je111orator ""-'ft1r111ncolo.. ic
P-6L
5-21
un
compr./zi;
ntre
Admin.
463
zile
pauza.
P-
6L
Ct.1x21. 3 x 21.
464
MEMOME D
2 0 14
M E M O M E D 2 0 14
465
@ > P-6L
> P-6L
JEANINE (Jenapharm,Germania)
YASMIN (Schering, Germania)
Drospirenona micronizata 3 mg; Etinilestradiol micronizat
0,03mg. Compr. film. Ct. >< 21. Pa:35,16.
G 03 AB PROGESTOGENI I ESTROGEN!,
DIENOGEST $1 ESTROGEN
> P6L
PREPARATE SECVENTIALE
(j;:J
>
P6L
@ > P-6L
M EMOM ED
466
M E M O M E D 2 0 14
2 014
0,05 mg levonorgestrel
0,03 mg etinilestradiol
0,75 mg levonorgestre l
0,4 mg etinilestradiol
0,12 mg levonorgestrel
0,03 mg etinilestradiol
IESTROGEN
G 03 AC PROGESTOGENI
LEVONORGESTRELUM
> P-RF
467
>
P-
1.
6L
> P-6L
MEMOMED
468
2 014
ll!l!momto.- de far111ncologic
MEDROXYPROGESTERONUM
M
E M OorM
D 2 014
llfc111omt
de E
fi1r111acologlc
469
LEVONORGESTRELUM
A se vedea G 03 DA.
ETONORGESTRELUM
PRF
OTC
><
1.
sexual neprotejat
ULIPRISTALUM ACETALUM
menstruale.
&_ &
DESOGESTRELUM
P-6L
Fein. Dupa administrare orala se absoarbe rapid i este transformatin etonogestrel, metabolit activ. Pie. la 1,8 ore. Biodisponibilitate 70%. Excre\ie urinara i n fecale (1,5/1 ). T Y, 30 ore.
28.
><
G 03 B
P-RF
1; 3; 6 blistere calendaristice
><
ANDROGEN!
MEM OM ED
470
M E M O M E D 2 0 14
20 14
@@
P-RF
><
SIP-RF
><
1.Pa: 484,53.
><
2,8, 24.
><
2, 8, 24.
G 03 C ESTROGENI
G 03 CA ESTROGEN! NATURAL! I SEMISINTETICI
*
*
47 1
Mcmomt or de farmacnl og ic
MEMOMED
472
M E M O M E D 2 0 14
2 0 14
/\lemorntor de fnrmncologie
473
/llemomt or dv fan11ncologiv
@ > P-6L
@ > P-RF
@ > P-RF
ESTRIOLUM
de 2 zile.
G 03
ex
TIBOLONUM
M E MOME D
474
2 014
M E M O M E D 2 0 14
G 03 D PROGESTOGENI
&@
PROGESTERONUM
P-6U P-RF
Caps.moi 100 mg, 200 mg. Ct.x 30. Pa: 19,49; 37,74 .
PROGESTOGEL {Lab.Besins, Fran\a)
Progesleron 10mg/g. Gel. Tub 80 g + regleta de dozare.
1regleta 2,5 g gel 25 mg progesleron. Pa:21, 14.
G 03 DB PREGNADIEN DERIVATI
G 03 DC ESTREN DERIVATI
*
DIENOGESTUM
475
P-6US
476
MEM OMED
2 0 14
M EM O M E D 2 0 14
P-6L
G 03 DB PREGNADIEN DERIVAJI
DYDROGESTERONUM
477
P-RF
NOMEGESTROLUM
&
P-RF
MEM O M ED
478
2 0 14
M E M O M E D 2 0 14
479
Me111on1/or de far111acofogle
NORETISTERONA SI ESTRADIOL
G 03 DC ESTREN DERIVAJI
> P- 6L
> P-6L
LYNESTR ENOLUM
R.a. Alergie, migrene, depresie, gre\uri, vome, diaree, conslipa\ie, colestaza , edeme, sangerari uterine, mastopatie.
Cind. Hepatopatii severe, icier colestalic, metroragii de cauza
necunoscuta.
Pree. Epilepsie, hipertensiune arleriala, migrene.
Admin.in endomelrioza 1compr./zi limp de 6 luni. n amenoree
in asociere cu un estrogen administrat intre ziua 7-20-a a ciclului
iar din ziua 16-25 cate un comprimat linestrenolfzi. in hemoragii
juve nile si menomelroragii 2 compr.fzilimp de 1O zile.in
continuar la urmatoarele 4 cicluri cale 1 compr/zi nlre ziua 1025 a ciclului.in menomet roragiile grave 2 compr/zilimp de 10 zile
apoi cate 1compr/zilimp de 3 luni.
ORGAMETRIL (N.V. Organon,Olanda)
Compr. 5 mg. Ct. x 30. Pa: 9,12.
G 03 F
G 03 FA
G 03 FB PROGESTOGE NI I ESTROGEN!,
PREPARATE SECVENJIALE
* *
G 03 FA PROGESTOGENI I ESTROGEN!, COMBINAJll FIXE
Clnd. Carcinom mamar, endometrial, neoplazii hormonodependente. Hepatita acuta sau cronica. Boala trombo-embolica .
Stlngerari genli ale. Sarcina.
Admin. Oral, un comprimat pe zi, faraintrerupere , de preferat la
aceea i ora a zilei. Daca se uita administrarea unui comprimat
filmat , acesta treb uie administrat cat mai curand posibilin
urmatoa rele 12 ore . Daca au t recut mai mull de 12 ore,
comprimatul uitat trebuie aruncat.
GYNAIKA (Zentiva, Cehia)
Estradiol 1mg/Noretisterona 0,5mg. Compr . film. Ct. 1x 28;
3x28.
DIDROGESTERON I ESTROGEN
> P-6L
480
M EMOMED
2 0 14
M E M O M E D 2 0 14
481
G 03 G
G 03 GA
GONADOTROPINE
G 03 GB
DIENOGEST IESTROGEN!
PRF
*
Dienille (Ladeepharma, Ungaria)
*
G 03 GA
GONADOTROPI NE
GONADOTROPHI NA CHORIONICUM
P-RF
P-6L
R.a. Reten\ie hidrosalina.in asociere cu HMG rise de hiperstimulare ovariana !?i de sarcini multiple, chiste ovariene, edeme,
ascita , hidrotorax, hiperaldosteronism secundar , hipercoagulabilitate.
Admin . 1compr.film/zi.
ANGELIQ (Bayer Pharma, Germania)
Drospirenon 2 mg; Estradiel 1 mg;micronizate .Compr. film.
Ct. x 28; x 84. Pa: 68,38; -.
G 03 FB PROGESTOGENI I ESTROGEN!,
PREPARATE SECVENJIALE
DIDROGESTERON
IESTROGEN
P-6L
MENOTROPINUM
SIP-RF
Fdln. Induce dezvoltarea i maturarea foliculului ovarian (administrat in prima faza a ciclului). Tratamentul va fi de obicei
completat cu gonadolrofine corionice pentru a declan!?a ovula\ia.
La barbat induce spermatogeneza in caz de deficit de LH.
_I
482
ME MOME D
M E M O M E D 2 0 14
2 0 14
483
Memomtor de fr1r111r1cologfe
FOLLITROPINUM ALFA
Fein. Dupa inj. i.v. distribu\iein lichidele extracelulare cu semivia\a ini\iafa de circa 2 ore ;;i eliminare cu semi-via\a finala de
circa 24 ore. Dupa administrare repetata, starea de echilibruin 34 zile.
[) /&,.
P-RFIR
UROFOLITROPI NUM
@ (f.J
P-RF/R
P-RF
Pulb. 75 u.i. Flac. pulb.+ nae. solv. Ct. x 5; 10; 30;. Pa: -;
796,99; -.
484
M E M O M E D 2 0 14
M E M O M E D 2 014
Mcmomtor de farmacologlc
LUTROPINUM ALFA
485
@@
PRF/R
Sol. inj. 150 u.i.I0,18ml; 300 u.i.10,36 ml; 600 u.i./0,72 ml;
900 u.i./1,08 ml. Cartu9. Ct. " 1. Pa: -; 517,31; 963,79;
1410,83.
Sol. inj 50 u.i., 75 u.i., 100 u.i., 150 u.i.; 200 u.i.;225 u.i./0,5
ml. Flac. 0,5ml. Ct x 1;5; 10.Pa: 106,34; -;200,89;-; -;-.
HORMON FOLICULOSTIMULANT
P-RF
Pulb.75 u.i. + solv. pt. sol. inj. Flac/fiola.Ct. x 1;3; 10. Pa:
146,72; 744,15; 2090,76.
Pulb. 450 u.i. + solv. pt. sol. inj. Stilou inj. preumplut. Ct. >< 1.
P
RF
R.a. Reten\ie hidrosalina.in asociere cu HMG rise de hiperstimulare ovariana 9i de sarcini multiple, chiste ovariene, edeme,
ascita , hidrotor ax , hiperaldosteronism secunda r, hipercoagulabilitate.
A.dmin. a femeie: iminen\a de avert, 1500 u.i./ziin primul
tnrnestru. In asociere cu HMG, sterilitate prin anovula\ ie:5000 u.i.
in zilele 14, 16, 18 ale ciclului, cu supravegherea volumului
ovarelor 9i a estrogenemiei. a barba\i: criptorhidie,500 u.i. de 23 ori/saptamana. dupa varsta, timp de 6 saptamani.in asociere
cu HMG, hipogonadism hipogonadotrofic , 1500 u.i. de 2 ori/
saplamana, limp de 3 luni.
M E M OMED
486
2 0 14
M E M O M E D 2 01 4
All!111omtor de farmncofog ic
487
P
RF
ANTIANDR OGENI
G 03 HA ANTIANOROGE NI
G 03 HB ANTIANOROGE NI I ESTROGE N!
*
*
G 03 HA ANTIAND ROGENI
CYPROTERONUM
P-RF
G 03 H
P-RF
488
M EMOMED
M EM OM ED 20
14
2 0 14
Jllc111or1llor,.ft1r111ncologle
489
R.a. La brbat: inhibilia spermatogenezei, impoten\a, ginecomastle. La femeie: tulburari de ciclu, cretere ponderala. La
ambele sexe : migrene, colestaza . insuf. venoasa, hepatite
citolitice (rar).
Cind. La femeie Clnd. gestagenilor. Hepatopatii grave, antecedente tromboembolice,tbc ,psihoze depresive. Sarcina, alaptare.
Diabet dificil de controlat.
Admln. Cancer de prostata: 200-300 mg/zi, tratament continuu.
La femeie dupa histerectomie sau menopauza 25-50 mg/zi, 21
zile, 7 zile pauza..in perioada sexuala este necesara asocierea
unui estrogen (de ex. preparatul Diane).in acnee severa 2 mg/zi
asocial cu 35 mcg etinilestradiol/zi, 21 zilein fiecar e ciclu
menstrual. Hipersexualitate 50 mg >< 2/zi.
G 03 XB
ANTIPROGESTOGENI
G 03 XC
MODULATOR! SELECTIVI
Al RECEPTORILOR ESTROGENICI
><
G 03 HB ANTIANDROGENI I ESTROGEN!
CLIMEN (Bayer Pharma, Germania)
Draj. con\inand:
Estradiolvalerat
Cyproteronal acetat
Excipient q.s. pentru un draj.
Ct. >< 21. Pa 27,37
draj.alba
2 mg
P-RF
draj. roz
2 mg
1 mg
G 03 XB ANTIPROGESTOGENI
MIFEPRISTONUM
PR
> P-6L
M E M O M E D 2 0 14
490
1\lc111orfl f 01'
tit!
M E M O M E D 2 0 14
Jannacologie
491
Memomtor de fi1minco/ogie
Compr. film 60 mg. Ct. x 7, 10,14, 20, 21,28, 30, 40, 42, 50,
56, 70,84, 100, 120, 140, 168.
> PR
> P-RF
BAZEDOX IFENUM
G 03 XC MODULATOR! SELECTIVI
Al RECEPTORILOR ESTROGENICI
RALOXIFENUM
> P-6L
>
P-RF
Ind. Prevenirea osteoporozei i fracturilor vertebral e netraumatice la femei in premenopauza, cu rise crescut de osteoporoza.
492
M E M O M E D 2 0 14
M E M O M E D 2 0 14
Mcmwmtmde farmacologie
Memomto1de farmacologic
493
G 04
G 04 B
ALTE UROLOGICE,
INCLUSIV ANTISPASTICE
OXYBUTJNI NUM
Fein. Pie seric dupa 30 minute. T1/2 sub 2 ore.
G 04 C MEDICAMENTE FOLOSITE
iN HIPERTROFIA BENIGNA DE PROSTATA
G 04 BX ALTE UROLOGICE
* *
G 04 BC ANTILITIAZICE
J<ENTERA (Nicobrand Limited, lrlanda)
COMBINAJll
P-6L
G 04 BO ANTISPASTICE URINARE
in unele forme de hiperactivitate vezicala i de incontinen\a se pot
ob\ine ameliorari simptomatice cu anticolinergice. Eficacitatea lor
TOLTERO DINUM
Fein.Absorb\ie digestiva rapida, pie plasmatic la 1-3 ore. T1/2 23 ore pentru tolterodina ?i 3-4 ore pentru metabolitul 5hidroxirnetil. Concentra\ii constante sunt atinsein 2 zile. Excre\ie
prin urina (77%) ?i prin fecale (17%).
Fdin. Antagonist specific competitiv al receptorilor muscarinici,
cu ac\iune selectiva, avand afinitate rnai mare pentru receptorii
din vezica urinara decal pentru cei din glandele salivare .
Metabolitul 5-hidroximetil are efecte asemanatoare.
494
M E M O M E D 2 0 14
M E M O M E D 2 0 14
Mc:111omtor de Jnnuncofogle
SOLIFENACINUM
495
P-6L
Fdin. Anticolinergic.
Ind. Tratament sirnptomatic al incontinen\ei de urina, mic\iuni
frecvente iurgente, la pacien\i cu vezica urinara hiperactiva.
Cind. Reten\ie urinara, megacolon, miastenie, glaucom, bolnavi
sub hemodializa, insuf. hepatica sau renafa severa.
Admln . Zilnic 5 sau 10 mgintr-o priza.
VESICARE (Astellas Pharma Europe, Olanda)
Compr. film. 5 mg; 10 mg. Ct. >< 30. Pa: 183,34; 227,12.
Caps. elib.prel. 2 mg;4 mg. Ct x 7;28; 49; 84; 280. Pa: -;-;
-;-;-; -;174,6;-;-:-.
TROSPIUM
Fein. Absorb\ie orala, diminuata de alimente bogatein lipide. Pie.
seric la 4-6 ore. Excre\ie predominant renala , nemodificat.
Fdin. Derivat cuaternar de nortropan, anticolinergic cu afinitate
pt. receptori rnuscarinici tip M1, M2 , M3, fara aiinitate pentru
receptori nicotinici.
Caps. elib. prel 4 mg. Ct. x 7; 10; 14;20; 28;30; 49; 60; 84;
90;98; 100; 250; 500.
Cornpr. film 1mg, 2mg. Ct " 28; 56. Pa: 22,2; -;26,66;-.
(SR) Caps. elib. prel. 2 mg, 4 mg. Ct x 7; 14;28; 30;49; 84;
98; 100;200.
M E M O M E D 2 0 14
496
'
M E M O M E D 2 0 14
497
ilfemorator de farmacolog fe
29% la doza de 25 mg !?i35% la doza de 50 mg. Administrarea cu
alimente bogatein grasimi scade absorb\ia.
Fdin. Anticolinergic.
Ind. Vezica hiperactiva.
SIP-RF
Ind. Litiaza
post-operator.
OTC
infec\ ii urinare,
profilaxia
litiazei
OTC
Compr.elib.prel. 4 mg !?i 8 mg. Ct. " 7; 14; 28; 30; 56; 84; 98;
100. Pa: 47,49; -; 170,92; -; -; 487,51;-;-;52,74; -; 190,1;-;
-; 533,4;-;-.
MIRABEGRONUM
P-RF
OTC
MEMOMED
498
MEMOME D
4
2 0 14
201
499
11/emora/ or de fm ma cologie
P-RF
P-RF
Fein. Absorb\ie orala rapida, pie plasmatic 0,5-2 ore. Biodisponibilitate 40%. Administrarea simul!ana cu alimente intarzie
absorb\ia pana la o ora i reduce cone. plasmatica max. cu 29%.
Biotransformare hepaticain proportii mari, metaboli\i mai pu\in
activi. Excre\ie principala biliara (75-80%). T1/2 = 4 ore.
500
ME M O ME D
ME M O ME D 2 0
14
Memom/01de fnrmncologie
2 0 14
501
Pa:-;-;-;-;51,44;73,31;-;-;-;-;-;-;-;-;-.
VIAGRA (Pfizer Limited, Marea Britanie)
SILDENAFIL HEMOFARM (Stada Hemofarm, Romania)
Compr. film 25 mg, 50 mg, 100mg. Ct. x 1; 2; 3; 4; 8; 12.
Pa:-;-;-;-;-;-;-;-;-;-;33,66;52,44
;-;-;-;88,11;-;-.
TADALAFI LUM
P-RF
mialgii.
M E M O M E D 2 0 14
502
MC!1110rato1" dejarmaco/ogiC!
M E M O M E D 2 0 14
503
1\IC!111orato,. de farmacologic
VARDENAFI LUM
PRF
Fein. Absorb\i e rapida. Pie. seric la 15-120 minute T 1/2 45 ore. Excre\ie prin fecale (91-95%).
DAPOXETINUM
PRF
2; 4; 8; 12.
OTC
G 04 C MEDICAMENTE FOLOSITE
504
M E M O M E D 2 0 14
M E M O M E D 20 14
Mcmomtor de fnrmncologle
.Mcmorntor de fnrmncologlc
TAMSULOSINUM
* *
G 04 CB INHIBITOR! Al TESTOSTERON-5-ALFA REOUCTAZEI
ex
P-6L
G 04 CA ANTAGONl TI ALFAADRENERGICI
G 04
505
* *
G 04 CA ANTAGONl TI ALFAADRENERGICI
ALFUZOSI NUM
P-6L
Compr.elib. prel. 0,4 mg. Ct. x 10; 14;20; 28;30; 50;56; 60;
90; 100; 200. Pa: -' -; -; -; 20,08; - ;-; -; -; -;-.
TAMSULOSIN AUROBI NDO (Aurobindo Pharma, Malta)
Caps. elib. prel. Ct x 4; 7; 10; 14; 15; 20;28; 30; 50; 56; 60;
90; 98; 100; 200; 250.Pa:-;-;-;-;-;-;-;26,93;-;-;-;-;-;-;-;-.
30. Pa:26,93.
Compr. film. elib. prel. (LP) 5 mg; 10 mg Ct. x 30; 56. Pa:
15,72;- .
Compr. film.elib. prel. (SR) 10 mg Ct. x 30.Pa: 40,59.
M E M O M ED
506
MEMOM ED
2 0 14
2 0 14
507
FINASTERIDUM
Compr. elib. pref. 0,4 mg. Ct. x 10; 16; 20; 26; 30; 50; 60; 90;
96; 100. Pa:-;-; -;-; 31,9; -;-; -; -; -.
DOXAZOSINUM
j /ft.
P-6L
Vezi C 02 CA.
P-6L
SILODOSINUM
COMBINAJll
Compr. film. 5 mg. Ct. x 14; 15; 20; 28; 30; 50; 56; 60; 84;
90; 96; 100; 120. Pa:-;-; -:-; 35,18; -; -; -;-;-;-;-;-.
7; 30; 90.
Pa:-: 122,54;-.
28. Pa 32,91.
DUTASTERIDUM
P-6L
debitului urinar.
M E M O M E D 2 0 14
508
OT
C
Ind. Hipertrofia benigna de prostate. Prostatita. Cistlta, Oisfunctii
urinare
GENTOS (Richard Bittner, Austria)
Cpr. sublinguale.1 cpr. Populus trit. 01 25,0 mg, Serenoa
repens (Sabal serrulatum) trit 06 37,2 mg, Conium 06 37,2
mg, Kaliumjodatum trit. 012 37,2 mg, Ferrum picrinicum trit.
012 37,2 mg. Ct. x 20; 40;60;80; 100.
REPENS
SABAL
SERRULATA
OT
C
Fdin. Extract lipidosterolic din fructele palmierului pitic american,
Serenoa repens, cu proprieta\i anli-androgenice. Ameliora rea
simptomelor subiective (polakiurie , nlcturie, mictiune
lmperloasa). reducerea volumului rezldual i normalizarea
recomandarea medicului.
M E M O M E D 2 0 14
509
Mcmomtor de farmacologlc
MEPARTRICINUM
P-
6L
Fdin. Reduce volumul prostatei. Inhibitor al reabsorb\lel
estrogenilor la nivelul circuitului hepato-entero-hepatic.
COMBINATll
OT
C
510
M E MOME D
2 0 14
ff
PREPARATE HORMONALE
SISTEMICE, EXCLUSI V
HORMONll SEXUALI I
INSULINE
ff 01
HORMONI HIPOFIZARI,
HIPOTALAMICI I ANALOGI
ff 02
CORTICOSTEROIZI DE UZ SISTEMIC
ff 03
TERAPIA TIROIDEI
H 04
JIE'4Ii,Ni
BIBt:o.,;'"'
ff 05
!Jr
',
AI
P.
y:
* * ;./}).,,: /f 2A:i13
H 01
HORMONI HIPOFIZARI,
HIPOTALAMICI ' ANALOGI
H 01 A
H 01 B
HORMONI Al
LOBUL I
HIPOFIZAR
POSTER IOR
H 01 C
HORMONI HIPOTALAMICI
H 01 A
* *
HORMONI Al HIPOFIZEI ANTERIOARE I
ANALOGI
H 01 AA ACTH
MEMOMED
ME MO ME D 2 014
/lf cmorator rte fn n11acologlc
512
513
2 0 14
lllcmomtor de fnrmacologlc
ff 01 AB THYROTROPINA
* *
H 01 AA ACTH
[ [8j
P-
ff 01 AB THYROTROPINA
THYROTROPI NUM ALFA
P-RF
514
ME MOM E D 2
014
Afemomtor de fnrmncologie
M E M O M E D 2 0 14
Mem omtor de farmacologie
515
P-RF
H 01 AX
PEGVISOMANTUM
HORMONI HIPOFIZARI
I ANALOG!
P-RF
Fein. Absorb\ie lenta dupa inj. s.c. Pie seric la 33-77 ore. Eliminat
lent din ser. T1/2 74-172 ore.
Fdin. Analog al hormonului de cre9tere uman, modificat genetic
pentru a fi antagonist al receptorilor hormonului de cre9te re.
Determina scaderea concentra\iei serice a factorului de cretere I
insulin-like (IGF-1) 9i a altar proteine serice sensibile la hormonul
de cre9tere.
Ind. Acromegalie. Pacien\i care au raspuns insuficient la metode
chirurgicale 9i/sau radioterapie 9i la care un tratament cu analogi
de somatostatina nu au dus la normalizarea concentra\iei IGF-1
sau nu a fost tolerat.
Admln. Sub supravegherea unui medic specialist.
M EMOM ED
516
M E M O M E D 2 0 14
2 0 14
517
Me111omto1 de farmncologlc
H 01 B
H 01 BA VASOPRESINA I ANALOG!
H 01 BB
TERLIPRESSINUM
OXITOCINA I ANALOG!
P-RF
*
* *
H 01 BA
[A]
VASOPRESINA I ANALOG!
ISBJIAJ
DESMOPRESSI NUM
P-RF
H 01 BB OXITOCINA I ANALOG!
OXYTOCINUM
Compr0,2 mg. Ct. x 7,10, 15, 30, 50, 60, 90, 100. Pa 128,50
ME MOMED
518
M E M O M E D 2 0 14
2 0 14
OCTREOTI DUM
PRF
CARBETOCINUM
PABAL (Fildas Trading SRL - Romania)
SIP-RF
H 01 C HORMONI HIPOTALAMICI
HORMONI HIPOTALAMICI
H 01 CB HORMONI ANTICRESTERE
H 01 CC HORMONI ANTl-GONADOTROPIN-RELEASING
* *
H 01 CA HORMONI HIPOTALAMJCI
HISTRELINA
@@
H 01 CA
519
Mc111om1or defnrmncologie
5. Pa 152,62
PR
M EMOM E D
520
2 0 14
M E M O M E D 20 14
521
Sol. inj. 0,3 mg, 0,6 mg, 0,9mg. Fiole x 1ml. Ct x 6, 18, .3.Q,
60. P.a. 7.863,11, 8.674,14, 9.264,78.
LANREOTIOUM
@@
> SIP-RF
H 01 CC HORMONI ANTlGONADOTROPIN-RELEASING
GANIRELIXUM
> P-RF
Fein. Dupa o singura administrare s.c. pie seric la 1-2 ore. T1/2
13 ore. Excre\ie prin fecale (75%) !?i urina (22%).
Fdin. Decapeptida sintetica, antagonist al GnRH, prin legare
competitiva de receptori corespunzatori din hipofiza. Supri.ma
rapid, profund, reversibi l gonadotropinele endogene,
determinand scaderea cone. plasmatice ale LH, FSH, E .
2
1. seringa preumpluta. Pa
> PR
CETRORELIXUM
> P-RF
522
ME M O ME D 2 0 14
tllcmomto,. de fnrmn cologic
M E MO M E D 2 014
Mcmorntor de fnrmacologlc
H 02
523
CORTICOSTEROIZI DE UZ SISTEMIC
H 02 AA MINERALOCORTICOIZI
H 02 AB GLUCOCORTICOIZI
_P:
* *
H 02 AA MINERALOCORTICOIZI
FLUDROCORTI SONUM
Fdin . Mlneralocorticoid intens, cu efecte reduse de tip
glucocorticoid.
Ind. lnsuficlen\a suprarenala cronica ( n asociere cu cortizon sau
hidrocor\izon). sindrom adrenoge ni\al, unele forme de
hipotensiune arteriala (esen\iala), hipotensiune ortostatica.
H 02 AB GLUCOCORTICOIZI
Substan\e de semisinteza, derivate de cortizol sau cortizon, cu
efecte mineralocorticoide reduse, utilizate ca medica\ie de
subs\itu\iein insuficien\a corticosuprarenala (asociate cu un
mineralocorticoid) fie, mai ales pentru alte ac\iuniin afara unei
insuficien\e corticosuprarenale. n primul caz se utilizeaza doze
mici, care determina niveluri fiziologice,in al doilea caz doze
mari,cu niveluri ridicate 9ireac\ii adverse frecvente 9iimportante.
Fein. Absorb\ie digestiva buna. Dupa i.m. absorb\ie rapida cu
excep\ia formelor retard. Dupa aplicarea pe tegumente absorb\ia
poa\e fi uneori suficienta pentru a determina efecte sistemice
(nedorite). Metabolizare hepatica variabila,in func\ie de compus.
Uniideriva\i sunt activi numai dupa o prima metabolizare hepatica
(hemisuccinat de hidrocortizon).
524
ME MOMED
2 0 14
M E M O M E D 2 0 14
525
Ind. a). Tratament de substitu\iein insuficien\a corticosuprarenala (in asociere cu un mineralocorticoid). b). Tratament
rarmacoterapic, in doze mari,in arara unei insuf. suprarenale,
grupatein doua categorii: 1. Arec\iuni acute (grave, cu rise vital);
2. Afec\iuni cronice severe, invalldante. Principalele indica\ii:
Antiinflamator in afec\i uni reumatice acute sau cron ice
(reumalism articular acut, poliartrita reumatoida), boli de colagen,
dermatoze (pemfigus, psoriasis, dermalita exfolialiva), unele
hepalite acute sau cronice, unele rorme de tuberculoza (sub
protec\ie de chimioterapice) , enceralite, edem cerebral etc.
Anlialergicin boala serului, stare de rau astmatic, aslm bron!?ic,
edem Quinke, laringotraheobron;;ita cu sindrom asfixic, accidente
terapeutice medicamentoase etc. Hemopalii maligne, leucemii.
Stari toxiinfec\ioase grave. Boli prin autoagresiune . Colila
ulceroasa. Sindrom nerrotic. Sindrom adrenogenita l pentru erect
frenator. Anemie aplastica. Anemia hemolitica autoimuna .
Purpura trombocitopenica idiopatica. Boala Graves' cu
oftalmopalie severa, tiroidita granulomatoasa subacuta. Sindrom
poslinfarct miocardic (rebra, durere pleuropericardica).
R.a. Utilizarea dozelor mari pe perioade lungi delimp, pentru
efecte farmacologice,in afa ra unei insuf. corticosuprarenale,
poate determlna frecvent reac\ii adverse . lnciden\a, gravitatea !?i
tipul de reac\ie adversa depindein special de: doza, durata tratamentului, schema terapeulica, varsta bolnavului, afec\iunea de
baza, afec\iuni asociate, factori favorizan\I , asocierea cu alte
medicamente, tipul de corticoid.Tulburari metabolice: reten\ia de
sodiu, hipopotasemie, erect diabetogen, creterea catabolismului
proteic. Tulburari osoase. (Doze zilnice mai mari de 2,5 mg
prednisolon sau echivalent cresc riscul de fracturi). Scaderea
rezisten\ei la infec\ii. Tulburari neuropsihice (euforie, insomnie,
agita\ie, convulsii, tulburari de comportamant , manifestari
psihotice, dependen\a psihica), digestive (ulcer gastric sau
duodena l), endocrine (inhibarea secre\iei i atrofia suprarenalei).
Efecte teratogene , insuficien\a suprarenaia la nou-nascut. R.a.
Oculare: ptoza palpebrala, cataracta.
>
P-RF
Corticoid cu poten\a mare, practic lipsit de efecte mineralocorticoide, cu ac\iune inhibitoare mare asupra hipofizel. De evitat
in tratamente de durata. Se utilizeaza sub forma de: a).
B.etam tazon disodiu fosfat, solubil. Admin. 1.v., i.m.,local. b). B.
d1prop1onat suspensie, cu absorb\ie lenta i efecte prelungite.
Unele preparate au asociate ambele forme asigurand un efect
imediat i unul prelungit.
MEMOM ED 20
14
M E M O M E D 2 0 14
526
527
> P-RF
Liof. pt. sol. inj. 125 mg; 500 mg. Ct. x 1: x 1. Pa 8,81;
31,02.
MEDROL (Pfizer Europe,Anglia)
Compr.4 mg; 16 mg; 32 mg.Ct. x 30: x 50: x 20. Pa 29,65;
32,62.
SOLU-MEDROL ACT-0-VIAL (Pfizer Europe,Anglia)
Liof.+ solv .pt.sol.inj . 250 mg/4 ml. Flac. bicompart. 1 ml.
Ct. x 1Pa 20,48.
> P-RF
PREDNISOLONUM
DEXAMED (Medochemie, Cipru)
Sol. inj. 4 mg/ml Fiole 2 ml. Ct. x 10; 100. Pa 14,38; 118,60.
SOLU-DECORTIN (Merck,Germania)
Admin . Afec\iuni acute grave i.m. dar mai ales i.v., ini\ial 1-3 g.
DEXAMETAZONA ROMPHARM (Rompharm . Romania)
Sol.inj. 4 mg/1 ml. Fiola 1 ml. Ct. x 10; 25; 100. Pa 8,32;
20,42; 73,64
Sol.inj. 4 mg/1 ml. Fiala 2 ml. Ct. x 1O; 25; 100. Pa 13,87;
33,18; 124,62.
METHYLPREDNISOLONUM
& f&.
> P-RF
_& &_
> P-RF
Admln . Oral, doza ini\iala 30-80 mg/zi.in 3 prize, timp de 37 zile. ntre\inere cu doza cat mai mica pentru a men\ine efectul
(in general 5-10 mg/zi).Tratamente de durata cu o singura doza
pe zi, diminea\a sau administrare n zile alternative. nAddison, n
loc de hidrocortizon, 5 mg diminea\a i 2,5 mg dupa amiaza. in
amiloidoza doze individualizate . Anemie hemolitica autoimuna
1-2 mg/kg/zi ini\ial,apoi doza mai mica,in func\ie de evolu\ie.in
528
M EM O M ED
2 0 14
M E M O M E D 2 0 14
Mcmomtor de fmwncologic
Jllc111omto1 de /nrmncologie
529
Admin. n articula\iile mari 1-2 ml,in cele mici 0,5 ml. Local in
sacul conjunctival, intranasal o fiola diluatain 1O ml ser fiziologic.
/S Q>.
lb
P-RF
Fdin. Ulilizat sub forma de H. acetat suspensie apoasa pentru
ac\iune antiinflamatoare 9i H. hemisuccinat solu\ie i.v. pentru
ac\iuni sis temice in afec\iuni severe, acute.
Ind. 9oc anafilactic, stare de rau astmatic, edem pulmonar toxic,
boala Addison etc.
Admin. in urgente, i.v., doza obi9nuita 100-250 mg sau peste
500 mg i.v. lent sau perfuzie. Solu\ia se pepara extemporaneu 9i
este incompatibila cu alte medicamente. In Addison, oral, 10 mg
diminea\a 9i 5 mg dupa amiaza (pana la 20-30 mg/zi, la adul\i
plus fludrocortizon). In caz de boli acute supraadaugate sau
traumatisme, doze duble . in 9oc anafilactic , adul\i, 250500 mg i.v. la 4-6 ore; copii 4-B mg/kg.
HYDROCORTISONE HF (Hemofarm,Stacia, Romania)
Liof.+solv .pt.sol.inj. 100 mg/5 ml; 500 mg/20 ml. Flac.
2 ml; 4ml. Ct. " 1 Pa 7,09; 11,91.
HIDROCORTIZON HEMISUCCINAT (Zentiva, Romania)
Sol. A : 5 f >< 1 ml hemisuccinat de hidrocortizon 25 mg/ml;
Sol. B: 5 f >< 4 ml hidrogen carbonat de sodiu (solv.) 9 mg.
Ct. >< (5 + 5). Pa 21,33
530
M EM OMED
M E M O M E D 2 0 14
2 014
531
H 03
TERAPIA TIROIDEI
H 03 A
PREPARATE DE TIROIDA
H 03 B
ANTITtROIDIENE
H 03 C IODOTERAPIE
*
* *
H 03 A PREPARATE DE TIROIDA
H 03 AA HORMONI TIROIDIENI
LEVOTHYROXI NUM
Fein. Absorb\i e digestiva 80% cu difuziunein toate \esuturile,
metabolizare hepatica cu transformare parjialain liotironina (T3).
T 1/2 pentru levotiroxina 6-7 zile.
Fdin. Efectele se instaleaza n 12-14 ore (maximum la 9-10 zile),
dureaza 2-3 saptamani (posibila cumulare).
Ind. Hipotiroidie. Pentru inhibarea secre\iei de tirotrofina dupa
tiroidectomie sau la bolnavi cu gu!?e simpla. Obezitate, la
persoane cu hipotiroidie certa.
P-6L
P-6L
H 03 B
ff 03 BB DERIVAJI DE IMIDAZOL
*
* *
H 03 BB DERIVAJI DE IMIDAZOL
532
MEMOMED
2 0 14
M E M O M E D 2 0 14
CARBIMAZOLUM
lllcmomtor tiefnrmncologle
P6L
/50>
P-6L
Fdin. Metabolit acliv al carbimazolului. Antitiroidian.
Ind. Boala Basedow, prepararea pentru tiroidectomie, adjuvant la
terapia cu radloiod.
R.a. Gre\uri,vome, cefalee, artralgie, erup\ii cutanate,prurit. Rar
H 03 C IODOTERAPIE
H 03 CA IODDTERAPICE
KALii IODIDUM
P-RF
533
M E MO MED
534
H 04
H 04 A
M E M O M E D 2 0 14
2 0 14
HORMONI PANCREATICI
ff 05
H 05 A
HORMONIPARATIROIDIENI $1 ANALOGI
H 05 B
PREPARATE ANTIHORMONI
PARATIROIDIENI
HORMONI GLICOGENOLITICI
GLUCAGONUM
Fein. Sufen3 degradare metabolica in ficat i \esuturi. _E!iiat
prin ficat $i rinichi (cate 30%). T 1/2 3-6 mmut. Dupa mi 1..
eiectul apare dupa un minut $i dureaza 5-20 minute. Dupa 1n1.
i.m. valorile respective sunt 5-15 minute $i 10-40 minute.
Fdin. Horman polipeplidic, secretat de celulele alfa din insul le
Langerhans. Produce cre$terea glicemiei, scade colesterole1a,
este anlicetogen. Are elect inotrop poziliv, cre$te deb1tul cardiac
$i coronarian.
535
H 05 A
* *
TERIPARATIDUM
Cind. Feocromocitom.
P-RF
M @
P-RF
Fein. Dupa inj. s .c. pie ser icin 1-2 ore. T 1/ 2 1,5 or a.
i trnsformare in fragmente peptidice, mai alesin ficat, pu\inin
nrnch1.
MEM OMED
536
M E M O M E D 20
14
20 14
PREPARATE ANTIHORMONI
PARATIROIDIENI
* *
H 05 B
537
P-RF
CINACALCETUM
P-RF
538
M EMOMED
2 0 14
1lfo111orntor de fnrmncologfc
ANTllNFECJIOASE
DE UZ SISTEMIC
J 01
J 02
J 04
ANTIMICOBACTERIACEE
J 05
ANTIVIRALE DE UZ SISTEMIC
J 06
IMUNOSERURI I IMUNOGLOBULINE
J 07
VACCINURI
*
* *
J 01
J 01 A
TETRACICLINE
J 01 B
AMFENICOLI
J 01
A se vedea A 11 CC
ANTIBACTERIENE BETALACTAMICE,
PENICILINE
J 01 D
J 01 E
SULFONAMIDE I TRIMETOPRIM
J 01 F
MACROLIDE, LINCOSAMIDE
I STREPTOGRAMINE
J 01 G
AMINOGLICOZIDE ANTIBACTERIENE
J 01 M CHINOLONE ANTIBACTERIENE
J 01
ALTE ANTIBACTERIENE
540
M EMOMED
4
M E M O M E D 2 0 14
/lfcm orntor de farmacofogic
201
541
* *
J 01 A
TETRACICLINE
10. Pa 3,61
przn\a
preparatelor lactate (cu excep\ia dox 1c1chne1 !?'.mmoc1ch.ne1),_a
anliacidelor, preparatelor cu calciu, fier, magnez1u. Depoz1tare m
oase i;;i din\i.
PRF
TETRACYCLINUM
@@
PRF
M E MOM ED
542
M E M O M E D 2 0 14
2 0 14
MINOCYCLINUM
543
Memorntor de Jarmacnloglc
@l @ @
P-RF
J 01 B
AMFENICOLI
CHLORAMPHENICOLUM
Fein. Absorb\i e digestiva par\iala. Eliminare renala, 70% metabolizat.
Fdin. Antib iotic cu spectru larg. Laten\a 2-4 zile.
TYGECYCLINUM
J 01 C
ANTIBACTERIENE BETALACTAMICE,
PENICILINE
MEMOMED
544
MEMOMED
4
2 0 14
Memomtor de farmacologfe
BETALACTAMAZA
545
201
i.v.in 10-20 ml apa distilata sau ser fiziologic, lnjectare lenta sau
perfuzie. Stabilitateain solu\ie la lemperatura camerei a ore 4
orein sol. glucoza 5% i inslabila la pH alcalin. Stabilitatea sca'de
cu creterea concetr_a\iei. De regula administrare imediata dupa
prepararea solu\ 1e1 sau la eel mull o ora. Numeroase
incompalibilita\iin solu\ie. Se evita asocierea cu alte substan\ e
mai ales in nacoanele de perfuzie.
'
AMPJCILINA (Antibiotice SA, Romania)
!&.
P-RF
Caps. 250 mg;500 mg. Cl. x 20; 1000; Ct. x 10; 1000. Pa
6,09.Pa 5,1B.
Pulb.pt.sol. inj./perf. 250 mg;500 mg; 1 g. Flac.Ct. x 1; .1QQ;
Cl. x 1; 50; 100;Ct. x 1;50; 100. Pa 178,76 Pa 197 OB Pa
277,98
.
'
Admin. Oral,in infec\ii U!?oare !?i medii. Adul\i, 2-4 g/zi,in prize la
6 ore. Copii: nou-nascut 50-100 mg/kg/zi,in 3-4 prize; sugar i
copil mic, 100-200 mg/kg/zi, n 3-4 prize. lnj. (i.m. sau i.v.
perfuzii),in afec\iuni severe. Adult, 4-12 g/zi,in 4 prize. Copil,
200-400 mg/kg/zi in 4 prize. lntrarahidian, n completarea
tratamentului general. 0 singura administrare zilnica : 5 mg la
sugar; 10 mg la copil mic; 15-25 mg la copil mare i adult (solu\ie
cu 5 mg/ml).in insuficien\a renala doze mai reduse. Pentru i.m.
con\inutul flaconului se dizolva in 2 ml apa distilata sterila.Pentru
1: 50. Pa 2,02
20; 100. Pa -.
M EMOM ED
546
2 0 14
M E M O M E D 2 0 14
547
Me111omto1di! fnr11111cologf(!
Ml!momtor de fnr111ncologie
AMOXICILLINUM
Pulb. pt susp. orala 125 mg/5 ml; 250 mg/5 ml. Fl. 100 ml.
Ct. x 1. Pa -
1. Pa -.
8. Pa 7,53
Caps. 250 mg; 500 mg. Ct. x 2Q; 1000; Ct. x 10; 1000. Pa
6,24. Pa 5,69.
Pulb. susp. 125 mg/5 ml; 250 mg/5 ml. Flac. 100 ml. Pa
7,55; 8,20
Caps. 250 mg; 500 mg. Ct. " 20; 1000; " 10; 500. Pa 5,95;
232,39; Pa 5,69; 133,00
1. Pa
548
MEMOMED
20 14
M E M O M E D 2 0 14
Mcmomtm de fnn11ncologle
&_
SIP-RF
549
550
MEMOMED
2 014
M E M O M E D 2 0 14
/llc111omto1de far111acologlc
&> PRF
Fein. Stabila in mediul acid gastric. Absorb\ie digestiva buna,
favor izata de administrarea pe stomacul gal. Concentra\ii
sanguine cu instalare mai lenta 9iin general inferioara fa\a de
penicilina G. Concentra\iile active se men\in 3-4 ore (in func\ie de
doza).
Fdin. Ac\iuni 9i mecanisme de ac\iune identice cu ale penicilinei
G.
Ind. lnfec\ii u9oare sau medii cu germeni sensibili: angine, erizipel,traheobron9 ite,antrax ,profilaxia reumalismului (cand nu este
posibila administrarea de benzatinpenicilina).
R.a. Gre\uri,vome (mai ales la doze mari la sugar), sensibilizare
&
BENZATHINI BENZYLPENICILLINUM
551
/lle111nm101 de fi1r111acolng fc
> SIP-RF
&
>P
RF
552
M EMOMED
2 0 14
M E M O M E D 2 0 14
553
BETALACTAMAZA
& P-RF
MEMOMED
554
2 0 14
Mcmomtor de Jamwcolop,ic
M E M O M E D 2 0 14
555
AMPICILLINUM + SULBACTAM
&_
P-RF
14. Pa -.
AMPIPLUS (Antibiotice SA, Romania)
MEDOCLAV (Medochemie Ltd, Cipru)
Amoxicilina/ Acid clavulanic
Pulb.pt.susp.orala 156,25 mg (125 mg/31.25 mg)/15 ml.
Flac.60 ml;100 ml. Pa 14,9.
Pulb.pt.susp.orala 312,5 mg (250 mg/ 62.5 mg)/5 ml
(FORTE). Flac. 60 ml; 100 ml. Pa 22,11.
Compr. film. 1000 mg (650 mg/125 mg). Ct. x 14. Pa -.
556
ME MOMED
2 014
M E M O M E D 2 0 14
P-RF
557
PIPERACILlNA/TAZOBACTAM
lslanda)
ACTAVI S (Actavis,
Piperacilina/ Tazobactam
Pulb. pt. sol. inj/perf .2 g/0.25 g; 4 g/0,5 g. Flac. Ct " 1 12
Pa -; Pa 540,43
' -
PIPERACILINA/TAZOBACTAM MYLAN (Mylan, Fran\a)
Plperacilina/ Tazobactam
Pulb. pt. sol. inj./perf. 2 g/0.25 g. Flac. 10 ml;50 ml. Ct x 1,
5, 10, 12. Pa 30,99
Pulb. pt. sol. inj./perf. 4 g/0.5 g. Flac. 50 ml. Ct. " 1 5 10
12. Pa 53,55
- '
'
Admin. Adul\i:Perfuzie i.v.3,2 g la 6-8 ore.Copii: 80 mg/kg la 68 ore. in infec\ii urinare necomplicate inj. i.m. sau i.v.
4 g/zi.in insuf. renala doze mai mici.
TIMENTIN (Beecham Group PLC. Marea Britanie)
Ticarcilina/ Acid Clavulanic.Flac. inj. 3,2 g (3 g/ 0,2 g). Ct. x
10. Pa 259,57
PIPERACILLINUM + TAZOBACTAMUM
SIP-RF
558
M E M O M E D 2 0 14
MEMOMED
* *
Ceialosporinele sunt antibiotice semisintetice derivate de la
cefalosporina C1, substan\a naturala produsa de mucegaiul
Cephalosporinum acremonium. Nucleul activ este acidul 7aminocefalosporanic, apropiat structural de nucleul penicilinelor.
Mecanismul de ac \ iune ;;i toxicitatea sunt asemanatoa re
penicilinelor. Eliminare renala sub forma activa. Principalul efect
advers este sensibilizarea alergica, uneori incruciata cu
penicilinele (10%).
Clasiflcarea.
A. Dupa genera\ii ;;i calea de administrare.
8. Dupa spectrul antimicrobian. 1.Grupul grampozitivi: genera\ia
I-a ;;i a II-a, cefotaxim, cefoperazon. 2. Grupul gramnegativi:
cefotaxim, ceflazidim,ceflriaxon, cefoperazon.
3. Compus Pseudomonas : cefsulodin, ceftazidim, cefoperazon.
4. Grupul anaerobi: cefoxilin,latamoxef, cefoperazon.
559
2 0 14
CEFALEXINUM
J 01 DB
CEFALOSPORINE GENERATIA lA
icter colestatic.
J 01 DC
CEFALOSPORINE GENERATIA ll A
J 01 DD
J 01 DE
J 01 OF
MONOBACTAMI
J 01 DH
CARBAPENEME
J 01 DI
ALTE CEFALOSPORINE
* *
J 01 DB
Caps. 250 mg; 500 mg. Ct. x 2.Q; 1000; x 10; 1000. Pa
11,82. Pa 10,51.
CEFALOSPORI NE GENERATIA lA
MEMOMED
560
14
20
M E M O M E D 2 0 14
561
P-RF
CEFUROXIMUM
SIP-RF
Cind. Alergie.
Admln . l.m. (suspensie), i.v. (solu\ie), injec\ii sau infuzie. De
evitat asociereain solu\ie cu alte medicamente . n infec!ii severe,
la adult 1,5-2 g/zi. opii 30-60 mg/kg/zi,in 3 prize. in insuf.
renala cronica marirea mte!Valulur, penlru clearance creatinina
50-30 ml/min. -8 ore; 20-10 ml/min. -12 ore; 9-5 ml/min. -24
ore; sub 5 ml/min. -48 ore. Oral (cefuroxim- axetil). lnfectii ORL,
adult 500 mg/ziin 2 prize. Copii peste 5 ani, 20 mg/kg/zl,in 2
prize. lnfec\ii respiratorii acute sau cronice, adul\i 500-1000 mg/
zi, n 2 prize.
ME MOMED
562
14
20
M E M O M E D 2 0 14
Jl/cmomtor de fnrmn cologie
563
M cmomtor de fn r111ncologie
AUROBINDO
(Aurobindo
Pharma ,
P-RF
564
MEMOMED
2 0 14
M E M O M E D 2 0 14
565
Pulb. susp. 125 mgf5 ml; 250 mgf5 ml. Flac. " 75 ml. Pa
11,9.Pa 21,4
Caps. 250 mg; 500 mg. Ct. " 16. Pa 21,4; 28,55.
><
P-RF
CEFTAZIDIMUM
SIP-RF
MEMOME D
566
M E M O M E D 2 0 14
2 0 14
Daza penlru
Ritm de
odata
g
adminislare
1
0,5
1
567
1-2/24 ore
1/ 24 ore
1/ 36 ore
1/ 46 ore
la fiecare 9edin\a
CEFTRIAXONUM
1, 10. Pa 52.61. Pa
PRF
MEDAXONE (Medochemie Ltd, Cipru)
Pulb. pt. sol. inj./perf. 500 mg; 1 g; 2 g. Flac. Ct. x 10; 50;
100; Ct. x 1,25, 50, 100; Ct x 1Q, 50, 100.Pa -. Pa -. Pa
257 ,43.
ore.
MEMOMED
568
2 0 14
M E M O M E D 2 0 14
Jllcmorntor de fnrmncofogle
OFRAMAX (Terapia,Romania)
Pulb. pt. sol. inj./perf. 250 mg; 1000 mg. Ct. x 50. Pa 300,35;
535,19.
ROCEPHIN (Roche SRL, Romania)
Flac. inj. 2 g; Ct.
1; .Q.Q. Pa 57,56.
CEFIXIMUM
569
CEFPODOXIMUM
> PRF
Fein. Absorb\ie orala, a Jeune, de 51%, crescutain prezen\a
alimentelor . Eliminare majoritar urinara (80%)in forma acliva.
> SIP-RF
CEFOPERAZONUM
CEFTIBUTENUM
> P-RF
Cind. Alergie .
Admin .Daza unica 400 mg/zi.in insuficien\a renalain func\ie de
clearance -ul la creatinina 40-30 ml/min. 200 mg/zi sau
400 mg la 48 ore; 20-5 ml/min 100 mg/zi sau 400 mg la 96 ore.
La bolnavii dializa!i de 2-3 ori/ saptamana 400 mg la sfaritul
fiecarei edin\e de dializa.
MEMOMED
570
M E M O M E D 2 0 14
2 0 14
571
Me111omto,. de /nmincologic
SIPRF
SIP-RF
Cefoperazona/ Sulbactam
Pulb. pt. sol. inj. 2 g (1 g/1g). Flac. Ct. " 1.Pa -.
SULCEF (Medochemie,Romania)
Cefoperazon/ Sulbactam
Pulb. pt. sol. inj./perf. 1000 mg/1000 mg. Flac. Cl.
50; 100.Pa 25,24; 219,94;963,48; 1856,12.
x . .
1, 10,
J 01 DE CEFALOSPORINE GENERAJIA IV a
sunl similare cu cele din genera\ia 111-a dar sunt mairzist nle, I
hidroliza prin betalactamaze. chiar ;;i la cele cre inact1veaza
cefalosporinele din genera\ia a Ill-a. F. aclle asura
aeruginosa, s. aureus. s. pneumoniae, Haemoph1
lus, Ne1ssena,
Enlerobacler. Palrundin SNC.
Adminislrare parenlerala: cefepim.
!"
CEFEPIMUM
SIP-RF
Cefalosporina parenlerala.
Fein. l.m. absorb\ie rapida ;;i completa. Difuziune_bun.a, inclusiv
in lichid peritoneal, intersti\ ial, mucoasa brn;;1c. 81otransfor_
mare redusa. Eliminare renala. 85% nemod1cata Conentr?\ 1
activein urina T1/2 = 2 ore. Cinetica nemod1ficata la varstrnc1,
hepatici.
J 01 OF MONOBACTAM I
AZTREONAM
SIP-RF
M E M O M E D 2 0 14
572
M E M O M E D 2 0 14
Memomtor de farmacologie
Memomtor de f amiacologle
J 01 DH CARBAPENEME
ERTAPENEMUM
SIP-RF
MEROPENEMUM
573
P-RF
Excretie renala.
Admln. l.v. lent (peste 5 min.) sau perfuzie (15-30 min.). Adul\i
Ind. lnfec\ii moderate-severe cu germeni sensibili, intraabdomlnale complicate, ale tegumentel or, tractului urinar,
pelvine, pneumonie, septicemie.
1:.1Q Pa
1; 10. Pa 182,99
626,31. Pa 1161,59.
DORIPENEMUM
1; 1O; 50. Pa
431,90; 779,82.
SIP-RF
1; 10.Pa -.
1; 10. Pa 4 1,15;
1;
10. Pa 1123,52
M EMOMED
574
2 0 14
M E M O M E D 20 14
Mcmorator de fnrmncofogll!
IMIPENEMUM + CILASTATINUM
575
Mc111om101 de fi1111wcofogfc
SIP-RF
J 01 DI
ALTE CEFALOSPORINE
CEFTAROLINA FOSAMIL
SIPRF
Pulb. pt. cone. pt. sol. perf. 600 mg. Flac. Ct. Ct. x 10. Pa
2647,94.
J 01 E SULFONAMIDE I TRIMETOPRIM
J 01 EB
J 01 EE
* *
J 01 EB
MEMOMED
576
MEMOMED
4
2 0 14
Mcmorntor de fnn11ncologic
COTRIMOXAZOL
&&
577
Jl!cmnrnt or de fnrmacologlc
SULFAFURAZOLUM
J 01 EE
201
P-RF
M EMOM ED
578
2 0 14
MEMOMED
J 01 F
2 0 14
579
MACROLIDE, LINCOSAMIDE
I STREPTOGRAMINE
ERITROMICINA
(Antibiotice,
Romania)
J 01 FA MACROLIDE
J 01 FF
LINCOSA MIDE
*
* *
J 01 FA MACROLIDE
ERYTHROMYCINUM
P-RF
lj &
SPIRAMYCINUM
&
P-RF
Compr. film 1,5 mil. U.i.; 3 mil. U.I. Ct. " 16: " 10. Pa g 86
25,56
' .
Fdln. Bacteriostatic . Spectrul asemanator penicilinei G: major itatea germenilor grampozitivi, stafilococi (inclusiv penicilinazosecretori), streptococi, pneumococi; unii gramnegati vi
(neisserii, hemofili), spirochete, unele rickettsii, micoplasme,
entamoeba. Rezisten\a se instaleaza lent.
R.a. Gre\uri, vome, rar alergie, diaree dupa doze mari, disfunc\ii
hepatice, icier colestatic.
Cind. Alergie, afec\iuni hepatice (mai ales sub forma inj .).
Admin. Adul\i, oral 0,25-0,50 g la 6 ore sau 0,5-1 g la 12 ore.
pana la 4 g/ziin infec\ii severe. Copii pana la 2 ani 125 mg la 6
ore; 2-8 ani 250 mg la 6 ore. Dozele pot fi dublatein infec\ii
severe. n acnee vulgara local i/sau oral 250 mg " 4/zi, 7-10 zile,
apoi doza minima eficace, mai multe luni. Acnee rozacee, local.
ROXIT HROMYCINUM
P-RF
ROKSOLIT (Eczacibasi,Turcia)
Compr. film. 150 mg.Ct. " 10. Pa -.
1O; 2.Q;
CLARITHROMYCINUM
7; 10. Pa
P-RF
buna,distribu\ia favorabila,concentratii
nd1cate 1n plaman. T Y. = 5 ore.
580
MEMOMED
2 0 14
M E M O M E D 2 0 14
581
Compr. cu elib. modif. 500 mg. Ct. >< 5, 6, 7, 8, 10, 14, 16,
20, 28, 30, 60. Pa -.
Compr.film . 250 mg; 500 mg. Ct. x 10; 14; x 14. Pa 32,23.
Pa 37,95.
Compr.film . 250 mg; 500 mg. Cl. x 7, 10, 12, 14, 21.Ct. x 7,
10, 14, 21. Pa -.
Gran. pt. susp. orala 125 mg/5 ml,250 mg/5 ml. Flac. x 50;
60; 80; 100; 120 ml; >< 50; 60; 80;1.QQ ml. Ct. x 1. Pa 26,21;
Pa 44,85; 61,52.
Compr.film. 250 mg; 500 mg. Ct. x 8, 10, 12, ,M, 16,20, 30,
100, 120. Pa 11,34; Pa 24,62.
Compr. cu elib. prel. 500 mg. Ct. " 5, .. 7, 10, 14, 20. Pa
29,37.
AZITHROMYCI NUM
Pa -. Pa
M E MOMED
582
2 0 14
M E M O M E D 2 0 14
583
J 01 FF LICOSAMIOE
Ct. x 1. Pa 16,36.
LINCOMYCINUM
> P-RF
0505.
> P-RF
Fein. Absorb\ie orala rapida. Pie seric la 1-3 ore. Eliminare prin
fecale (76%) 9i urina (17%).
CLINDAMYCINUM
> P-RF
584
MEMOMED
20 14
J\lcmomtor de Jarmacologle
M E M O M E D 2 0 14
585
llfcmomlor de fnrmacologf c
Admin. 600-1800 mg/ziimpar\ilein 3-4 doze. Copii 6-14 ani 825 mg/kg corp/ziin 3-4 doze. n acnee local sol. 2% in apa.
CUNDAMYCIN (Stacia Hemofarm SRL, Romania)
10.Pa 55,59.
R.a. Ototoxicitate cu tulburari de echilibru (reversibile ), hipoacuzie, surditate ireversibila favorizata de doze mari, tratamente
de lunga durata, insuf. renala {aten\ie la varstnici), asociere cu
substan\e ototoxice. Nefrotox icilate in caz de leziuni preexistente, doze mari, tratamente prelungite, asociere cu alte
nefrotoxice. Reac\ii alergice minore. Administratain cantita\i mari
in plaura, peritoneu, poate produce paralizie musculara, mai ales
in caz de absorb\ie rapida i Insur. renala.
J 01 G AMINOGLICOZIDE ANTIBACTERIENE
Bactericide , active pe bacterii grampozitive i mai ales
gramnegative. Absorb\ie digestiva absnta..Eimi are redominant renala, redusain insuficien\a renala (pos1b1le mve1un tox1ce) .
Reac\ii adverse caracteristice, ototoxicitatea i nefrotoxicitatea,
maiales la varstnici siin insuf. renala. Traverseaza placenta, pot
produce efecte toxic la fat. Ac\iunea ototoxica este poten\ata de
asocierea cu diurelice {furosemid, acid etecrinic). Pol produce
bloc neuro-muscular, mai ales la bolnavi cu miastenia gravis.
Dupa tratamente prelungite poate apare hipomagneziemie. Rar
colila pseudomembranoasa.
J 01 GA STREPTOMICINE
; 1.Q.Q.; Pa 170,57;
STREPTOMI C INA
SA, Romania)
BP
SULFAT
(Ant ibiotice
J 01 GB ALTE AMINOGLICOZIDE
J 01 GB ALTE AMINOGLICOZIDE
*
*
J 01 GA STREPTOMICINE
TOBRAMYCI NUM
P-RF
Vezi gentamicina.
TOBI (Novartis Pharma GmbH, Germania)
STREPTOMYCI NUM
Fein. Absorb\ie buna dupa i.m., distribu\ie in majo itate
\esuturilor, trece placenta,in laptele mtrn. Nu_ rea 1':.eaza
concentra\ii activein l.c.r. Eliminare renala in forma acliva 7090% i biliara 1%.
Sol. pt. inhalare 300 mg/5 ml. Fiole gemene a 5 ml. Ct. x 56,
112, 168. Pa 8880,31.
Ind. Tratament de durata alinfec\iilor pulmonare cronice produse
de P.seudomonas aeruglnosain fibroza chistica la pacien\i peste
6 am.
M E M O M E D 2 0 14
M EMOMED
Me111omtor de fa rmacolo. ic
piele prin care lan\ul de perle pole fi mobilizat prin trac\ iune intre
ziua 4-8 i apoi extras progresivintre ziua 12-20.
586
GENTAMICINUM
& /&
2 0 14
587
Sol. inj. 40 mg/ml. Fiola 1ml;2 ml. Ct. x 10; 50. Pa 7,13; -.
Pa 9,58; 41,48.
10. Pa -.
10. Pa 6,76.
& /&
SIP-RF
& f&
P-RF
Vezi Gentamicina.
Admin. Adult i.m.sau i.v.foarte lent sau perfuzie, 30 min. -1ora.
Doza zilnica 15 mg/kg, nu mai mull de 1,5 g,imparjilain 2-3
administrari (7,5 mg/kg la 12 ore sau 5 mg/kg la 8 ore). Durata
tratamentului 7-10 zile, control al func\iei renale, audiograma.
Sugar, copil 15 mg/kg/ziin 2-3 administrari. in insuf. renala
spa\ierea intervalelorin func\ie de nivelul creatininei, folosind
aceea i doza (7,5 mg pentru o administrare . Valoarea
creatininemiei nmul\i a cu 9 da inlervalul n oreintre administrari.
AMIKOZIT (Zentiva SA, Romania)
Sol. inj. 50 mg/ml; 250 mg/ml. Flac. 2 ml. Ct x 1. Pa -: 6,96.
588
M E M O M E D 2 0 14
M E M O M E D 2 0 14
/lfemomtor de farmacologie
Jlfemorator de farmacologl c
OFLOXACINUM
P-RF
J 01 M CHINOLONE ANTIBACTERIENE
J 01 MA FLUOROCHINOLONE
J 01 MB ALTE CHINOLONE
OFLOXIN
*
*
589
OFLOXACIN (Laropharm
(Zentiva
SRL, Romania)
AS, Cehia)
J 01 MA FLUOROCHINOLONE
Chimioterapi ce cu spectru ultralarg, farmacocinetica foarte
avantajoasa, reac\ii adverse reduse.
10. Pa 11,36.
CIPROFLOXACINUM
P-RF
><
10. Pa 13,22.
M E MOMED
590
2 014
M EMOMED
14
20
591
P-RF
Cone. pt. sol. perf. 100 mg/10 ml. Fiola 10 ml. Ct.
16,79.
2:10. Pa
NORFLOXACINUM
5. Pa -.
NORFLOX (Cipla, India)
Romania)
Sol. perf. 2 mg/ml. Punga 50 ml; 100 ml; 200 ml. Ct. x 10. Pa
-. Pa 87,49. Pa 157,33.
CIPROLEN (AC Helcor SRL,Romania)
10. Pa 8,81.
Compr. film. 250 mg; 500 mg. Ct. x 10. Pa 6,83; 13,22.
CUMINOL (Gedeon Richter SA, Romania)
Compr. film. 250 mg; 500 mg. Ct. x 1.Q; 20; 2000 x 10; 2000.
Pa 6,83; 12,3; Pa 13,22.
LEVOFLOXACI NUM
Sol. perf.2 mg/ml. Punga 50 ml;100 ml; 200 ml. Ct. x 10. Pa
162,58.
PEFLOXACINUM
Admln. Oral,i.v., 400 mg la 12-24 ore.
P-RF
P-RF
592
M E MOM E D
MEMOMED
14
2 0 14
Mc11wrator de fan11t1cologfc
20
593
33,65.
z. 10. Pa
Compr. film 250 mg; 500 mg. Ct. >< 1, 3, 5, 7, 50, 200, 500.
Pa -.
TAVANIC (Aventis Pharma, Germania)
z.
136,96.
MOXIFLOXACINUM
P-RF
z.
594
M EMOMED
2 0 14
MEMOMED
2 0 14
J 01
ALTE ANTIBACTERIENE
J 01 XA
GUCOPEPTIDE ANTIBACTERIENE
J 01 XB
POLIMIXINE
J 01 XO DERIVAJIDE IMIDAZOL
J 01 XE DERIVAJIDE NITROFURAN
J 01
Compr.film.400 mg. Ct. x 5; 7; 10; 14; 25; 30; 50; 70; 80;
100; 1000. Pa -.
VANCOMYCI NUM
J 01 MB ALTE CHINOLONE
ACIDUM NALIDIXICUM
P-RF
595
xx
ALTE ANTIBACTERIENE
*
*
*
s
596
MEMOMED
2 0 14
M E M O M E D 2 0 14
/lfemomtor de farmacologfe
TEICOPLANINUM
597
> PRF
J 01 XB POLIMIXINE
EDICIN (Lek Pharmaceuticals DD, Slovenia)
Liof.pt.sol.lnj/perf.500 mg; 1g.Flac. Ct. x 1.Pa -.Pa 71,94.
COLISTINUM
> PRF
Pulb. pt. cone. pt sol. perf. 500 mg; 1000 mg. Flac. Ct. x 1.
Pa
1.Pa 32,82;63,52.
598
MEM OMED 2
014
M E M O M E D 2 0 14
,lfc111orator de farmacologic
599
J 01 XO DERIVAJI DE IMIDAZOL
METRONIDAZOLUM
Fein. Absorbtie orala, 80%
intr-o era, neinfluen\ata de alimente.
Difuzare
in plaman, rinichi, iicat, bila, lcr, piele, saliva, lichid
seminal, secre\ii vaginale. Trecein laptele matern, traverseaza
placenta. Biotransformareintr-un metabolit principal, activ pe
anaerobi, cu 30% din ac\iunea metronidazolului 9i T 1/2 11 ore 9i
un alt metabolit mai pu\in activ. Cone. hepatica 9i biliara forte ,
slaba in colon 9i fecale. Excre\ie urinara. 35-65% din doza
adminlstrata.
Germania)
Sol. perf. 5 mg/ml. Flac. 100 ml. Ct. >< 10; 20. Pa 48,37/
48,92; 278,47.
TINIDAZOLUM
P-RF
Fein. Absorb\ieinalla digestiva, pie plasmatic la 2 ore. T1/2 = 1214 ore. Excre\ie urinara.
M E M OM E D
600
M E M O M E D 2 0 14
2 0 14
601
J 01 XX ALTE ANTIBACTERIENE
FOSFOMYCINUM
[:] i&,
P-RF
Fein. Absorb\ie orala 50%. Pie serlc dupa 2-2 1/2 ore. Eliminare
urinara sub forma activa. T1/2 2 ore.
Fdfn. Bactericid cu spectru larg (Grampozilivi !?i negativi):
colibacil, Proteus, Klebsiela, Enterobacter , Pseudomonas ,
Serralia, Enterococcus, Staphylococcus.
J 01 XE DERIVAJI DE NITROFURA N
NITROXOLINUM
NITROFURANTOI NUM
P-RF
P-RF
602
MEMOM ED
2 0 14
Mc:momtor de ft1r111nco/ogic
LINEZOLIDUM
Lth @
SIPRF
MEMOMED
603
2 0 14
Clearance-ul
creatininei
= 30 ml/min
Doza
recomandata
< 30 ml/min
4 mg/kg o data pe zi
4 mg/kg la 48 ore
6 mg/kg o data pe zi
1; 1Q; 30. Pa
SIP-RF
1.Pa -.
604
MEMOMED
M E M O M E D 2 0 14
2 0 14
605
llfc111omtor de farmacolog/c
llfc111orntor deJar111acologlc
J 02 A ANTIMICOTICE SISTEMICE
J 02 AA ANTIBIOTICE
J 02 AB DERIVATI DE IMIOAZOL
ginecomastie.
J 02 AC DERIVATI DE TRIAZOL
* *
J 02 AA ANTIBIOTICE
AMPHOTERICINUM
P-RF
J 02 AB DERIVATI DE IMIOAZOL
KETOCONAZOLUM
P-RF
J 02 AC DERIVAJI DE TRIAZOL
FLUCONAZOLUM
P-RF
606
M E M O M E D 2 0 14
MEMOMED
Mcmorator de fan11awlogic
Mcmomtor de far111acologle
607
20 14
Sol. perf. 2 mg/ml. Fl. 50 ml; 100 ml: 200 ml. Ct. x 1: 50. Pa
53,14
@ FLUCONAZOL (Slavia Pharm SRL, Romania)
Caps. 50 mg.; 150 mg. Ct x 7; x 1. Pa 19,58. Pa 9,68.
Caps. 150 mg. Ct. x 1. 2, 4, 6, 7, 10, 12, 14, 20, 21, 28, 30,
50, 60, 90, 100. Pa 10,06
z.
10, 14,
20. 21, 28. 30, 50, 60, 90, 1oo " 1, 2, 3, 4, 5, 6, I. 10, 14, 20.
21, 28, 30, 50, 60, 90, 100 x 1.2, 3, 4, 5, 6, 7, 10, 14, 20, 21,
28, 30, 50, 60, 90, 100. Pa 29,61. Pa 43,36. Pa 13,54
FLUCONAZOL
Germania)
Sol. perf. 2 mg/ml. Fl. 50 ml; 100 ml: 200 ml. Ct. x 1Q; 2.Q; 50
x .ill: 2.Q: 50; x 10; 20; 50. Pa 223,28; 433,33. Pa 533,65:
906,22 Pa 878,17.
@ FLUCONAZOL BIOGALENICA (Lab. Prof. Dr. MORAIT,
Romania)
Caps. 50 mg: 100 mg: 150 mg: 200 mg. Ct. x 7: x 28; x 1; x
7; 20. Pa 61,72; Pa 236,41; Pa 22,51; Pa -.
Sol. perf. 2 mg/ml. Flac. 100 ml. Pa 45,82.
Sol. perf. 2 mg/ml. Fl. 50 ml; 100 ml;200 ml. Ct. x 20; x 20;
x 10. Pa 419,65. Pa 724,85. Pa 866,55.
Caps. 50 mg; 150 mg. Ct. >< 1, 2, 3, 4, 6, I. 10, 12, 14, 20,
28, 30, 42, 50, 60, 100, 500. Ct. x 1. 2, 3, 4, 6, 7, 10, 12, 14,
20, 28, 30, 42, 50, 60, 100, 500. Pa 56,54; 25,08.
Pulb. pt. susp. orala 10 mg/ml. Flac.
: 175 ml. Pa
Sol. perfuz. 2 mg/ml; Flac. 25 ml; 50 ml: 100 ml; 200 ml.
Pa -.
Sol. perf. 2 mg/ml. Fl. 50 ml: 100 ml; 200 ml. Ct. x 1:.ill: 2.Q;
2.Q: 30; 40; 50; 60. x 1.;.1Q: 2.Q; 25; 30; 40: 50; 60. )( 1;.ill: 20;
25; 30; 40. Pa 25,47, 222,1; 431 ,39; 521,39. Pa 44,84;
398,62; 726,39; 890,27. Pa 103,62; 868,42.
31,71.
608
M EM O MED 2 014
llfc111ora/01" de fnr111n cofogic
MEMO MED 2 0 14
609
llfc111omt or de fnr111ncofogic
@ FLUCONAZOL MEDICO
Pharmaceutical SRL, Romania)
UNO (Medico
Uno
SRL,
ITRACONAZOLU M
>
P-RF
Caps.150 mg. Ct
1.Pa 12,94
Caps. 50 mg; 100 mg; 150 mg. Ct. >< 7; x 4; >< 1.Pa 22,56;
25,61; 9,94.
Caps. 50 mg; 100 mg. Ct. >< 4; ; " 8; 1.. Pa 19,04; Pa 82,66
=-
100 mg. Ct. >< 4, 6, 14, 15, 16, 18, 28, 30, 32, 60, 100.
MEMOMED
610
2 0 14
P-RF
1.Pa 2750,28
M EMOMED
612
2 0 14
M E M O M E D 2 0 14
J 04
ANTIMICOBACTERIACEE
J 04 A
J 04 B
MI CAFUNGINUM
glucan).
/nd.Tratamentul candidozei invazive la pacien\i supui transplantului medular sau neutropenici. Candidoza esofagiana.
R.a. Leucopenie, neutropenie, anemie,hipopotasemie, hipomagneziemie, hipocalcemie), cefalee, flebita, grea\a, varsaturi,
diaree, dureri abdominale, creterea fosfatazei alcaline,
aspartatamin otransferaza, alaninaminotransferaza , bilirubina,
erup\ii cutanate, pirexie, frisoane.
*
J 04 A
J 04 AB ANTIBIOTICE
J 04 AC HIDRAZIDE
J 04 AD DERIVAJIDE TIOCARBAMIDAA
J 04 AK ALTE ANTITUBERCULOASE
AN IDULA FUNGINUM
S
613
ilfcmomtor defarmacologlc
*
1. Pa
* *
J 04 AB ANTIBIOTICE
>
CYCLOSERINUM
.&_
> SIP-RF
M E M OM E D
614
MEM OMED
14
2 0 14
Mc111omtor de fnr111ncologic
20
615
Memomtor de fnrmncologfc
Caps. 150 mg; 300 mg. Ct. x 20; 1000: x 10; 1000. Pa
199,62. Pa 615,85
RIFAMPICINUM
f&
> P-RF
R.a. Gre\uri, vome, meteorism, diaree, rar colita pseudome mbranoasa; reac\ii cutanate moderate, hepatotox icitate {favorizata
de leziuni preexistente, alcoolism); trombopenie, purpura
{reversibila), eozinofilie, leucopenie; ..sindrom gripal" (Ou-syndrom) cu febra, frison, cefalee, ame\eli, curbatura (apare la 3-6
luni de tratament, mai ales discontinuu) insuf. renala acuta, de
obicei reve rsibila; tulb. respiratorii, hipotensiune, anemie
hemolitica. Poate colorain rou urina, sputa,lacrimile.
Cind. Suferin\e hepatice, alergie, asociere cu hepatotoxice,
porfirie, alcool. De evitat alaptarea la san.
Admin. Oral. Tubercul oza. Adult. Tratament zilnic 10 mglkg zi,
{in medie 600 mglzi) intr-o singura prizii, inainte de masa.
Tratament discontinuu {bisiiptamanal) 750 mg la greutate sub 60
kg !?i 900 mg la peste 60 kg,intr-o singurii priza pe zi. Copil 7-15
ani, 10 mglkg/zi; sugar i copil pana la 7 ani, 10-25 mg/kg/i;
nou-nascut 1O mg/kglzi. Durata tratamentul ui 6-12 luni. In
stafilococii :;;i alte infec\ii grave cu germeni sensibili, la adult,
sugar si copil in medie 20-30 mg/kg/ziin 2 prize; la nou-niiscut
15-20 g/kg/ziin 2 prize. Gonoree, adult 900 mg zi, o singurii
administrare. Profilaxia meningitelor cu meningococ i purtatori
2-3 zile, adult cate 600 mg la 12 ore, copil 10 mg/kg la 12 ore,
nou-nascut 5 mg/kg la 12 ore. l.v..in forme grave, perfuzie lenta
(90 min), diluarein 250 ml sol. glucoza 5%. Aceea:;;i posologie ca
la forma orala. Nu se asociaza cu alte substan\ein solu\ie.
> SIP-RF
CAPREOMYCINUM
Fein. Pu\in absorbitii din tractul digestiv. Dupa 1 g l.m. pie seric la
1-2 ore. Eliminare neschimbata prin filtrare glomerulara (50%
in
12 ore).
Fdin. Bacteriostatic fa\a de micobacterii. Rezisten\a se instaleaza repede la administrare in monoterapie. Rezisten\a
incruciata cu Kanamicina, neomicina, viomiclna.
Ind. Tratamentul tuberculozeiin scheme multidrog.
J 04 AC
HIORAZIOE
ISONIAZIDUM
&_ &,
> SIP-RF
!n
616
MEMOMED
2 0 14
M E M O M E D 2 0 14
617
ETHIONAMIDUM
SIP-RF
J 04 AD
><
DERIVAJI DE TIOCARBAMIDA
&
PROTIONAMIDUM
SIP-RF
J 04 AK ALTE TUBERCULOSTATICE
PIRAZINAMIDUM
&
SIP-RF
Fein. Absorb\ ie digestiva buna, distribu\iein majoritatea \esuturilor ;;i n l.c.r., epurare mai ales prin metabolizare.
R.a.Anorexle, vome, hepatotoxicitate,artralgii, tulb. ale hematopoezei, erup\ii, fotosens ibilizare, hiperuricemie.
><
100. Pa 124,62
Ra. Hiperuricemie.
Admin. Asociere obligatorie cu alte antituberculoase. Posologie
uzuala 30 mg/kg/zi, o singura prizain tratament zilnic ;;i 60 mg/
kg/zi, o singura priza, n tratament discontinuu (blsaptamanal),
maximum 4 g/zi. Copii 20 mg/kg/zi.
M E M O M E D 2 0 14
618
M E M O M E D 2 0 14
SIP-RF
ETHAMBUTOLUM
J 04 AM COMBINAJll DE SUBSTANJE
SIP-
RF
SINERDOL ISO (Antibiotice SA, Romania)
Rifampicina 300 mg; lsoniazida 150 mg. Caps. Ct. x 10;
1000. Pa 670,35.
J 04 B
619
OAPSONUM
Fein. Absorb\i e digestiva aproape completa. T 1/2 28 ore.
Oifuzare buna in toate \esuturile i lichidele biologice. Acetilare
hepalica. Ciclu entero-hepatic. Eliminare renala.
Ind. Antilepros . Dermatita herpetiforma. Malarie (profilaxie si
tratamen tin asocieri).
'
100. Pa -.
M EMOMED
620
2 0 14
J 05
ANTIVIRALE DE UZ SISTEMIC
J 05 A
J 05 AE INHIBITOR! DE PROTEAZA
J 05 AF NUCLEOZIDE INHIBITORI DE REVERS
TRANSCRI PTAZA
ALTE ANTIVIRALE
Caps. 200 mg; 400 mg. Ct. x 20; 1000: x 10. Pa 21,42;
805,66; Pa 19,48.
621
*
*
2 0 14
ilfcmora/or de fnrmacologlc
J 05 AH
MEMOMED
&
P-RF
Fein. Absorb\ie orala cu biodisponibilitate 20%. in l.c.r. concentra\ii 50% din cele plasmatice.
20. Pa 20,23,
622
MEMOMED
MEMOMED
2 0 14
2 0 14
623
Me111orator de faruwcologle
@@
RIBAVIRINUM
P-RF
L'.&.
SIP-RF
P-RF
Compr. film 500 mg.Cl. x .1Q; 24; 30; 42; 90; 112. Pa 56,95.
624
M E M O M E D 2 0 14
M E M O M E D 2 0 14
Mcmomlor de farmncofogic
Mc111omto1 de fnn11ncofogic
CIDOFOVIRUM
625
60. Pa 5338,93.
J 05 AE INHIBITORI DE PROTEAZA
SAQUINAVIRUM
SIP-RF
P-RF
BRIVUDINUM
Pree. Afectare hepatica, renala, diaree. malabsorbtie, adolescen\i sau varstnici, hemofilie, diabet zaharat,sarcina, alaptare (se
intrerupe alaptarea). Evitarea asocierii cu rifampici na,
fenobarbital, fen itoina, dexametazon, carbamazepina,
ketoconazol, itraconaz ol, miconazol, flucomazol, terfenadina,
astemizol, cisaprid.
Admin. Adul\i 9i adolescen\i peste 16 ani.in asociere cu ritonavir,
1000 mg/zi, n 2 prize + 1DO mg ritonavir,in 2 prize, n acela9i limp
cu Fostovase 9i la 2 ore dupa mese. Cand cele 2 se asociaza cu
alte antiretrovirale se reduce doza de Fostovase.
1; I; 35. Pa 332,58
VALGANCYCLOVI RUM
RF
M E MOM E D
626
2 0 14
M E MOM E D 2
014
Mcmomtor de farmncologic
627
Ind. HIV.
NELFINAVIRUM
!&_
SIP-RF
R.a. Diaree.
Admin. Oral, 1250 mg de 2 ori/zi sau 750 mg de 3 ori/zi.
VIRACEPT (Roche Ltd, Marea Britanie)
180; x 180;
1. Pa -.
SIP-RF
AMPRENAVI RUM
SIP-RF
Adm in. 300 mg x 2/zi, 3 zile, apoi crescut cu 100 mg/zi pana la
600 mg x 2/zi oralinainte sau
in timpul meselor nu mai mutt de 14
zile. Reducerea dozelor n afec\iuni hepatice sau renale.
La copii: seincepe cu 250 mg/m2 9i se cre9te cu 50 mg/m2 de
2 ori/zi peste 2 ani, la 2-3 zile pana la 600 mg x 2 /zi.
NORVIR (Abbott Lab.Ltd, Marea Britanie)
Caps.moi 100 mg. Ct. x 84; 336. Pa -.
Compr. film. 100 mg. Ct. x 30; 60; 90. Pa 239.74; 460,05 ;
654,64
Sol. orala 80 mg/ml. Flacon 90 ml. Ct. x 5. Pa -.
SIP-RF
M E M O M E D 2 0 14
628
M emorntor de fnrmncologie
ME MOME D 2
014
629
SIP-RF
ATAZANAVI RUM
Fein. Absorb\ie digestiva. Excre\ie prin fecale ;;i urina. T 1/2 8,6
ore. Cone. de echilibruin 4-8 zile.
Fdin. Inhibitor de proteaza.
Ind. Tratamenlul infec\iei cu HIV-1,asocial cu alte antiretrovirale.
TIPRANAVIRUM
Caps. 100 mg; 150 mg; 200 mg; 300 mg. Ct. x 60; x 60; "
60; x 30; 90. Pa -. Pa1760,22; Pa -. Pa 1881,78.
Pulb. pt. sol. orala. 50mg/1,5g. Flacon 180 g. Ct x 1. Pa -.
TELAPREVI RUM
168. Pa 40157,32.
SIP-RF
BOCEPREVIRUM
&&
SIP-RF
MEM OMED
630
2 0 14
M E M O M E D 2 0 14
631
Fdin. Activata in organism prin transformare in zidovudintrifosfat. lnhiba transcriptaza virala,in special cea a HIV.
STAVUDINUM
impunand reducerea dozelor sau oprirea tratamentului; enomenele sunt reversibile. Anorexie,gre\uri, vome,febra ,alopecie,
prurit, dureri toraclce, mialgii, somnolen\a,tulburari hepatice.
&lflD.
> SIPRF
tare .
lflD.
DIDANOSINUM
>
SIP-
20%.
Admin .200 mg
2/zi.
; 60. Pa
RF
Fein. lnstabilin pH acid gastric, T1/2
&&
> SIPRF
M E M O M E D 2 0 14
632
MEM OMED 20
14
Jlfcmorator de fm11wcologlc
633
TENOFOVIRUM DISOPROXIL
Compr. film 150 mg; 300 mg. Ct. x 30, 60, 90, 120.Pa -.
16 ani.
ABACAVIRUM
RF
&
SIP-
M E MOMED
634
2 014
M E MOME D
14
20
635
P-RFIR
EMTRICITABINUM
J 05 AG NENUCLEOZIDE
TRANSCRIPTAZA
NEVIRAPINUM
ENTECAVIRUM
.!P0.
SIP-
RF
INHIBITOR!
DE
REVERS
.!P0.
SIP-RF
TELBIVUDINUM
.!P0.
SIP-
RF
MEMOMED
636
2 0 14
M E M O M E D 2 0 14
Compr. cu elib. prel. 50 mg; 100 mg; 400 mg. Ct. x 180; "
90; x 30; 90. Pa 835,6.Pa 835,6. Pa 1091,94.
Susp.orala. 50 mg/5 ml. Flac. 240 ml. Pa 228,1.
EFAVIRENZUM
637
Mcmomtor <lefnrmncologie
lj
> SIP-RF
><
120. Pa 2160,38.
RILPIVIRINUM
> SIP-RF
J 05 AH INHIBITORI DE NEURAMINIDAZA
ZANAMIVIRUM
> P-RF
> SIP-
ETRAVIRINUM
RF
&
M E M O M E D 2 014
636
'
M E M O M E D 2 0 14
639
&
P-RF
MEMOMED
640
14
20
MEMOMED
2 0 14
641
fllcmomtor de farmacnlogi c
fl/cmorator de farmacologlc
><
><
30; 90. Pa .
2/zi.
LOPINAVIR IRITONAVIR
ABACAVIR $1 LAMIVUDIN
PRF
PRF!R
EMTRICITABINUM+TENOFOVIRUM
><
P-RFIR
30. Pa .
ABACAVI RUM+LAMIVUDINUM+ZIDOVUDINUM
M E M O M E D 2 0 14
642
M E M O M E D 2 014
Memnmtor de farmacofogle
643
Memorator de farmacofogle
J 05 AX ALTE ANTIVIRALE
RALTEGRAVI RUM
INOSINUM PRANOBEX
P6L
P-RF/R
> SIPRF
Fein. Absorb\i e dupa admin. s.c. Pie. seric dupa 4 ore. T 1/2
4 ore.
Fdin. Inhibitor de fuziune. lnhiba rearanjarea structurala a gp 41
HIV-1, prin legarea specifica de aceasta proteina virala.s_e leaga
de o glicoproteina care pemrite trecerea transmembranara a HIV,
opreste unirea virusului cu receptorii CD4 din celulele bolnavulur.
Previne patrunderea HIVin celula.
Ind. Asocial cu alte antiretrovirale,in trat. bolnavilor infecta\i cu
HIV-1deveni\ i rezisten\i n timp de trei luni de tratament antiviral.
R.a. Apar la 70% dintre cei tra.ta\i, cu orirea ad.mi . la 8%.
Neuropatie periferica, pneumome, depres1e, duren 1 nodul la
locul inj.
Admin. Numai de catre medici speciali!iiti. lnj. sc. de 2 " zi.
FUZEON (Roche Registration Ltd., Marea Britanie)
Pulb. pt sol. inj.90 mg/ml. Flac. Ct " 60. Pa .
Pulb. pt sol. inj. 90 mg/ml. Flac. + nae. solv. Ct " 60. Pa
6677,11.
MARAVIROCUM
P-RFIR
MEMOMED
644
20
M E MOM E D
20
645
14
4
Mcmorator '"for11UJcologic
J 06
IMUNOSERURI I IMUNOGLOBULINE
J 06 B
IMUNOGLOBULINE
*
*
*
J 06 B
IMUNOGLOBULINE
*
* *
J 06 BA IMUNOGLOBUUNE DE ORIGINE UMANA, NORMALA
IMUNOGLOBULINA UMANA
EXTRAVASCULARA
NORMALA
PT. ADM
P-RF
><
1.
646
M E M O M E D 2 0 14
ll/e111omto1 tie far111acof ogle
M E MOM ED
14
20
647
llfemomtor de farmacologie
J 06 BB IMUNOGLOBULINE SPECIFICE
Fdin. lmunoglobulina Anti-D conline anticorpi specifici ( lgG)
impotriva antigenelor umane eritrocitare
Sol.perf. 50 g/I ; 100 g/I. Flac. 10 ml; 20 ml; 50 ml; 100 ml;
200 ml. Ct. x 1
1MUNOGLOBULINA SPECIFIC.ii. AN Tl D
648
MEMOMED
2 0 14
M E M O M E D 2 0 14
llf c111ornto1 tic f nrmacologic
649
>s
pALIVIZUMABUM
Fdin. Proteina umana 150 mg/ml, din care eel pu\in 96% este
lgG , cu un con\inut de anticorpi impotriva antigenului de
suprafa\a (HBs) al virusului hepatitic B de 500 u.i./ml.
Ind. Prevenirea reinfec\iei cu virusul hepatitic B (VHB) la bolnavi
cu ADN-VHB negativ,dupa eel pu\in 6 luni de la un transplant de
ficat pentru insuficien\a hepatica indusa de hepatila B.
Fdln. Con\inut proleic de 30-70 mg/ml, din care imunoglobulina
G (lgG) 96%, cu un con\inut specific mare de anticorpi impotriva
antigenului de suprafa\a al virusului hepatitei B (Ag HBs).
Fein. Dupa inj. i.m. este disponibilain circula\je dupa 2-3 zile.
T 1/2 de eliminare 3-4 saptamani.
Ind. lmunoprofilaxia hepatilei B:in cazul expunerii accident ale a
subiec\ilor neimuniza\i; la pacien\ii care fac hemodializa; la nounascu\i din mame purtatoare ale virusului hepatitei B; la subiec\i
care nu au avut un raspuns imun dupa vaccinare.
IMUNOGLOBULINA SPECIFICA ANTIRABICA
>
s
FAVIRAB (Sanofi-Pasteur SA, Fran\a)
Sol. inj. i.m. 200-400 Ul/ml. Flac. 5 ml. Ct. x 1; 10
Ind. Profilaxia rabieila persoanele cu suspiciune de expunere la
virus ul rabic, atunci cand animalul domestic sau salbatic nu
poate fi examinat , este infectal sau suspectat a fi lnfectat cu
virusul rabic.
IMUNOGLOBULINA SPECIFICA ANTITETANI CA
2347,88; 3852,21.
MEMOMED
650
MEMOMED
2 014
J 07
J 07 A
I VIR A LE ,
*
*
651
VACCINURI
VACCINURI BACTERIENE
J 07 B VACCINURI VIRALE
J 07 C VACCI NU RI BACTERI ENE
COMBINATll
J 07 X ALTE VACCINURI
2 0 14
Mcmomtor de fnn11acologic
J 07 A VACCINURI BACTERIENE
J 07 AE VACCINURI HOLERICE
VACCI N HOLERIC ORAL
Ind. lmunizarea aclivairnpotriva bolii cauzate de Vibrio cholerae,
serogrupul 01, la adul\i !?i copii cu varsta peste 2 ani, care
urmeaza sa rneargain zone endemice/epidemice.
Admin. Adul\i !?i copiii cu varsta peste 6 ani: 2 doze de vaccin. La
copiil cu varsta cuprinsaintre 2 !?i 6 ani: 3 doze. Dozele se
administreaza la interval de eel pu\ in o saptamana una de
cealalta.
Doza de rapel: adul\i !?i copiii cu varsta peste 6 ani: o singura
doza de rapel dupa 2 ani; copiii cu varsta cuprinsaintre 2 !?I 6 ani,
dupa 6 luni.
652
MEM OMED
2 014
M E M O M E D 2 0 14
Mcmomtor de farmacologie
Mcmorator de farmacologlc
653
J 07 AH VACCINURI MENINGOCOCICE
J 07 AJ VACCINURI PERTUSSIS
c (Sanon
Flac. monodoza cu liofilizat (polizaharid purificat de Neisseria menin9ilidis de 9rup A 50 119; polizaharid purificat de
Neisseria menin9itidis de 9rup C 50 119) l?i serin9a
preumpluta cu solvent pt. reconstituire. Ct. >< 1; 10.
Fdfn. Polizaharidele menin909ocice purificate de Neisseria
menin9itidis sero9rup A l?i C induc nlveluri protectoare de
anticorpi antimenin9ocociincepand din a 7-a zi.
Ind. lmunizare aclivaimpotriva infec\iilor invazive cu menin9ococ
de sero9rup A i,;i C la adul\i i,;i copii peste 2 ani.
R.a. Durere, eritem, cefalee, varsaturi, anorexle, rar aler9ii sau
anafilaxii.
Cind. Boli acute sau febra (se amana).
J 07 AL VACCINURI PNEUMOCOCICE
VACCINURI
PURIFICATE
PNEUMOCOCI CE
POLIZAHARIDICE
POLIZAHARIDICE
Admin . lmunizare primara: copii cu varsta cuprinsaintre 2 luni 1 an: 2 doze a cate 0,5 ml,la un interval de eel pu\in 2 luni.Copii
cu varsta peste 12 luni, adolescen\i i,;i adul\i: o singura doza de
0,5 ml.
654
M E M O M E D 2 0 14
M E M O M E D 2 0 14
J 07 AP VACCINURI TIFOIDICE
TYPHIM Vi {Sanofi Pasteur SA, Fran\a)
Polizaharid capsular purificat de Salmonella typhi 25 mcg/
doza
Sol. inj. Flac. multidoza 5 ml (10 doze); 10 ml (20 doze).Ct.
" 1.
Sol. inj. Seringa preumplula monodoza cu/ fara ace 0,5 ml.
Ct. x 1; 20.
J 07 AM VACCINURI TETANICE
2 ani.
J 07 AN VACCINURI TUBERCULOASE
655
Mcmomt or de fan11acologtc
Ind. Vaccinarea activa contra febrei tifoide la adul\i !;li copii peste
Admin. 0 doza de 0,5 ml i.m.
PRF
656
M E M O M E D 2 0 14
Memorntor de farmacologie
ME MOM E D
14
20
657
Memomtor de farmacologie
J 07 B VACCINURI VIRALE
SIP-RF
ENCEPUR ADULTl (Novartis Vaccines and Diagnostics
GmbH, Germania)
Susp. inj. Virus TBE (virus encefalitic transmis de capuse)
inactivat si purificat, tulpina K23 1,5 g/0,5 ml. Seringa
preumplut . Ct. x 1; 1O
J 07 BB VACCINURI GRIPALE
658
MEM OMED
2 0 14
Mc111omto1 de fnrmacologic
Admin. I. m. sau s.c.. Adul\i l?i copii peste 36 luni 0,5 ml. Copii
6-35 luni, 0,25 ml sau 0,5 ml. Pentru copiii nevaccina\i anterior se
mai adm. o doza dupa eel pu\in 4 saptama ni.
VACCIN GRIPAL INACTIVAT $1 PURIFICAT
MEM OMED
2 0 14
659
J 07 BC VACCINURI HEPATITA
VACCI N HEPATITIC B
SIP-RF
660
M E M O M E D 2 0 14
Jllemnmtor de fnrmncologie
MEMOME D
14
20
661
Memomtor defnrmacologle
VACCIN HEPATITIC A INACTIVAT
>S
Admin. La copii (nou nascu\i, sugari !?i copii cu varsta > 15 ani)
>s
662
M EMOME D
2 0 14
Mcmomtor de fn rnwcologic
ME MOME D
014
663
J 07 BD VACCINURI RUJEOLA
VACCIN RUJEOLIC,RUBEOLIC, URLIAN, VIU ATENUAT
M-M-RVAXPRO (Sanofi Pasteur MSD SNC, Fran\a)
J 07 BF VACCINURI POLIOMIELITICE
IMOVAX POLIO (Sanofi Pasteur SA, Fran\a)
Susp. inj. O doza de 0,5 ml con\ine virusuri poliomielitice
inactivate tip 1: 40 U.D.; tip 2: 8 U.D.; tip 3: 32 U.D. Seringa
preumpluta 0,5 ml. Flac. 5 ml(10 doze); 10 ml (20 doze); 25
ml (50 doze). Ct. x 1; 20; x 1; 10, x 20; x 50.
Ind. Prevenirea poliomielitei la sugari, copii, adul\i, pentru
vaccinarea primara ;;i rapel.
Admin. Vaccin area primara, 3 doze succesive de 0,5 ml la 1-2
1uni.incepand cu varsta de 2 luni. Rapel la 1 an, apoi la 5 ani. La
adul\i la 10 ani.
J 07 BH VACCINURI ROTAVIRUS
VACCIN ANTIROTAVIRUS VIU,ATENUAT
P-RF/ S
664
M E M O M E D 2 0 14
Mcmomtor
rlc Jarmacologlc
665
M E M O M E D 2 0 14
> P-RF!S
J 07 BK VACCINURI VARICELICE
ATENUATE
I ZOSTERIENE VII,
Pulb. + solv. pt. sol. inj. 0 doza (0,5 ml) con\ine virus
varicelo-zosterian viu, atenuat tulpina OKA. Flac.
monodoza cu pulb. + seringa preumpluta cu sau fara ace/
fiola cu solvent. Ct. x 1 ; 10 ; 25 ; 100
> P-RFIS
666
M E M O M E D 2 0 14
M E M O M E D 2 0 14
11fc111on1tor de fi1n11ncofogif.!
J 07 c VACCINURI BACTERIENE
COMBINAJll
>
> P-RF/S
P-RF/S
I VIRALE,
667
Mcmomtor de farmacologlc
>
P-RF/S
668
M E M O M E D 2 0 14
M E M O M E D 2 0 14
llfemomtor de fan11acologlc
Memorntor defnn11acologie
Liof.+susp.pr.susp.inj. 0 doza de 0,5 mlcon\ine:Anatoxina
difterica 30 u.i. Anatoxi na tetanica 40 u.i.; AnatoxiM
pertussis 25 mcg; Hemaglutinina pert. 25 mcg; Virus polio
tip 1 40 U.D.; tip 2 - 8 U.D.; tip 3 - 32 U.D.; Polizaharid
Haemophylus tip b 10 mcg. Flac. liof. + Oac. 0,5 ml sotv./
seringa 0,5 ml solv. Ct. x 1; 10; 25; 50.
Ind. lmunizare activa de la varsta de 2 luni. Nu se utilizeaza peste
5 ani.
PENTAXIM (Sanofi Pasteur, Fran\a)
Susp. inj. 0,5 ml con\in: Anatoxina difterica 30 U.1.;
Anatoxina tetanica 40 U.I.; Anatoxi na Bordetella 25 mcg;
Hemaglutinina Bordetella 25 mcg; Virus polio tip 1-40 U.D.;
tip 2 - 8 U.D.; tip 3 - 32 U.D. Polizah. Haemophilus
influenzae 10 mcg. Flac. + seringa preumpluta cu/fara ace.
Ct. x 1; 20
Ind. Vaccinarea primara I de rapelimpotriva difteriei ,
tetanosului, tusei convulsive, poliomielitei ?i bolli invazive cu
Haemophilus influenzae de tip b la sugari i copii de lavarsta de 6
saptamani.
VACCIN DIFTERIC, HEMOPHILUS INFLUENZAE PERTUSSIS,
POLIOMIELITIC, HEPATITA B $1 TETANIC
P-RF/S
INFANRIX HEXA (GlaxoSmithl<line Biologicals SA, Belgia)
Pulb. + solv . pt. susp. inj. 0 doza de 0,5 ml con\ine:
Anatoxi na difterica 30 u.i. Anatoxina tetanica 40 u.i.;
Anatoxina pertussis 25 mcg; Hemaglutinina pert. 25 mcg;
Pertactina 8 mcg; Virus polio tip 140 U.D.;tip 2 -8 U.D.;tip
3 - 32 U.D.;Antigen de suprafa\a al virusului hepatic B 10
mcg; Polizaharid Haemophylus tip b 10 mcg. Fiac.
monodoza + Seringa preumpluta cu/ fara ace. Ct. x 1; 10;
20; 50.
HEXACIMA (Sanofi Pasteur, Fran\a)
Susp.inj. 0 doza de 0,5 ml con\ine: Anatoxi na difterica 30
u.i. Anatoxina tetanica 40 u.I.;Anatoxi na pertussis 25 mcg;
Hemaglutinina pert. 25 mcg; Virus polio tip 1 - 40 U.D.; tip 2
- 8 U.D.: tip 3 - 32 U.D.; Antigen de suprafa\a al virusului
hepatic B 10 mcg; Polizaharid Haemophylus tip b 10 mcg.
Seringa preumpluta cu/ fara ace.Ct. x 1; 10.
Ind. Vaccinarea primara ?i de rape! a sugarilor,impotriva difteriei,
tetanosului, tusei convulsive, hepatitei B, poliomielitei ?i a bolii
determinate de Haemophilus influenzae tip b.
669
J 07 XN ALTE VACINURI
BRONHO-VAXOM (Om Portuguesa SA, Portugaiia)
Liofilizat de Haemophilus influenzae, Diplococcus pneumoniae, /(/ebsie//a pneumoniae, Klebsie//a ozaenae, Neisseria
catharalis, Staphylococcus aureus , Streptococcus
pyogenes; Streptococcus viridans
Caps.7 mg (adul\i); 3,5 mg (copii). Ct. x 10; 30.
Pulb.pt.susp .orala. Plic 240 mg. Ct. x 10; 30.
Ind. Adjuvantin tratamentul i:;i profilaxia infec\iilor respiratoril,
ORL.
Admin.in faz.a acuta o capsulaJzi, n medie 10 zile. Preventiv i
pentru consohdarea tratamentului o capsula/zi, 10 zile pe luna,
limp de 3 luni. Copii aceea i schema folosind capsule pentru
copii.
RIBOMUNYL (Pierre Fabre Medicament, Fran\a)
Frac\iuni ribozomale 70% ARN standard de Klebsiel/a
pneumoniae, Streptococcus pneumoniae, Streptococcus
pyogenes , Haemophilus influenzae. Fracvuni membranare
de Klebsie//a pneumoniae.
Compr.500 mg. Ct. x 4; 12; 20.
Granule sol. orala 500 mg. Piic Ct. x 4; 12; 20
Ind. lnfec\ii cai respiratorli superioare 9i ORL (rinofaringlte,
laringite, sinuzite, otite). lnfec\ii intercurente, infec\ii recidivante
ale aparatulul respirator. Compiica\ii ale rino-traheo-bronielor.
Admin. Prima luna. Un plic dlminea\a, 4 zile/saptamana,limp de
3 saptamani. Ulterior, 4 zile/tuna, limp de 2-5 !uni.
M EMOM ED
670
2 014
L
L 01
L 02
L 03
L 04
ANTINEOPLAZICE
'I IMUNOMODULA TOARE
ANTINEOPLAZICE
TERAPIA ENDOCRINA
IMUNOSTIMULANTE
IMUNOSUPRESOARE
L 01
ANTINEOPLAZICE
L 01 A
AGENJI ALCHILANJI
L 01 B
ANTIMETABOLITI
L 01 C
L 01 D
ANTIBIOTICCITOTOXICE I
SUBSTANJE INRUDITE
L 01 X
ALJIAGENJI ANTINEOPWICI
*
L 01 A AGENJIALKILANJI
L 01 AA
L 01 AB
ALKIL SULFONAJI
L 01 AD NITROZOUREE
L 01 AX
* *
l 01 AA ANALOG! DE AZOT MUTAR
CYCLOPHOSPHAMIDUM @ @
M E M O M E D 2 014
672
M E M OM E D
14
/lfc111orntol' de fnn11aco/ogie
20
673
/lfemorator de farmacologic
25; 50. Pa -
@ @ > PR
IFOSFAMIDUM
tractului urinar pot fi mal severe i pot implica atat rinichii cat i
vezica.
CHLORAMBUCI LUM
> PR/PRF
1: 10. Pa -;
> PRIPRF
> PR
MEMOMED
674
2 014
M E M O M E D 2 0 14
M emomtor de fnr111acologlc
675
Compr.film. 2 mg.Ct.
25; 100. Pa -
varsaturi.
Cind. lnsuficien\a hepatica severa, icier, alaptare, supresie
severa a maduvei osoase !}i modificari severe ale
hemoleucogramei (scadere a valorilor leucocitelor !}i/sau
trombocitelor la <3000/I sau, respectiv , <75.000/il), Vaccinare
impotriva febrei galbene.
Admin. Monoterapie : 100 mg/m'suprafa\a corporalain zilele 1 i
2: la interval de 4 saptamani(leucemia limialica cronica); 120 mg/
m' suprafa\a corporala in zilele 1 $i 2; la interval de 3 saptamani
(non-Hodgk in latent); 120 - 150 mg/ m' suprafa\a corporala in
zilele 1 si 2,in asociere cu prednison i.v. sau per os 60 mg/m'
suprafaia corporala in zilele 1 pana la 4 ; la interval de 4
saptamani (mielom mulliplu)
L 01 AD
NITROSOUREE
&.@
LOMUSTINUM
PR Fein. Absorb\ie
orala rapida. Pie. seric la 1-4 ore. Difuziunein
t.c.r. Eliminare urinara.
Ind. Tumori cerebrate primitive !?i secundare. Neoplas m
pulmonar, gastric, pancreatic, de colon, mamar, ovarian, uterin.
Tumori osoase !?i ORL.
R.a. Toxicitate hepatica. Tulburari digestive (70%)
LCh @ @
PRIPRF
CECENU
><
20. Pa -
&.
FOTEMUSTINUM
Ind. Leucemia mieloida cronica. Policitemia vera. Trombocitopenie primara. Pre-transplantul de celule hematopoietice
progenitoare, mielofibroza.
PR
M E MOM E D
676
2 0 14
M E M O M E D 2 0 14
Jlfemarntar de fnrmncafagie
L 01 AX
TEMOZOLOMIDUM
@@
677
Jllemamtar de fnrmncafagf<
PRIPRF
TEMOZOLOMI DA
GLEN MARI<
(Glenmarl<
Caps. 5 mg; 20 mg; 100 mg; 140 mg; 180 mg; 250 mg.
Ct x flac. " ; 20. Pa -;-;578,35; 810,95; 1022,42; 1446,51.
Cind. Mielosupresie.
Caps. 5 mg; 20 mg; 100 mg; 140 mg; 180 mg; 250 mg.
Ct x flac. x 5. Pa -; 130,63; 552,91; -; -; 1728,03. Ct. x 5; 20
caps. ambalate individualin plicuri.Pa -
Caps. 5 mg; 20 mg; 100 mg; 140 mg; 180 mg; 250 mg.
Ct x flac . x 5. Pa -; 117,48; 467, 12; -; -; -. Ct. x ; 20 caps.
ambalate Individual n plicuri. Pa -; 117,48; 467,12; -; -; -.
Caps. 5 mg; 20 mg; 100 mg; 140 mg; 180 mg; 250 mg.
Ct x 1flac."; 20. Pa -;140,98; 560,54; -;-;1735,81. Ct. x 5;
20; caps. ambalate individualin plicuri.Pa TEMOZOLOMI DE HEXAL (Hexal AG, Germania)
Caps. 5 mg; 20 mg; 100 mg; 140 mg; 180 mg; 250 mg.
Ct x flac." 5; 20. Pa -. Ct. x 5; 20; caps.ambalate individual
in plicuri.Pa TEMOZOLOMI DE HOSPIRA (Hospira UK Limited, Marea
Britanie)
Caps. 5 mg; 20 mg; 100 mg; 140 mg; 180 mg; 250 mg.
Ct x flac. x 5; 20. Pa -
Caps. 5 mg; 20 mg; 100 mg; 140 mg; 180 mg; 250 mg. Fl.
x ; 20. Pa -; 280,38; 1186,87; -; -; 2806,17.
Caps. 5 mg; 20 mg; 100 mg; 140 mg; 180 mg; 250 mg.
Ct. x ; 20. Pa -; 173,24; 773,95; -; -; 2806,17.
MEM OM ED
678
2 0 14
M E M O M E D 2 0 14
Mcmnmtor d1f11r11111cologic
Lili @
DACARBAZINUM
> PR
10. Pa 905, 18
L 01 B ANTIMETABOLIJI
L 01 BA ANALOGI Al ACIDULUI FOLIC
L 01 BB ANALOGI Al BAZELOR PURINICE
L 01 BC ANALOG! Al BAZELOR PIRIMIDIN ICE
*
* *
Lili @ @
METHOTREXATUM
679
> PRJPRF
> PR
M E M OM E D
014
M E M O M E D 2 0 14
680
/llcmorntor de farmacologic
681
lllcmomto,. de fa1'111acolog fc
><
25. Pa -
CLADRIBINUM
., PR
Cind. Vaccinare.
><
1 flac. Pa -;
@@
., PRF
><
@@
., PR/PGL
Admin. Oral, pe stomacul gol 1-2,5 mg/kg/zi. (20-30 mg/m2 50-75 mg/m2).
@@
., PRF
FLUOARABINA ACTAVIS (Actavis SRL, Romania)
granulocitara cronica.
682
ME MOM E D
2 0 14
M EMOME D
Me111omtor de fnr111acologl e
Llli.
CLOFARABI NUM
683
2 0 14
Lili @ @
PR/PRF
1
: 3; 4 ; 10; 20. Pa
Lili @ @
PR
Lili
g; 40 g. Pa 116,36.
GEMCITABINUM
PR Ind. Leucemia
CYTARABINUM
@@
PR
Analog al Citarabinei.
Ind. Cancer de vezica urinara, cancer mamar, cancer ovarian,
cancer pulmonar altul decal eel cu celule mici, cancer de
pancreas.
_1
694
ME M O M E D 2 0 14
Jlfcmorator de farmacologi c
ME M O ME D 2 0
14
Mc111ort1tor tic farmacologlc
695
mg
(Pharma
Resources
GMBH,
Germani
a)
Pulb. pt. sol. pert. Flacon 200 mg; 1ODO mg. Pa GEMCITABI NA STRIDES ARCOLAB INTERNA TIONAL 39 mg/ml (Strides Arcolab International Limited,
Marea Britanie)
686
MEMOMED
M E M O M E D 2 0 14
2 0 14
687
M1:111omt or de farnwcologie
60;x 120. Pa -
Cone. pt. sol. perf. 40 mg/ml. Fl.5 ml;25 ml; 50 ml. Ct. x 1;
5; 10; x 1;x 1. Pa 54,34; 226,79; 439,01
@ CAPECITA BINA
GLENMAR f<
Pharmace uticals S.R.O., Republica Ceha)
( Glenmarl<
Compr. film. 150 mg; 500 mg. Ct. x 30; 60; 120. Pa -
CAPECITABINUM
@@
PR
><
60; x 120. Pa -
688
M E M O M E D 2 0 14
M E M O M E D 2 0 14
PRF
oECITABINUM
689
Ceha)
Compr. film. 150 mg; 500 mg. Ct. >< 10;30; 60; 120. Pa @XALVOBIN (Alvogen IPCO S.AR.l., Luxemburg)
Compr. film. 150 mg;500 mg. Ct. ><; 60; x 120. Pa
Compr. film. 150 mg;500 mg. Ct. >< 30;60; 120. Pa XELODA (Roche Registration ltd, Marea Britanie)
Compr. film.150 mg; 500 mg. Ct.
1649,33
AZACITIDINUM
@@
PR
Fein. Dupa inj. s.c. pie seric la 1/2 ora. Eliminare rapidain 42
minute, 50--85% prin urina.
proteinelor.
Ind. Sindrom mielodisplastic. (SMD) cu rise intermediar - 2 sau
ridicat, dupa indexul pronostic interna\ional. Leucemie cronica
mielomonocitara (MMC), cu 10-29% bla9ti medulari. Leucemie
acuta mieloblastica (LAM) cu 20-30% bla9ti.
R.a. Pneumonia, rinofaringita, septicemia, neutropenie febrila,
trombopenie, anemie, aplazie medulara, anorexie, confuzie,
anxietate, insomnie, ame\eli, cefalee, hemoragie intracraniana,
oculara.
Cind.Tumori hepatice avansate.
Admin. S.c.75 mg/mp/zi, penlru 7 zile,la liecare 28 zile.
VIDAZA (Celgene Europe Ltd, Marea Britanie)
Pulb.pt.susp.inj. 25 mg/ml. Flacon cu 100 mg. Pa -
TEGAFUR, COMBINATll
PRF
M E M O M E D 2 0 14
690
M E M O M E D 2 0 14
L 01 C
VINCRISTINUM
.&b,, @ @
I ALTE
L 01 CD TAXANI
ex
*
* *
VINORELBINUM
@@
PR /PR F
PR
L 01
691
@@
PR
n. Pa
M E MOM E D
692
M E M O M E D 2 014
2 0 14
.&_ @ @
VINFLUNINUM
693
PR IPRF
L 01 CD TAXANI
PR
pACLITAXELUM
L 01 CB DERIVAJI DE PODOFILOTOXINA
.&_ @ @
ETOPOSIDUM
PR
1.
Cone. pt. sol. perf. 6 mg/ml. Fl. 5 ml (30 mg); 16,7 ml (100
mg); 50 ml (300 mg). Ct x 10: x 4: x 1. Pa 1106,20; 1417,57;
1140,04
ETOPOSIDE
Romania)
Cone. pt. sol. perf. 6 mg/ml. Fl. 5 ml (30 mg); 16,7 ml (100
mg); 25 ml (150 mg); 50 ml (300 mg). Ct. x 1. Pa 140,30;
427,24; 647,79; 1237,86
MEMOMED
4
M E M O M E D 2 0 14
694
Mcmumtor de fnrmnculogic
201
695
Mcmomtor de fn rmncologlc
(Ebewe
Pharma
Cone. pt. sol. pert. 6 mg/ml. Flac. 5 ml (30 mg); 16,6 ml (100
mg); 25 ml (150 mg); 50 ml (300 mg). Ct. x 1. Pa 140,33;
427,27; 945,12; 1237,89
PACLITA X EL KAB I 6 mg/ml (Fresenius l< abi SRL,
Romania)
Cone. pt. sol. pert. 6 mg/ml. Flac.5 ml (30 mg);16,6 mt (100
mg); 25 ml (150 mg); 50 ml(300 mg); 100 ml (600 mg) Ct. "
1; 5. Pa 129,59; 587,42. Pa 407,51; 1754,09. Pa 527,02;
2351,69. Pa 1139,99; 5416,56. Pa @ PACLITAXEL SCHLUTIIG 6 mg/ml (Pharma Resources
Dr. Schluttig Gmbh , Germania)
Cone. pt. sol. pert. 6 mg/ml. Flac.5 ml (30 mg); 16,6 ml (100
mg);25 ml (150 mg); 50 ml (300 mg); Ct. " 1. Pa -
@@
Cone. pt. sol. pert. 10 mg/ml. Fl. 2 ml;B ml; 13 ml;20 ml Ct.
x 1; 5. Pa -
PR
a -.
MEMOMED
696
M E MOMED 2
014
2 0 14
Me111omtor de fa rmacologlc
697
@@
PR
><
1. Pa
L 01 D ANTIBIOTICE CITOTOXICE I
SUBSTANJE iNRUDITE
L 01 DA ACTINOMICINE
L 01 OB ANTRACICLINE I SUBSTANJE iNRUOITE
L 01 DC ALTE ANTIBIOTICE CITOTOXICE
L 01 DA ACTINOMICINE
JEVTANA (Sanoti-Aventis, Fran\a)
Cone. pt. sol. perf.60 mg. Fl. 1,5 ml. Ct. x1. Pa 17873,65
L 01
ex
TRABECTEDI NUM
PR
@@
DACTINOMICINUM
PR
Llli @ @
PR
698
M E M O M E D 2 014
M EM O M E D 2014
Memomtor titJt1r111ncologie
699
_& @ @
PR
Admin . Perfuzie i.v. Doua medie 1-2 mg/kg/zi sau la 2 zile, timp
de 2-8 zile.Doza totala nu va depai25 mg/kg.
PR /PRF
MEM OMED
700
2 0 14
M E M O M E D 2 014
Mcmorator defan1mcofogi c
Mcmorator de farmacologlc
701
Ind. Cancer de san, leucemie acuta mieloida, limfoame nehodgkiniene, carcinom hepatic primitiv.
Admin. 1.v. lent, eel pu\in 5 minute. Cancer de san: 12-14 mg/m2,
a data la 21-28 zile. Leucemie acuta: 10-12 mg/m2/zi,
5 zile.
BLEOMYCINUM SULFAS
PR
@@
PR /PRF
L 01 X
ALJIAGENJIANTINEOPLAZI CI
L 01 XA COMPU I Al PLATINEI
L 01 XB ALTE ANTINEOPLAZICE
L 01 xc ANTICORPI MONOCLONALI
MITOXANTRONUM
@@
PR
xx
702
MEMOMED
2 0 14
M E M O M E D 2 0 14
703
M1!111omtor de far111acolog ie
Mc111orat o1 de fm 11wcologil
* *
L 01 XA COMPU IAl PLATINEI
@@
CfSPLATINUM
PR
Admln. 360-400 mg/mp/4 saptamani ,in perfuzie lenta, de 1560 minute. Doza se reduce in insuficienta renala, rise de
mielosupresie, asociere cu alte anlineoplazice.
CARBOPLATIN EBEWE (Ebewe Pharma Ges.M.B.H. NFG
KG, Austria)
Cone.pt.sol. pert. 10 mg/ml. Fl. 5 ml;15 ml; 45 ml. Pa 29,55;
79,05; 217,39
CARBOPLATIN ACTAVIS 10 mg/ml (Actavis SRL,
Romania)
Cone. pt. sol. pert. 10 mg/ml. Flac. 5 ml;15 ml;45 ml; 60 ml.
Pa 24,39; 63,22; 162,41;-
OXALIPLATI NUM
L&.
PR
@@
PR
704
MEMOMED
2 014
Mcmomtor de fan11ncologie
MEMOM ED
014
705
Pulb.pt.sol.perf. 5 mg/ml. Fl. 50 mg; 100 mg. Pa REZIDOL (Egis Pharmaceutical s PLC, Ungaria)
OXALIPLATIN EBEWE (Ebewe Pharma GES.M.B.H.
NFG. KG, Austria)
Pulb.pt.sol.perf. 5 mg/ml. Flac. 50 mg; 100 mg; 150 mg Pa
536,60; 988,16; 1792,01
Cone. pt. sol. perf. 5 mg/ml. Fl. 10 ml;20 ml; 30 ml; 40 ml. Pa
322,48; 608,56; -; 1560,32
OXALIPLATIN KABI (Fresenius Kabi Oncology Pie., Marea
Britanie)
Pulb. pt. sol. perf. 5 mg/ml. Fl. 50 mg; 100 mg. Pa 202,35;
399,38
Cone. pt. sol. perf. 5 mg/ml. Fl. 10 ml; 20 ml; 40 ml.Ct. x 1.
Pa 202,35; 399,38; 727,88
@OXALIPLATIN MEDICO UNO (Medico Uno, Ungaria)
L 01 XB ALTE ANTINEOPLAZICE
PROCARBAZINUM
PRF
Cone. pt sol. perf. 5 mg/ml. Fl. 50 mg; 100 mg; 200 mg. Pa
M E M O M E D 2 0 14
706
M E M O M E D 2 0 14
L 01 XC ANTICORPI MONOCLONALI
RITUXIMABUM
@@
PR
707
@@
PR
@@
PR
708
MEMOMED
014
M E M O M E D 2 0 14
709
@@
ALEMTUZUMABUM
PR
@@
PANITUMUMABUM
PR
PR
PR
MEMOMED
710
2 0 14
M E M O M E D 2 0 14
OFATUMUMABUM
Admln. l.v.
PR
711
PR
tJ [lJ
( r1 . n
4-11
ly r)l;Ef?rta
gradinalt la pac1en{ii-cu esofag<E.aaett.
min
afrfp1
.'\
11re-
'=">;) 11,,
&
@@
PR
PR
M E M O M E D 2 0 14
M E M O M E D 2 0 14
712
713
Caps. 50 mg; 100 mg.Ct. x 30;90. Ct. x 24, 48, 60, 96, .12Q,
180.Pa - .Pa 5782,45
Compr.film. 100 mg; 400 mg. Ct. x 10; 20; 30; 60; 90; 120;
180; x 10; 30; 60; 90. Pa -.
Sol. inj. 1 mg/ml;4 mg/ml. Fl. x 1 ml, 3 ml, 6 ml; x 3,5 ml;
5 ml. Pa -. Pa -; 26746,19.
Compr.film. 100 mg; 400 mg. Ct. " 20, 30, 60, 90, 100; 120.
180. Ct. x 10;20; 30; 60;90. Pa -.
@@
PR
@ IMATINIB GLENMAR K
(Glenmark Pharmaceuticals
IMATINIB RICHTER
Romania)
Compr.film. 100 mg; 400 mg. Ct.
180.Pa -.
Compr.film. 100 mg; 400 mg. Ct. x 20, 30, 60, 90; 100, 120,
180. Ct. x 10, 20, 30, 60, 90. Pa -.Pa -.
90; 100.Pa - .
Compr.film. 100 mg; 400 mg. Ct. x 30, 60, 90; 12Q. Ct. x 30,
60, 90. Pa 5782,62. Pa -.
Pa -.
NEOXELL (Romastru Trading SRL, Romania)
IMAKREBIN (Alvogen lpco S.AR.L., Luxemburg)
Compr.film. 100 mg; 400 mg. Ct. x 10, 20, 30, 60, 90, 120,
180.Pa 5782,62; - .
Compr.film. 100 mg; 400 mg. Ct. x 10, 20, 30, 60, 90, .12Q,
180. Ct. x 10, 20, .fill, 60, 90, 120, 180. Pa 5782,62. Pa
5782,62.
MEMOMED
714
M E M O M E D 2 0 14
2 0 14
715
Caps. 100 mg;400 mg. Ct. x 30, 60, 90, 100.129.. 180.Ct. x
10, 30, 60, 90, 100. Pa 5782,62. Pa -
SUNITINIBUM
Compr.lilm. 100 mg; 400 mg. Cl. x 20, 60, 120, 180. Ct. x
10, 30,90. Pa -. Pa -.
GEFITINIBUM
PRF!PR
Fein. Abso rb\ie orala moderat lenta. Pie seric la 3-7 ore , 5
metaboli\i mai pu\in activi. Excre\ie mai alesin fecale, pu\in in
urina (4%). T 1/2 terminal 41 ore.
Fdin. Factorul de cretere epidermica (EGF} i receptorii sai
(EGFR [HER 1; Erb 81}] sunt importan\iin cre tere.celular
proliferarea celulelor normale i canceroase. Gef1tm1b 1nh1ba
selectiv tirozin kinaza receptorului factorului de cretere
epidemrica.
Ind. Cancer bron ic nu cu celule mici (CBNPC) local avansat sau
metastatic cu muta\ii aclivatoare ale EGFR-TK.
PRFIPR
30. Pa 2121,51;
@@
PRF/PR
cretere epidermal.
Ind. Cancer pulmonar, alte tipuri decal cele micl, dupa eecul
terapeutic al altar chimioterapice .
SORAFENI BUM
PRFIPR
M E M OM E D
716
M E M O M E D 2 0 14
Mcmomtor tic fnrma cof ogle
2 0 14
..&_ @ @ >
717
@ @ > PR
LAPATINIBUM
@ @ > PR
NILOTINIBUM
PRFIPR
Pa 3105,32;
MEMOM ED
718
2 0 14
M EM OME D
@@
TEMSIROLIMUS
2 0 14
._ PRF
VEMURAFENI BUM
>
EVEROLIMUS
PRFIPR
PAZOPANIBUM
> PR
Fein. Absorb\i a
719
> PR
720
M E M O M E D 20 14
M E MOM E D
PR
60. Pa 9436,29 ;
721
2 0 14
RUXOLITINIBUM
Fein. Se absoarbe rapid dupa administrare orala, cu concentra\ia
plasmatica maxima (Cmax) atinsain aproximativ 1 era de la
administrare. Se leaga de proteinele plasmatice in procent mare
97%. Este metabolizat,in principal, de CYP3A4, !?i CYP2C9. Se
elimina 74% prin urina, iar 22% prin fecale.
Fdin. Inhibitor selectiv al JAK kinazelor (JAK), JAK 1 9i JAK2.
Acestea mediaza semnalizarea unui numar de citokine i factori
de cre9tere care sunt importan\i in hematopoieza ;;i func\ia
sistemului imun. lnhiba semnalizarea JAK-STAT ;;I proliferarea
celularain cazul modelelor celulare dependente de citokine ale
PRJPRF
722
M E M O M E D 2 0 14
M E MOM E D
!llemomtor de fa rmacologlc
320,36; 381,39
@@
HYDROXYCARBAMIDUM
PRFIPR
723
2 0 14
eel pu\in 10 mg/kg, cu 1-2 oreinainte sau 2-3 ore dupa mese, cu
un pahar de apa. Nu se asociaza cu lapte, lactate , calciu,
rnagneziu, aluminiu. Daca dupa 4-6 saptamani nu se constata
nici un efect favorabil, se oprete tratamentu l. lnj. lni\ial 5 mg/kg/
zi (300-450 mg), 3 saptamani, apoi ntre\inere cu 300 mg x 2/
saptamana. lnj. i.v. lent,intr-o vena periferica sau cu un cateter,
intr-o vena centrala. Alternativ, diluarein 250 ml glucoza 5% i
perfuzie l.v.eel mull 3 ore.
ESTRACYT (Pfizer Europe MA EEIG,Marea Britanie)
3 zile.
100. Pa -
TRETINOINUM
ESTRAMUSTINUM
100. Pa 83,10
PRF
PRF
100. Pa 790,33
TOPOTECANUM
PRF/ PR
R.a. Neutropenie, leucopenie, trombocitopenie, tulburari gastrointestinale, hepatobiliare , respiratorii, alopecie, parestezii.
1; 5. Pa -.
Pulb. pt. cone. pt. sol. perf. 1 mg/ml. Fl. x 1 mg;4 mg. Pa -;
745,67
724
MEMOMED
14
20
MEMOMED
14
lllcmorntor de farmacofogic
20
725
/nd. Tratamentul de linia a II-a al cancerului colorec tal cu melastaze. care nu a raspuns la 5-FU.
Admin. Doza uzuala este 350 mg/mp, perfuzat n 30 de minute,
la intervale de 21 de zile.
CAMPTO (Pfizer Europe MA EEIG, Marea Brilanie)
Cone.pt.sol. perf. 20 mg/ml. Fl. 5 ml; 15 ml. Pa 735,09;
2359, 12
Cone.pt .sol. perf. 1 mg; 4 mg. Fl. Ct. x 1.Pa TOPOTECAN ATB (Anlibiotice S.A., Romania)
Pulb. pt. cone. pt. sol. perf.1mg; 4 mg. Fl. x 5 ml (1 mg);10
ml (4 mg). Ct. x 1. Pa 207,85; 275,66
@TOPOTECAN CIPLA (Cipla (Uk) Ltd., Marea Britanie)
Pulb. pt. sol. perf.1mg;4 mg. Fl. x 5 ml (1mg); 10 ml (4 mg).
Ct. x 1; 5. Pa TOPOTECAN EBEWE (Ebewe Pharma Ges.M.B.H. Nfg.
Kg, Austria)
Cone. pt. sol. perf. 1 mg/ ml. Fl. x 1;3; 1. Ct. x1
; 5; 10. Pa
745,67
@TOPOTECAN HF (Stacia Hemofarm Sri, Romania)
Pulb. pt. sol. perf.1 mg/ ml. Fl. x 5 ml (1 mg); 1O ml (4 mg).
Ct. x 1; 5;10. Pa TOPOTECAN KASI (Fresenius Kabi Oncology Pie, Marea
Britanie)
Pulb. pt. cone. pt. sol. perf. 4 mg.Fl. x 6 ml (4 mg). Ct. x 1; 5.
Pa 743,64; 3434,83
Cone. pl. sol. perf. 20 mg/ml. Fl. 2 ml(40 mg); 5 ml (100 mg);
25 ml (500 mg). Ct. x 1. Pa 186,15; 446,51; 1949,12
RINOTECANUM
s
Fdin. Inhibitor al ADN-topo-isomerazei; carboxilesteraza
genereaza un metabolit, SN-38, cu ac\iune inhibitoare mai mare
decal a produsului parental.
M E M O M E D 2 0 14
726
M E M O M E D 2 014
Mcmomtor de fal'l11acologlc
727
Memomtor de farmacologie
Cone. pt. sol. perf. 20 mg/ml. Fl. 2 ml (40 mg); 5 ml (100 rng).
Ct. x 1. Pa -.
@ IRINOTECAN
Germania)
Cone. pt. sol. perf. 20 mg/ml. Fl. 2 ml (40 mg); 5 ml (100 mg).
Ct. x 1. Pa -; 1g9,59
@ @ > PRF/PR
BEXAROTENUM
@@
ALITRETINOINUM
> PRFIPR
Fein. Dupa inj. i.v. pie seric la finele perfuziei. Admin. zilnic,
echilibruin 8-10 zile. Eliminare 80%in 8 zile.
Ind. Leucemie promielocitara acuta.
Admin. De catre medici speciali ti
TRISENOX (Cephalon Europe, Marea Britanie)
BORTEZOMlBUM
60 g. Pa -
@@
@ @ > PRF/ PR
ARSENICUM TRIOXIDUM
> PRF/PR
10 Pa > PR
Fein. Dupa inj. i.v. are o faza de distribu\ie rapida cu T 1/2 10 min
i o faza de eliminare terminala cu T 1/2 de 5-15 ore.
Fdin. lnhiba activitatea chemotripsin-like a proteozomilor 268 , un
complex proteic care degradeaza proteine ubiquitare. Efectul
final este moartea celulei canceroase.
M E M OM E D
728
2 0 14
M E M O M E D 2 014
llfc111omtor de farmacologie
5 ml; x 10 ml. Pa -;
@@
ANAGRELIDUM
729
PRFIPR
VISMODEGIB
PR
AFLIBERCEPTUM
ERIBULINUM
100. Pa -.
@@
PR
PR
M E M O M E D 2 0 14
M E M O M E D 2 0 14
730
L 02
TERAPIA ENDOCRINA
L 02 A
HORMONI$1SUBSTANJE NRUDITE
L 02 B
ANTAGONl$TI HORMONALI $1
SUBSTANJE NRUDITE
L 02 A
HORMONI$1SUBSTANJE NRUDITE
L 02 AB
PROGESTOGENI
@@
PRIPRF
Fein. A bsorb\ie orala. Pie seric la 2-3 ore. T 1/2 15-20 ore.
Eliminare urinara 60-80% !;iin fecale, maximum 30%.
Fdin. Ac\ iune antineoplazica in cancerul mamar prin eiect
antiestrogenic i un mecanism citotoxic direct.
Ind. Tratament paliativ al carcinomului mamar. Nuinlocuie!;lte
tratamentul chirurgical, radio- sau chimioterapic, cand acestea
sunt indicate. Anorexie. caexie asociate cu SIDA.
R.a. Cretere in greutate, tromboflebite. embolii. gre\uri, vome,
edeme, metroragii, mastodinie, ginecomastie, dispnee, hiperglicemie, alopecie, hipertensiune, rash.
Cind. Antecedente tromboembolice.
Admin . Oral, 160 mg/zi, intr-o priza. Eficacitatea nu poate fi
apreciatainainte de 2 luni de tratament.in caexie BOO mg/zi
prima luna,apoi 400-BOO mg/zi eel pu\in 3 luni.
MEDROXYPROGESTERONUM
; 100. Pa 123.59
PRIPRF
Vezi G 03 D.
L 02 AE
PR
Lief. (microsfere) pt. susp. inj. cu elib. prel. 3.75 mg; 11,25
mg. Flac + fiola solv. Pa 429,71; 994,94.
*
* *
MEGESTROLUM
731
Mcmomtor de fnrmncologic
/lfc111omt or de Jar11u1cologic
Gonadotrophin-releasing hormone (GRH), sintetizatin hipotalamus, stimuleaza sinteza i eliberarea gonadotrofinel or FSH i
PR IPRF
M E MOME D
014
732
M E M O M E D 2 0 14
733
Memomtor de f mwncologlc
L 02 B
ANTAGON1$TI HORMONALI $1
SUBSTANJE NRUDITE
L 02 BA ANTIESTROGENI
L 02 BB ANTIANDROGENI
L 02 BG INHIBITOR! ENZIMATICI
L 02 BX ALJI ANTAGONl TI HORMONAL! ISUBSTANJE
iNRUDITE
*
*
TRIPTORELINUM
@@
> PR IPRF
L 02 BA ANTIESTROGENI
@@
TAMOXIFENUM
> PRIP6L
7. Pa
134.62
TOREMIFENUM
Pulb.+ solv. pt. susp. inj. cu elib. prel. 3,75 mg; 11,25 mg.
Flac + fiola solv.Ct x 1. Pa 440.58. Pa 1184.81.
Fein.U or absorbit oral. Pie. seric la 2-5 ore.T 1/2 2-10 ziie.
630,48
> PR
M E M O M E D 2 0 14
734
M E M O M E D 2 014
/lfcmorntor de f<1r111<1cologte
735
Jlle111orntor de for111<1cologie
BJCALUTAMIDUM
Admin. 60 mg/zi.
P6U PR IPRF
PR
FULVESTRANTUM
Fdin. Antiestrogen.
L 02 BB ANTIANDROGENI
FLUTAMIDUM
PR IPRF
Fdin. Diminua transformarea testostero nuluiin dihidrotestosteron. La nivelul prostatei impiedica legare a dihidrotestosteronului de receptorii androgeni.
Ind. Carcinom prostatic inoperabil, metastazat sau invaziv l?i la
pacienti castrati chirurgical.
100. Pa 139.14
736
M E M O M E D 2 0 14
M E M O M E D 2 0 14
737
Compr.film 50 mg; 150 mg.Ct. >< H.. 28, 30, 50, 56, 60, 90;
100; >< 2; 30; 50; 70; 90; 98; 100. Pa 90,28; 171,22. Pa
425,99.
ANASTROZOLUM
P6U PR IPRF
Compr.film.50 mg. Ct. >< 2, 30, 50, 56, 60, 86, 90, 100. Pa
205.82.
BICALUTAMID SANDOZ (Sandoz SRL, Romania)
Compr.film. 50 mg, 150 mg. Ct. >< 20, 28, 30, 56, 60, 84 , 90,
98, 100 >< 5, 7, 10, 14, 20, 28, 40, 30, 50, 56, 60, 80, 90, 98,
100, 140, 200, 280. Pa 182,63. Pa 491,46.
BICATLON (Medico Uno Pharma Kft, Ungaria)
Compr.film . 50 mg. Ct. x 10, 14, 2, 30, 50, 60, 90, 100. Pa
227.4
Compr.film. 1 mg. Ct. >< 2., 30, 50, 90, 98, 100. Pa 113,29.
Compr.film. 1 mg. Ct. >< 10, 14, 20, 28, 50, 56 60, 84, 90, 98,
100, 120, 300, 500. Pa -
468.06.
L 02 BG INHIBITORI ENZIMATICI
AMINOGLUTETHIMIDUM
PR IPRF
Compr.film. 1 mg. Ct. >< 10, 20, 28, 30, 50, 56, 84, 90, 98,
100. Pa 119,66.
738
ME MO ME D 2 0 14
Memoralor de f nrmnco/ oglc
ME M O ME D 2 014
Mcmorntor de fa rmncologic
739
Compr. film. 1 mg. Ct. x 10, 14, 20, 28, .J.Q, 50, 56, 60, 84,
90, 98, 100,300, 500. Pa 115,64.
KYARESTA (Romastru,Romania)
Compr. film 1 mg. Ct. x 2.a; 30. Pa 120,36.
Compr. film 1 mg.Cl. x 1, 10, 14, 20, 28, 30, 30, 50, 56, 60,
84, 90,98, 100,300. Pa 131,3; 138,17.
Compr.film. 1 mg. Ct. x 20, :ill. 30, 50, 84, 98, 100, 300.Pa
120,37
LETROZOLUM
PR /PRF
Compr. film . 1 mg. Ct. x 10, 14, 20, 28, 30, 50, 56, 60, 84,
90, 98, 100,300, 500. Pa 138,16; 407,26
Compr.film. 2,5 mg.Ct. x 10, 28, 30, 50, 60, 84, 90, 98, 100.
Pa 240.
FA LVAX (Dr. Reddy's, Romania)
Compr.film. 2,5 mg.Ct. x 10, 14, 28, 30, 100, 120. Pa -.
740
M E M O M E D 2 0 14
M E M O M E D 2 0 14
Memorntor de fnn11acologle
741
Compr. film.2,5 mg. Ct. x 10, 14,28, 30, 50, 60,90, 100.Pa
91,71; 123,96; 243,5.
Compr. film. 2,5 mg. Ct. x 10,28,30, 50, 60, 84,90, 98. 100.
Pa-.
Compr. film. 2,5 mg. Ct. x 7, 10, 14, 20, 28, 30, 56, 60, 84,
90, 98, 100, 112, 120, 180, 200, 500. Pa -.
Compr. film. 2,5 mg. Ct. x 10, 28,JQ, 50, 60, 84, 90, 98, 100.
Pa 82.42.
@TROZEL (Glenmark, Cehia)
Compr.film. 2,5 mg. Ct.
><
><
><
EXEMESTANUM
PRF
742
MEMOMED
2 0 14
M E M O M E D 2 0 14
Memomt or defnn11ncolo g le
743
Compr. film 25 mg.Ct. x 10, 14, 20, 30, 60, 90, 100. Pa -.
28,
.90. Pa 224,23
30, 100. Pa -.
.90. Pa 102,61.
M E M O M E D 2 0 14
744
ME MOMED
Mcmomlor de fnrmncologic
745
2 0 14
I SUBSTANTE
DEGARELIXUM
Fein. Biodisponibilitate 30-40% . Legare de proteinele serice
90%. Excretiein urina (20-30%) !?i ecale (70-80%). T 1/2 23-6 1
zile.
Fdin. Este un peptid sintetic analog decapeptidului natural GnRH
hormon secretat de neuronii din hipotalamus. Se leaga de recep'.
torii hormonului gonadotropin-releaxing (GnRH) in glanda pituitara, blocand lnterac\iunea lor cu GnRH. Se reduc LH !_;i FSH si
supresiunea testosteronului de catre testicul. Reduce
dimensiunea i cre!?terea cancerului prostatei.
L 03
IMUNOSTIMULANTE
L 03 A
PR IPRF
FILGRASTIMUM
Sin. rHuG-CSF.
Pulb. + solv. pt. sol. inj. 80 mg; 120 mg. Flac + nae solv. inj
Ct. x 2 seturi. Pa 634,55.Pa 1097,04
FIRMAGON 120 mg
Oanemarca)
ABIRATERONUM
Fein. Se administreaza oral sub forma de abiraterona acetat care
este rapid convertita in vivoin abiraterona. Biodisponibilitate
orala scazuta in prezen\a alimentelor. Legarea de proteinele
plasmatice 99,8%. Se elimina majoritar digestiv (88%) si
aproximativ 5% in urina.
'
Fdin. Inhibitor selectlv al enzimei 17a-hidroxilaza necesara
pentru biosinteza hormonilor androgeniin \esuturile tumorale din
testicule, suprarenale !_;i prostata. CYP17 catalizeaza conversia
pregnenolonei !?i progesteronului la precursor ii testosteronului ,
dehidroepiandrosterona !?i androstenediona.
Ind. n asociere cu prednison sau prednisolonin tratamentul
neoplasmului de prostata metastatic.
MEMOMED
746
M E M O M E D 2 01 4
2 0 14
fdin. lmunomodulator.
PEGFILGRASTIMUM
@@
747
Mcmomtor defnrmncologlc
PRFI PR
&_ @ @
PRF
Sol inj. 3 M u.i./ 0,5 ml;4,5 M u.I./ 0,5 ml;6 M u.i.I 0,5 ml;9
M u.I./ 0,5 ml;Seringa preumpluta 0,5 ml. Ct. " 1. Pa 87,43.
Pa -. Pa -. Pa 183,22.
INTERFERONUM ALFA 2b
NEULASTA (Amgen Europe BV, Olanda)
&.@ @
PR
L 03 AB INTERFERON!
Fein. Cone. serice medii dupa in]. s.c. i i.m. sunt comparabile.
Pie seric la 3-12 ore pt. doze mici i6-8 ore. T1/2 respectiv de 23 ore i6-7 ore. Dupa inj. i.v. piela finale perfuziei idispari\ja din
ser la 4 ore dupa perfuzie.
Fein.Dupa perfuzie i.v.T112 4-8 ore.Dupa s.c. sau i.m. pie seric
la 4 ore. Eliminare renala.
748
MEMOMED
2 014
M E M O M E D 2 0 14
749
Me111orator de Jar111acofogle
Me111orator de farmacologlc
@@
INTERFERONUM BETA 1b
@@
PRF
750
MEMOM ED
Z 0 14
MEMOMED
/llemorntor de farmacologie
PEGINTERFERON ALFA-2a
Pulb. + solv.pt.sol.i nj. 250 g/ml. Flacon cu pulbere +
seringa preumpluta cu solvent Ct " 5; 1; 45. Pa 3859,85
@@
751
PEGINTERFERON ALFA-2b
2 0 14
PR IPRF
.. se
Fein. Cone. plasmatice maxime la 15-44 ore de I inj:s:c.
men\in 48-72 ore. T1/2 30,7 ore. Excre\ie renala (30 Vo), intarzrata
in Insur. renala.
Fdln. Peginterferon este un conjugal cvalet de Interferon alfa2b recombinant cu monometoxipolietrlenghcol. 1_'.llerferonu!se
leaga de membrana celulara 9i ini\iaza o e n\a coplexa de
evenimente intracelulare ca inhibarea rephcaru v1ral r n elulele
infectate de virus, supresia proliferarii celulare, ac\rune rmunomodulatoare.
Ind. Monoteraple, n caz de intoleran\a _sau cotraindica\ie I
ribavirina, pentru bolnavi adul\i cu hepatrta cro.nica c.confirmata
histologic, cu markeri serici pentru rephcarea v1rusul u1 C.
@@
PR!PRF
Fein. Oupa inj. s.c. este masurabilin plasma la 3-6 ore, atinge
cone. plasmatice maxime la 72-96 ore. Excre\ie renala.
Fdin. Interferon alfa-2a recombinat conjugal cu bis-(monometoxipolietilenglicol) cu masa moleculara 40.000. Ac\iune
antivirala 9i antiproliferativa caracteristica interferonului alfa-2a.
Ind. Hepatita cronica tip C confirmata histologic la pacien\i adul\i
cu valori crescute ale transamlnazelor icu ARN-VHC pozitlv iJa
pacien\i cu ciroza compensata. Se asociaza cu ribavirina,
exceptand paclen\ii cu lntoleran\a sau contraindica\ii pentru
ribavirina.
PR
Fdin. Stimularea sistemului imun.
752
MEMOMED
MEMOMED
14
2 014
Jllc111orator de farmacologie
20
753
1lfc111orator de fan11acofogic
TASONERMI NUM
@@
> PR
> PRF
Fdin. mbunata\ete efectele imunostimulatoare ale interleukinei2. Reduce riscul recaderii n AML mai ales la bolnavi,in prima
remisiune i avand varsta sub 60 ani.
Ind. Prevenirea recidivei la bolnavi diagnostica\i cu leucemie
mieloida acuta (AML). Asociata cu doze mici de imunostimulantul
interfeukin-2 in faza post-remisiune, cand bolnavul a completat
chemoterapia ini\iala.
CEPLENE (Epicept, Germania)
Sol. inj. 0,5 mg/0,5 ml. Flac. Ct. x 14. Pa -.
MIFAMURTIDUM
> PR
MEMOMED
754
2 0 14
M E M O M E D 2 0 14
11/l!morntor de fnrmncologle
> PR
755
VJSCUM ALBUM
> PR
> PR
@@
> OTC